Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),0.8561633153491913,2.3567149038724,0.0,0.0009889064634603104,0.001,8/22,2.58%,PTGDS;ALDH1A2;ADH7;ADH4;ABCA4;RBP1;CYP26B1;CRABP2
prerank,cadherin binding (GO:0045296),-0.47532768485768945,-2.2321662070512382,0.0,0.0010128703307146676,0.001,115/315,15.20%,PTPRM;DOCK9;SPTBN1;COBLL1;PTPRB;FMNL2;STXBP6;CDH11;ABI1;AHNAK;PDLIM5;MRTFB;BMPR2;DAB2IP;MYO1B;CALD1;ESYT2;BSG;ITGA6;VCL;TJP1;LRRFIP1;CLINT1;FXYD5;ACVR1;NOTCH3;PROM1;WASF2;YWHAE;MYH9;CDH13;IQGAP1;EGFR;CDH1;MACF1;PTPRJ;TMPO;TAGLN2;KDR;CAST;F11R;CTNNA1;YWHAB;EIF3E;PHLDB2;SERBP1;FLNA;CHMP2B;ITGB1;MB21D2;TJP2;PAK2;NUMB;PPFIBP1;RACK1;SNX1;EEF2;ANXA1;NCK1;CHMP4B;CLIC1;TRIM25;SPTAN1;EPN2;ALDOA;TRPC4;APC;SCYL1;SWAP70;KTN1;STK24;CNN2;RPL29;RPL7A;RPS26;LDHA;GAPVD1;SRC;TMOD3;VASN;PTPN1;RPL6;PPP1CA;EPS8L2;S100A11;PSMB6;CD2AP;YWHAZ;CTNNA3;FASN;PARVA;LRRC59;RPL24;PRDX6;CAPG;TES;LIMA1;FNBP1L;EHD4;ARHGAP1;PFN1;STK38;RPL34;SHTN1;IST1;TBC1D10A;GOLGA3;CIP2A;RAB11B;CDH2;RPL14;SNX2;CBL;VAPB;CEMIP2
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.8471482936706071,-2.0853462244767056,0.0,0.006077221984288005,0.008,6/12,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE2A
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8733659411581655,2.017365979311381,0.0,0.03906180530668226,0.064,3/10,0.48%,SLC6A13;SLC6A1;SLC6A12
prerank,amino acid:sodium symporter activity (GO:0005283),0.8205077878614332,1.9566336307032186,0.0,0.06823454597876143,0.167,4/11,3.98%,SLC6A13;SLC6A1;SLC6A12;SLC38A1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.5873088637551048,-1.9486150294773217,0.0,0.03578808501858492,0.09,11/34,12.45%,CYTH3;MYO10;MYO1B;ARAP2;PARD3;IQGAP1;ARAP3;ARAP1;ZFYVE16;JPH2;HIP1R
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.752163335975211,1.9368304553773583,0.0,0.07293185168019789,0.225,7/15,10.60%,ALDH1A2;ADH4;ALDH1L1;ALDH7A1;ALDH1A1;ALDH3B1;ALDH2
prerank,histone demethylase activity (GO:0032452),0.6546485631226839,1.9233593670605107,0.0,0.06764120210068524,0.262,10/27,11.87%,KDM7A;FBXL19;PHF8;JARID2;KDM5B;KDM6B;PHF2;KDM2A;KDM5C;KDM4A
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.706654392462957,-1.9226925436283762,0.0,0.04228733630733737,0.136,7/17,7.63%,ATP10A;ATP8B1;PITPNC1;ABCA1;PLTP;MTTP;ABCA3
prerank,cAMP binding (GO:0030552),-0.7648152642647146,-1.843906384899676,0.00199203187250996,0.09439951482260701,0.341,5/11,7.16%,PDE4D;RAPGEF2;PDE10A;PDE2A;RAPGEF4
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.7072267197628879,1.8102626523076553,0.008048289738430584,0.22662439787632116,0.692,11/15,16.66%,HS3ST3A1;HS3ST3B1;HS6ST1;HS6ST3;NDST1;NDST4;HS3ST6;HS3ST5;HS6ST2;NDST2;HS2ST1
prerank,retinoic acid binding (GO:0001972),0.7412996093940151,1.7774997171419142,0.010438413361169102,0.268134923949667,0.79,4/12,16.36%,CYP26B1;NR2F2;RXRA;RARA
prerank,vinculin binding (GO:0017166),-0.7247872191064463,-1.7700758330522133,0.009560229445506692,0.19227655111400108,0.619,4/11,6.74%,UTRN;CTNNA1;ACTN1;PXN
prerank,carbohydrate:cation symporter activity (GO:0005402),0.769612864561678,1.7618315346116613,0.00819672131147541,0.2712075976039901,0.836,4/11,2.73%,SLC5A3;SLC5A10;SLC23A2;SLC23A1
prerank,AMP binding (GO:0016208),0.7487772339838533,1.760534746386792,0.011320754716981131,0.24458953196251676,0.836,5/11,12.43%,PRKAG2;PRKAG3;ACSS2;MPPED2;PYGL
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.6142468478927634,-1.758448630245178,0.0021231422505307855,0.18738101118221348,0.671,8/21,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE10A;PDE9A;PDE2A
prerank,acid-thiol ligase activity (GO:0016878),0.7107500422694281,1.754136111277458,0.0038314176245210726,0.23407415990105546,0.855,5/13,9.63%,ACSL1;ACSM2A;ACSM2B;AASDH;ACSS2
prerank,sulfotransferase activity (GO:0008146),0.5703744417959893,1.7386180692120727,0.0070921985815602835,0.24947413055476014,0.89,6/33,4.36%,HS3ST3A1;UST;CHST4;CHST15;HS6ST1;CHST10
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.5073517822453815,-1.7327193530207137,0.00437636761487965,0.21688085956427822,0.771,15/42,13.17%,STXBP6;PDLIM5;BSG;ESAM;CD200;PALLD;NPTN;ANXA1;ROBO4;TMOD3;PPP1CA;S100A11;DSCAML1;JAM3;EMB
prerank,phospholipid transfer activity (GO:0120014),-0.583237313137491,-1.7240938029792596,0.004081632653061225,0.2096641584579362,0.804,16/21,28.24%,PITPNC1;CERT1;PLTP;PLEKHA8;TNFAIP8L3;MTTP;ABCA3;PRELID3B;PITPNB;GLTP;TRIAP1;C2CD2L;PRELID2;PLEKHA3;PITPNM1;CPTP
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5079847951117687,1.7193990919327735,0.0036231884057971015,0.2749159968419663,0.929,13/55,9.21%,SLC16A6;SLC6A13;SLC13A3;SLC6A12;SLC16A11;SLC38A3;SLC23A2;SLC23A1;SLC16A12;SLC38A1;PDPN;SLC19A1;SLC38A9
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.7126608009147537,1.7152692317660225,0.012170385395537525,0.26342946792023497,0.934,6/12,19.44%,KDM7A;PHF8;PHF2;KDM4A;KDM1A;KDM3B
prerank,ligand-gated ion channel activity (GO:0015276),0.5738493013970876,1.7059438445792434,0.007462686567164179,0.26488565985544027,0.945,8/30,8.71%,ANXA6;TRPV1;GRIN3A;GRID2;GRIN2D;GRIK5;GRIK2;CHRNB2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.5354725806247661,-1.6967417315886033,0.012244897959183673,0.2456210551983069,0.863,11/28,20.49%,DAB2IP;TRAF5;TRIM37;CASP8AP2;FEM1B;BABAM2;MADD;TMBIM1;RIPK1;MYD88;TRAF4
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6592284941102524,1.6948236963125687,0.01818181818181818,0.2733337465004298,0.958,2/15,0.80%,CCR9;ACKR2
prerank,actin binding (GO:0003779),-0.3876157650583398,-1.6935688972951075,0.0,0.23019780243515173,0.87,36/170,11.65%,UTRN;SYNE1;ACTN4;PDLIM5;MYRIP;CALD1;ABLIM1;VCL;MICAL2;NOS3;TMSB4X;FXYD5;GSN;PARVB;SMTN;MYH9;MACF1;MTSS1;SSH2;ITGB1;CAP2;EPS8;MSRB2;KLHL2;ALDOA;CEACAM1;TPM2;SYNPO2;CAP1;MYO19;EPS8L2;MYO1F;TMSB10;PARVA;LIMA1;LDB3
prerank,CARD domain binding (GO:0050700),-0.6427893431706708,-1.6875308877533077,0.012875536480686695,0.22316909620079842,0.883,9/14,23.21%,NOD1;CARD14;CARD16;NOD2;CARD19;CASP4;RIPK2;CASP1;BCL10
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5706728075003872,-1.6808363967862303,0.006276150627615063,0.2192474700485442,0.9,8/23,6.37%,PDE3A;PDE4D;PDE7B;PDE8A;PDE8B;PDE10A;PDE9A;PDE2A
prerank,alkali metal ion binding (GO:0031420),0.6832425526998805,1.6798252131942657,0.016981132075471698,0.29234547326045424,0.976,5/13,13.52%,ATP1A2;CAPN3;ACAT1;DRG1;HDAC4
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7215885119623311,1.661643797674245,0.02681992337164751,0.32191813934055047,0.988,1/10,0.04%,PRKAG2
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.415698035179432,-1.655565405788393,0.0,0.25792019492841356,0.947,23/100,10.77%,HIP1;CYTH3;MYO10;PLA2G4A;DAB2IP;MYO1B;ARAP2;PARD3;CERT1;IQGAP1;WIPI1;ARAP3;ANKFY1;SNX13;PLEKHA8;ARAP1;SH3PXD2B;OSBP;PLEKHA4;ZFYVE16;GOLPH3;PLEKHA5;JPH2
prerank,calcium:sodium antiporter activity (GO:0005432),0.7125117088864663,1.6529721065140013,0.029411764705882353,0.3274379179013027,0.991,2/10,0.73%,SLC8A3;SLC24A3
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6307299837043123,-1.650701098127504,0.010460251046025104,0.23549235189116025,0.954,4/16,3.95%,PTPRM;PTPRB;PTPRG;PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6307299837043123,-1.650701098127504,0.010460251046025104,0.23549235189116025,0.954,4/16,3.95%,PTPRM;PTPRB;PTPRG;PTPRK
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5753922984248814,1.6500235797995524,0.021568627450980392,0.31795945185679136,0.992,7/26,4.48%,SLC16A6;SLC6A13;SLC6A1;SLC6A12;SLC16A11;SLC16A12;MPC2
prerank,Tat protein binding (GO:0030957),-0.6971901375937456,-1.6402275239941562,0.012219959266802444,0.24499545881757137,0.966,3/10,4.30%,ACTB;MDFIC;DNAJA1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.7054037426408424,1.6219609647054551,0.03711340206185567,0.3737571978648243,0.997,4/10,11.87%,KDM7A;PHF8;KDM2A;KDM4A
prerank,cyclic nucleotide binding (GO:0030551),-0.5602990869874044,-1.6201776239143102,0.01616161616161616,0.27634478856331846,0.986,5/21,7.16%,PDE4D;RAPGEF2;PDE10A;PDE2A;RAPGEF4
prerank,CoA-ligase activity (GO:0016405),0.6466367431795484,1.6176291757509844,0.0300187617260788,0.3678732044072354,0.997,4/14,9.63%,ACSL1;ACSM2A;ACSM2B;ACSS2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.44172603980349623,-1.6152534224414274,0.01834862385321101,0.2721955741383733,0.988,20/60,15.76%,NRP1;ROR1;TEK;NTRK3;NRP2;TIE1;INSR;MERTK;EGFR;CRIM1;KDR;MET;FLT1;FLT4;EPHB2;RET;ROR2;FGFRL1;ALK;CSF1R
prerank,fatty acid synthase activity (GO:0004312),-0.6843062802499922,-1.6147056653363934,0.0189873417721519,0.2597505963117765,0.988,6/10,18.45%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;ELOVL4;MCAT
prerank,outward rectifier potassium channel activity (GO:0015271),0.6627087301698107,1.6071448521255098,0.044989775051124746,0.3820325469522354,0.998,4/11,7.16%,KCNK2;KCND3;KCNT1;KCND2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6091787661133506,1.6054123575695267,0.025691699604743084,0.36950704986860466,0.998,5/16,13.53%,IDO1;ETHE1;ADI1;HAAO;CDO1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6593272295129728,-1.5989999036862959,0.02263374485596708,0.2837001564411274,0.996,5/11,7.63%,ATP10A;ATP8B1;ATP8A1;ATP11C;ABCA3
prerank,lipase activity (GO:0016298),0.4978879105584423,1.5977364278737853,0.02264808362369338,0.3738066431879974,0.999,11/43,11.80%,CEL;LIPA;DDHD2;ABHD5;PLA1A;PNPLA8;SMPD3;SEC23IP;SMPD2;PLA2G15;ABHD3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.6655050869976217,1.5940242387153276,0.03822937625754527,0.36925767345607985,0.999,1/11,0.05%,PPP1R1A
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.631217143396393,-1.5938727100081151,0.03112033195020747,0.28369577172108096,0.997,3/12,2.68%,DAB2IP;VEGFC;ITGA5
prerank,SUMO binding (GO:0032183),-0.6340995166205903,-1.5931654499630186,0.02766798418972332,0.2730786487287675,0.998,5/13,9.03%,RNF111;HERC2;SERBP1;CASP8AP2;USPL1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.6515093354681771,1.586486703128072,0.03406813627254509,0.37407288723585197,0.999,5/13,10.60%,ALDH1A2;ALDH1L1;ALDH7A1;ALDH1A1;ALDH2
prerank,phospholipase C activity (GO:0004629),-0.5306373617982391,-1.580728089978032,0.022271714922048998,0.2890900735581447,0.999,6/25,4.43%,PLCB4;EDNRA;PLCE1;PLCL1;PLCG1;PLCG2
prerank,death receptor binding (GO:0005123),-0.5944110044821009,-1.5780225055133639,0.030800821355236138,0.28380626666624986,0.999,11/15,31.52%,DAB2IP;NGF;CASP8AP2;FEM1B;MADD;TMBIM1;RIPK1;MYD88;EDA;FADD;PIDD1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.5024526325573876,-1.5750294024628837,0.008602150537634409,0.2784224712929896,0.999,11/30,14.78%,GAS6;CAST;RPS6KA3;CARD16;CST3;XIAP;TNFAIP8;SERPINB9;BIRC3;PTTG1;MT3
prerank,semaphorin receptor binding (GO:0030215),-0.5348482872408092,-1.5700381439295796,0.026490066225165563,0.2789519918220099,0.999,13/23,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;SEMA4D;SEMA4F;SEMA6B
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.6382964095857853,-1.5670152764018492,0.01875,0.2753922081332416,1.0,5/11,21.79%,MAP3K5;EGFR;MAP3K20;MAP3K6;MAP3K4
prerank,store-operated calcium channel activity (GO:0015279),-0.6762387844265714,-1.5599682717528944,0.018218623481781375,0.27969191752976064,1.0,5/10,9.94%,STIM2;TRPC3;TRPC6;TRPC4;TRPC1
prerank,triglyceride lipase activity (GO:0004806),0.5770367757817386,1.5530939915329998,0.03932584269662921,0.45050183335414135,1.0,4/20,11.37%,CEL;DDHD2;ABHD5;PLA2G15
prerank,ion channel activity (GO:0005216),0.43550527019545526,1.55172022797741,0.008431703204047217,0.4379796090489753,1.0,13/80,8.71%,TRPM3;ANXA6;TRPM6;TRPV1;TMEM120B;GRIN3A;GRID2;GRIN2D;NALCN;GRIK5;GRIK2;UNC80;CHRNB2
prerank,ligand-gated channel activity (GO:0022834),0.52360622085065,1.544818758354446,0.02824858757062147,0.4426890934014396,1.0,7/29,8.71%,ANXA6;GRIN3A;GRID2;GRIN2D;GRIK5;GRIK2;CHRNB2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5486732372953737,1.527446154392651,0.048638132295719845,0.4785318376684442,1.0,7/20,12.86%,LPGAT1;AGPAT4;ABHD5;MOGAT1;PLA2G15;DGAT2;LCLAT1
prerank,BMP binding (GO:0036122),-0.6210823453162936,-1.5268105909807261,0.037109375,0.3487650172094172,1.0,3/11,2.04%,BMPR2;GREM2;ENG
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4159388759928284,-1.524788487049149,0.01366742596810934,0.3429709632745763,1.0,17/60,12.90%,ROR1;TEK;NTRK3;ACVR1;ACVRL1;TIE1;INSR;MERTK;EGFR;TGFBR2;KDR;MET;FLT1;FLT4;EPHB2;RET;ROR2
prerank,N-acetyltransferase activity (GO:0008080),0.572337882101619,1.5191614155208533,0.04423076923076923,0.48832839169840103,1.0,4/19,6.56%,GNPNAT1;SAT1;ATAT1;NAT2
prerank,voltage-gated potassium channel activity (GO:0005249),0.4205105471327529,1.5158996814885313,0.018484288354898338,0.48215370759086756,1.0,14/80,10.77%,KCNK2;KCND3;KCNA3;KCNT1;KCNJ13;LRRC38;KCNJ5;KCNJ10;KCNC3;KCND2;KCNH2;KCNC2;KCNJ16;KCNH7
prerank,C-C chemokine receptor activity (GO:0016493),0.5339847191068217,1.5144475136876288,0.04554079696394687,0.4719181511082718,1.0,2/21,0.80%,CCR9;ACKR2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.39137389846601556,-1.5133119581224088,0.009153318077803204,0.36096166410843966,1.0,23/72,16.63%,HIP1;STXBP6;MYO1B;MARK1;PARD3;SVIL;GSN;KCNJ2;SNX18;FCHO2;PLEKHA4;KCNQ1;AMER1;JPH2;EXOC1;CAPG;HIP1R;PFN1;VILL;AVIL;AMER2;SYTL2;LDLRAP1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.34640732864653223,-1.5122833173015693,0.00273224043715847,0.35306204285487336,1.0,56/173,21.36%,KLF12;FOXP1;ZBTB16;ZFHX3;ELK3;TRPS1;ZEB1;LRRFIP1;FOXP2;PLAGL1;PPARD;TBX3;FOXO3;CTCF;PRDM16;TBX18;ZNF25;DACH1;JUN;BHLHE40;CREB3L1;KLF8;HES1;ZNF3;JDP2;TGIF1;ZNF436;HEYL;NACC2;PRDM5;ZBTB1;HEY2;MAFK;ETV6;ETS2;SREBF2;HHEX;TBX2;NACC1;NFIL3;ZBTB5;SKIL;SP2;ZBTB33;ZFP57;BCL6B;HEY1;ZBTB37;NR2F1;PRDM1;ZNF177;NFATC3;ATF3;ZBTB25;ZBTB45;THAP1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5434811500232092,-1.5114711499896918,0.04781704781704782,0.34526962155832347,1.0,7/18,3.58%,LTBP4;BMPR2;LTBP1;ACVR1;ACVRL1;ENG;TGFBR2
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.5670850734640881,1.509108647830734,0.045368620037807186,0.47563492344018987,1.0,6/18,10.60%,ALDH1A2;ALDH8A1;ADH4;ALDH1A1;ALDH3B1;ALDH2
prerank,LRR domain binding (GO:0030275),0.6038016093530558,1.502394783671771,0.06563706563706563,0.48233206393517025,1.0,2/14,2.44%,ROBO1;PAWR
prerank,leak channel activity (GO:0022840),0.5598916846000209,1.500723195951102,0.07157057654075547,0.4745652239650089,1.0,3/18,5.43%,KCNK2;TMEM175;NALCN
prerank,chemorepellent activity (GO:0045499),-0.5007979691553301,-1.5003572992573544,0.04139433551198257,0.36341787466042275,1.0,14/25,29.14%,SEMA6A;SEMA3C;SEMA7A;SEMA5B;SEMA3E;SEMA3G;SEMA5A;SEMA6D;SEMA3F;SEMA4C;EPHA7;SEMA4D;SEMA4F;SEMA6B
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.6007855780690613,-1.4972325672061861,0.055900621118012424,0.3606662435953146,1.0,7/12,3.58%,LTBP4;BMPR2;LTBP1;ACVR1;ACVRL1;ENG;TGFBR2
prerank,MAP kinase activity (GO:0004707),0.602468691846101,1.4946035940210765,0.052734375,0.47991363399711706,1.0,5/14,12.42%,MAPK4;MAPK6;MAPK10;MAPK14;MAPK9
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.546471747726099,-1.494361780248528,0.036093418259023353,0.35828234833496136,1.0,6/18,9.92%,STXBP6;PDLIM5;ANXA1;TMOD3;PPP1CA;S100A11
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.5087282534609543,-1.4935991910162438,0.04139433551198257,0.3509329151102451,1.0,5/23,4.43%,PLCB4;EDNRA;PLCE1;PLCG1;PLCG2
prerank,cGMP binding (GO:0030553),-0.6220231654418065,-1.4921643899198358,0.05102040816326531,0.3454666958760643,1.0,3/11,6.37%,RAPGEF2;PDE10A;PDE2A
prerank,SH3 domain binding (GO:0017124),-0.4000878980195366,-1.4863249103342553,0.027972027972027972,0.3503771691524714,1.0,18/62,14.93%,AFAP1L1;ABI1;SHANK3;DAB2IP;CBLB;PTPN12;WASF2;AFAP1L2;PLSCR1;WIPF1;SGIP1;ABI3;GPX1;CD2AP;LANCL1;ADAM15;ARHGAP27;CBL
prerank,death domain binding (GO:0070513),-0.609381205574391,-1.4851176076319772,0.0736196319018405,0.34462295398706366,1.0,7/11,19.76%,BCL2L1;DAPL1;CRADD;RACK1;DAP;MCL1;RIPK1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5922680144838983,-1.4832800123137313,0.0498960498960499,0.3409514460867612,1.0,2/12,2.85%,PIEZO2;PIEZO1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.4428414223357097,-1.4814700515992325,0.03333333333333333,0.33761559186356577,1.0,23/42,28.81%,BCAR3;YWHAE;PIK3R1;SHE;YWHAB;PLCG2;VAV2;YES1;PFN1;FBXW7;IRS1;LDLRAP1;SH3BP2;PTPN6;HCK;NEDD4;SYK;RASA1;SHD;PTPN11;GRB2;PTPN3;SAMSN1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.5370410164358129,1.4809723016327678,0.0682261208576998,0.5087923754503296,1.0,4/21,8.71%,P2RX6;TRPV1;GRIK2;CHRNB2
prerank,voltage-gated cation channel activity (GO:0022843),0.3952649687060688,1.4803597597710452,0.01854974704890388,0.4974199511205361,1.0,15/97,9.39%,CACNA1D;CACNA2D3;KCND3;CACNG7;KCNA3;CACNB1;CACNB3;LRRC38;GRIN3A;CACNA2D2;GRIN2D;KCNC3;KCND2;KCNH2;KCNC2
prerank,actin monomer binding (GO:0003785),-0.5041408056177746,-1.4801359253671131,0.04535637149028078,0.33293508166195995,1.0,7/22,16.89%,NOS3;TMSB4X;MTSS1;TMSB10;LIMA1;PFN1;MYL4
prerank,phosphoric ester hydrolase activity (GO:0042578),0.44460606747642006,1.4739201693125192,0.03866432337434095,0.5050345308891805,1.0,11/49,15.10%,ATP1A2;DUSP11;PXYLP1;PRUNE1;ARMT1;MPPED2;ACP6;PPP1CB;PTPRO;DUSP28;EPHX2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3443184229457288,-1.4735112834785669,0.0028328611898017,0.3408196121706999,1.0,33/147,10.02%,DOCK9;CYTH3;PREX2;FARP1;FGD5;ARHGEF28;DOCK1;DOCK10;PLCE1;RAPGEF2;FGD6;RAP1A;BCR;SPATA13;RASGRF2;DENND6A;HERC2;MON1A;ARHGEF2;ARHGEF15;RAPGEF4;RAPGEF6;DOCK2;EIF2B2;GAPVD1;ABR;TIAM1;VAV2;EPS8L2;DENND2C;DOCK8;RABIF;DENND5B
prerank,C-C chemokine binding (GO:0019957),0.5132808973715998,1.4686698545507657,0.06870229007633588,0.5085632385868449,1.0,2/22,0.80%,CCR9;ACKR2
prerank,transforming growth factor beta binding (GO:0050431),-0.49971192948213095,-1.4590900148350268,0.05870020964360587,0.3677379868101231,1.0,10/23,9.46%,LTBP4;LTBP1;ACVR1;ACVRL1;ENG;THBS1;TGFBR2;CD109;VASN;TGFB3
prerank,high voltage-gated calcium channel activity (GO:0008331),0.6434878432278789,1.458254887567971,0.06666666666666667,0.527322598944217,1.0,3/10,1.76%,CACNA1D;CACNB1;CACNB3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5904412777510957,1.4552509489187535,0.07272727272727272,0.5239824386855747,1.0,5/12,9.99%,SLC25A42;SLC25A5;SLC19A1;SLC25A25;SLC25A23
prerank,GTPase activator activity (GO:0005096),-0.30871193980583833,-1.452230318116068,0.0,0.3761628004813728,1.0,67/313,10.07%,ARHGAP31;NRP1;DOCK9;CYTH3;ARHGAP10;PREX2;TBC1D4;CHN2;FARP1;RABGAP1L;FGD5;ARHGEF28;DOCK1;DOCK10;PLCE1;RAPGEF2;ARHGAP42;RGS3;FGD6;RGS5;SIPA1L2;RASGRP3;RAP1A;STARD8;TBC1D8;CHN1;IQGAP1;ASAP2;BCR;SPATA13;RASGRF2;ARAP3;DENND6A;STARD13;TBC1D12;HERC2;JUN;USP6NL;TBCD;TBC1D5;ARAP1;TBC1D2B;MON1A;ARHGEF2;SIPA1L3;ARHGEF15;ARHGAP32;TBC1D1;ARHGAP35;RAPGEF4;RAPGEF6;RGS6;DOCK2;EVI5L;EIF2B2;SEC23A;GAPVD1;ABR;TIAM1;VAV2;TBC1D13;EPS8L2;DENND2C;DOCK8;RABIF;DENND5B;RP2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6260124643549573,-1.4474187249722692,0.07214428857715431,0.37898231540907146,1.0,2/10,3.32%,MECOM;PRDM16
prerank,gated channel activity (GO:0022836),-0.550823981826963,-1.4473501732401757,0.06638115631691649,0.37141334902614587,1.0,2/14,2.85%,PIEZO2;PIEZO1
prerank,cell adhesion mediator activity (GO:0098631),-0.4795851741285427,-1.4444553236018034,0.03505154639175258,0.3711359465804685,1.0,9/24,13.17%,BSG;ESAM;PALLD;NPTN;ROBO4;DSCAML1;BCAM;JAM3;EMB
prerank,amyloid-beta binding (GO:0001540),-0.3704688510809531,-1.4441970491269944,0.036613272311212815,0.36449429763933905,1.0,22/79,18.83%,APBB2;COL25A1;FZD6;TGFB2;INSR;ITM2A;BCHE;CST3;IAPP;GRIN2B;APOE;EPHB2;CACNA1B;CD74;FZD4;GSAP;ITM2B;LRP1;APBB3;LDLRAP1;GRIN1;PFDN6
prerank,potassium channel activity (GO:0005267),0.38793422697893865,1.4407031338272305,0.02972027972027972,0.555945233639869,1.0,20/89,16.88%,KCNK2;KCND3;KCNA3;KCNT1;LRRC38;TMEM175;KCNC3;GRIK5;GRIK2;KCND2;KCNH2;KCNC2;KCNN4;KCNH7;KCNK4;KCNS3;TMEM38A;KCNA4;KCNQ3;KCNK10
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.47226469538561855,-1.4395769082512448,0.053418803418803416,0.36784723452974033,1.0,11/26,29.96%,CSGALNACT1;B3GNT2;CHSY3;B3GNT3;B3GALT5;B4GALNT3;B3GNT8;B3GALT1;CSGALNACT2;B3GNT6;B4GALNT1
prerank,syntaxin binding (GO:0019905),0.41325049598721103,1.4382379455079788,0.033628318584070796,0.551260414131153,1.0,18/61,12.83%,UNC13C;SYT12;SYT9;NAPB;SYT1;STX16;SNAP29;SNAP47;STXBP5L;NAPA;LRRK2;GOLGA2;SNAP25;NSF;SYT10;STXBP4;TMED9;CPLX1
prerank,potassium ion leak channel activity (GO:0022841),0.5569553352519059,1.4369714772492792,0.0951417004048583,0.5426301748739499,1.0,2/15,4.96%,KCNK2;TMEM175
prerank,sialyltransferase activity (GO:0008373),-0.4954374902457566,-1.4339531769178955,0.07291666666666667,0.37394025964328115,1.0,11/20,19.98%,ST3GAL4;ST6GALNAC3;ST8SIA4;ST3GAL6;ST3GAL1;ST6GALNAC5;ST8SIA6;ST8SIA2;ST6GALNAC2;ST3GAL2;ST6GAL2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.573684925310354,-1.4290650352099958,0.05508474576271186,0.37751928048692807,1.0,5/12,8.58%,APAF1;NOD1;RACK1;CASP8AP2;ATP2A3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3976620210969247,1.4280941037772013,0.04421768707482993,0.5570699473739399,1.0,12/73,10.90%,LGR4;GCGR;PTH2R;NPR3;BDKRB1;OPRD1;CRHR1;BDKRB2;NMUR1;LTB4R2;GPR37;GRPR
prerank,ADP binding (GO:0043531),0.5028220611212499,1.4278357549312575,0.07220216606498195,0.5461441966639452,1.0,7/25,10.19%,PRKAG2;MYO9B;PGK1;MYO3A;MSH6;ABCD1;MYO18A
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5536113951102433,-1.4272899277359854,0.08183632734530938,0.3743752900563359,1.0,5/13,10.62%,PIP5K1B;PIP4K2A;PIK3C2A;PIK3CA;PIK3CD
prerank,death receptor activity (GO:0005035),-0.5886216629227653,-1.4235307799931436,0.07824427480916031,0.3758834145162897,1.0,5/11,12.55%,TNFRSF1B;FAS;TNFRSF11A;EDA2R;TNFRSF19
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.5605514406433324,-1.4231992835181921,0.08032128514056225,0.3699109065699515,1.0,7/13,13.82%,IL1R1;ITGA5;PTPRJ;ERN1;PDGFC;PDGFD;VEGFA
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.4286039148316656,-1.4220552207684858,0.05543237250554324,0.36589067532989167,1.0,10/38,10.77%,HIP1;PLA2G4A;DAB2IP;PARD3;WIPI1;SNX13;SH3PXD2B;PLEKHA4;PLEKHA5;JPH2
prerank,voltage-gated calcium channel activity (GO:0005245),0.4501649584662323,1.41928219052573,0.06533575317604355,0.561053054779523,1.0,6/37,4.27%,CACNA1D;CACNA2D3;CACNG7;CACNB1;CACNB3;CACNA2D2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.505252374842665,-1.4175635453987065,0.07613168724279835,0.3701783549355996,1.0,6/19,13.67%,ABI1;GAS6;AFAP1L2;PAK2;EFNA5;CD24
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.5452063247930298,-1.416472653181926,0.06889352818371608,0.3662707927586024,1.0,5/14,8.58%,APAF1;NOD1;RACK1;CASP8AP2;ATP2A3
prerank,acylglycerol lipase activity (GO:0047372),-0.5776071815172141,-1.4140238218049561,0.10526315789473684,0.3658454425678077,1.0,3/11,12.54%,ABHD2;MGLL;ABHD6
prerank,hydro-lyase activity (GO:0016836),0.44125464634837397,1.4045788567373356,0.07205623901581722,0.5957370317177602,1.0,11/41,10.93%,HACD3;ENO1;ACO1;NAXD;ENO4;HACD4;HACD1;FAHD2A;ECHDC3;ECHS1;ECHDC2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.3500092942313794,-1.4001831733438859,0.030232558139534883,0.3910496307470484,1.0,25/91,15.57%,HIP1;STXBP6;MYO1B;MARK1;PARD3;SVIL;GSN;KCNJ2;WIPI1;SNX18;FCHO2;SH3PXD2B;PLEKHA4;KCNQ1;PLEKHA5;AMER1;JPH2;EXOC1;CAPG;HIP1R;PFN1;VILL;AVIL;AMER2;SYTL2
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.39889562457592426,-1.4001784684746967,0.048723897911832945,0.3848907256715737,1.0,19/46,27.74%,GCNT2;EXT1;B3GNT2;MGAT5;MGAT4A;HEXA;GCNT1;MFNG;MGAT4B;LFNG;B3GNT3;B3GALT5;PIGQ;B3GNT8;MGAT3;EXT2;GCNT4;RFNG;B3GALT1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.5811623496902498,1.3956849325166263,0.10828025477707007,0.6131026170225795,1.0,4/13,5.24%,BMP7;BMP6;BMP3;BMP8A
prerank,methyl-CpG binding (GO:0008327),0.5083433826885957,1.3935324546544552,0.08876811594202899,0.6084247016439559,1.0,4/22,4.65%,CXXC5;ZBTB38;CXXC4;TET1
prerank,protein tyrosine kinase activity (GO:0004713),-0.3430366172549355,-1.3897013318116513,0.02528735632183908,0.4025368259644933,1.0,25/108,12.90%,ROR1;TEK;NTRK3;HIPK1;TIE1;INSR;MERTK;PEAK1;EGFR;KDR;BMX;TEC;MET;LYN;FLT1;SCYL1;SRC;FLT4;JAK1;YES1;EPHB2;DYRK1A;RET;PTK2B;ROR2
prerank,chemokine receptor activity (GO:0004950),0.47487136470101776,1.385938824622603,0.09496124031007752,0.6214064313034373,1.0,2/24,0.80%,CCR9;ACKR2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.5025600957979086,-1.3820658126876548,0.08,0.41493401794261797,1.0,7/18,14.78%,GAS6;RPS6KA3;XIAP;TNFAIP8;SERPINB9;BIRC3;MT3
prerank,frizzled binding (GO:0005109),0.4474272707223003,1.3814010391936586,0.10580204778156997,0.624604310171126,1.0,6/34,9.38%,RNF43;WNT4;WNT5B;WNT7A;WNT6;FZD7
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.5422059440857148,-1.3806320254073383,0.12266112266112267,0.4122996106815191,1.0,6/13,28.79%,SREBF2;ECI1;ECH1;IDI1;DDT;MIF
prerank,GDP binding (GO:0019003),-0.37140250219121224,-1.378749824627782,0.053738317757009345,0.41056018569476027,1.0,28/63,26.43%,RAB14;RAP1A;RAB31;RALB;RAP2A;RASL12;RAB22A;KRAS;NRAS;GNAI3;RAB27A;RERG;NME2;RAB11B;RAB5C;RAP2B;MRAS;ARL8B;RRAGD;RAB27B;MIEF1;RAB35;RAB3B;RAB9B;RAB5B;TRIM23;RASEF;RHEBL1
prerank,anion channel activity (GO:0005253),-0.37897064656831303,-1.3740923145174837,0.05,0.41573858530260427,1.0,16/61,16.14%,SLC26A7;LRRC8D;CLIC4;ANO1;LRRC8C;LRRC8A;CLIC1;GABRA3;GLRB;CLCC1;LRRC8B;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,BMP receptor binding (GO:0070700),0.581165628109664,1.3705108560534656,0.12050739957716702,0.6496755862583891,1.0,4/12,5.24%,BMP7;BMP6;BMP3;BMP8A
prerank,fibroblast growth factor receptor binding (GO:0005104),0.501310929951533,1.3694097880111964,0.11154598825831702,0.6416237043458377,1.0,3/21,3.86%,FGF1;FGF4;FGF9
prerank,monocarboxylic acid binding (GO:0033293),0.5059234533287457,1.365075212732126,0.12871287128712872,0.6445935218141118,1.0,5/18,16.36%,CYP26B1;NR2F2;RXRA;PYGL;RARA
prerank,neurexin family protein binding (GO:0042043),0.5958085248500695,1.359692381992964,0.14285714285714285,0.6517575598661004,1.0,4/10,7.03%,CEL;NLGN2;SYTL3;NLGN3
prerank,lysine N-methyltransferase activity (GO:0016278),0.4922310912265999,1.3592088884597493,0.119140625,0.6422528452012233,1.0,6/20,13.15%,KMT5A;EEF2KMT;ANTKMT;SETD4;SETD7;SMYD2
prerank,cardiolipin binding (GO:1901612),0.582107914259856,1.3552027547821195,0.14072494669509594,0.6451790585358975,1.0,3/10,17.58%,GSDME;GSDMD;UQCC3
prerank,epidermal growth factor receptor binding (GO:0005154),-0.4433428195162808,-1.3549489295812889,0.10585585585585586,0.45611459298501666,1.0,9/25,28.19%,HIP1;PLSCR1;SNX1;SNX2;EFEMP1;FAM83B;EGF;GRB2;BTC
prerank,muscle alpha-actinin binding (GO:0051371),-0.5158448725901653,-1.3533366628143,0.11336032388663968,0.45357780367018125,1.0,4/15,11.65%,PDLIM5;PALLD;SYNPO2;LDB3
prerank,protein tyrosine kinase binding (GO:1990782),-0.3609853204144139,-1.348767449292479,0.06997742663656885,0.4588873229309678,1.0,17/71,11.52%,BMPR2;CBLB;ACVR1;GAS6;GRB14;CPNE3;ITGB1;ANGPT2;TJP2;RACK1;NCK1;CEACAM1;PTPN1;SOCS5;NEDD9;DUSP3;SQSTM1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.45378007211974253,1.3451140019711991,0.0972972972972973,0.6678523060444417,1.0,2/29,1.98%,PRKAG2;CDKN2A
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.46032882959323684,-1.3419694801894457,0.09740259740259741,0.4694372629992841,1.0,7/23,12.45%,HIP1;WIPI1;SH3PXD2B;PLEKHA4;PLEKHA5;JPH2;HIP1R
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3736928837133816,1.341091191194441,0.0851063829787234,0.6697767776391186,1.0,17/69,12.98%,LPGAT1;SPHK1;ASPG;SOAT2;PLAAT5;ZDHHC12;PLA2G4C;DBT;GLYAT;SOAT1;MOGAT1;ZDHHC1;ZDHHC16;PLA2G15;ZDHHC6;DGAT2;ZDHHC3
prerank,sterol binding (GO:0032934),0.39596165766290914,1.3405872738560054,0.08347529812606473,0.6606366083754616,1.0,12/56,9.09%,RORA;OSBPL8;ANXA6;SOAT2;SIDT1;INSIG2;GRAMD1B;STARD5;APOF;SOAT1;OSBPL5;NR1H3
prerank,guanyl ribonucleotide binding (GO:0032561),-0.3011542981177235,-1.3393938911614984,0.02925531914893617,0.4694445858821926,1.0,66/196,24.01%,RHOJ;RAPGEF2;RHOBTB1;RHOA;INSR;RAB14;RAP1A;ATL3;EEF1A1;MFHAS1;RAB6A;RAB31;GTPBP10;RALB;PDE10A;GNL3;GBP4;RAP2A;GCH1;GBP5;PDE2A;TUBA1A;TGM2;RASL12;EIF2B2;BMS1;RAB22A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;RERG;ARL5A;NME2;RAB11B;RAB5C;RAB1B;GLUD1;RAP2B;ARF5;ADSS1;GNL1;MRAS;NUDT16;RHOBTB3;ARL8B;ARHGEF5;CDC42;RRAGD;AGAP2;RAB27B;RHOB;RAC3;MIEF1;RAB35;ARL4D;TUBE1;TUBA4A;RND2;RHOT2;RAB3B;RAB9B;RAB5B;TRIM23
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5251721313515029,1.339204287920693,0.14003944773175542,0.6548569504361158,1.0,6/15,24.14%,P2RX6;GPR87;P2RX4;PTAFR;GPR34;P2RY12
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4028220616688457,1.338583353645645,0.09040590405904059,0.6469121805045516,1.0,10/49,7.90%,SYT11;SYT12;ANXA6;CPNE1;ANXA5;SYT9;CPNE4;PLA2G4C;SYT1;SYT13
prerank,myosin binding (GO:0017022),-0.3709474924596139,-1.3372761233479755,0.06103286384976526,0.4685346525769431,1.0,10/55,7.50%,MYRIP;CALD1;SHROOM4;SPATA6;RHOA;GSN;RAB14;RAB6A;NKD2;MYOC
prerank,retinoid X receptor binding (GO:0046965),-0.5396754459796173,-1.333567055793072,0.1384297520661157,0.47090367415586326,1.0,6/11,14.83%,TACC1;NRIP1;RARG;NCOA6;NR4A2;ARID5A
prerank,insulin-like growth factor I binding (GO:0031994),-0.5321608482975141,-1.3301531938371094,0.1487964989059081,0.47309040789091145,1.0,4/13,5.12%,ITGA6;INSR;ITGB4;IGFBP6
prerank,receptor tyrosine kinase binding (GO:0030971),-0.3723017530518816,-1.3272870287470189,0.07142857142857142,0.47424693549683,1.0,17/56,16.25%,CBLB;GAS6;PIK3R1;GRB14;CPNE3;ANGPT2;RACK1;NCK1;PTPN1;SOCS5;DUSP3;SQSTM1;SH2B2;IRS1;CBL;DOCK4;SHC4
prerank,cation channel activity (GO:0005261),0.3558180990290998,1.325347373862711,0.07213114754098361,0.6801279119604607,1.0,6/94,1.13%,TRPM3;CACNA1D;ANXA6;SLC24A3;TRPM6;TRPV1
prerank,glutamate receptor binding (GO:0035254),-0.48026400530087043,-1.3243984991308837,0.12836438923395446,0.47611398302119595,1.0,2/17,0.56%,HIP1;SHANK3
prerank,kinase activator activity (GO:0019209),0.4480495450708928,1.32347005291571,0.1102803738317757,0.6761463446435346,1.0,4/30,4.06%,PRKAG2;GPRC5A;GPRC5C;GPRC5B
prerank,kinase binding (GO:0019900),-0.2730080944092527,-1.3197173216501643,0.0,0.4819724236990605,1.0,88/434,13.98%,UTRN;TTC28;ACTB;LIMS1;GHR;FRMD5;CAV1;SLC12A7;SLC12A2;PDE8A;DAB2IP;PTN;RHOBTB1;RHOA;BCAR3;GSN;ACVRL1;PKD1;IQGAP1;EGFR;FOXO3;BCL2L1;PLCG1;BTG1;STAT3;EEF1A1;PTPRJ;PPP1R12A;CSPG4;IRAK3;PTPRK;STX1A;ESR1;CACUL1;PLCG2;FAS;FLNA;CAB39;CARD16;SPRED2;TFRC;SMAD1;PIK3IP1;PAK2;CIT;ADAM10;EEF2;MIDN;TRIM14;PRKCD;CALM3;RELB;RPS7;RB1CC1;ANKRA2;APC;SPRY2;RPS3;EMP2;CEACAM1;ACTA2;HDAC7;SRC;PTPN1;TIAM1;PFKL;BCAR1;CIR1;RPTOR;DUSP3;YWHAZ;PER1;CAV2;ACSL3;BAG5;FBXO5;HSPB1;SQSTM1;GSKIP;RND3;TRPV4;PEBP1;PTPRC;CD24;PGAM1;CNTLN;PPP1CC;AP2A1
prerank,neuropeptide binding (GO:0042923),0.4903214820349569,1.316042786854386,0.1436893203883495,0.6892678050318364,1.0,7/18,24.16%,OPRD1;NMUR1;GPR37;OPRM1;GPR149;OPRL1;NMUR2
prerank,transcription coactivator binding (GO:0001223),0.46974050312010573,1.3144923686253198,0.14763779527559054,0.6846672401800862,1.0,7/20,13.37%,RORA;SMAD3;THRB;CCNT2;MED25;ZBTB49;TERT
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.42764590970241456,1.313167127390087,0.1316270566727605,0.6792798497508872,1.0,10/34,13.72%,KMT5A;EEF2KMT;DOT1L;ANTKMT;N6AMT1;SETD4;SETD7;SMYD3;SMYD2;MEN1
prerank,nucleosomal DNA binding (GO:0031492),-0.4629052924473961,-1.312246068741949,0.12941176470588237,0.4953442352360082,1.0,5/21,8.40%,ACTB;H3-3A;SMARCC1;GATAD2B;RBBP4
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5518261664013762,1.3117402604236685,0.15336134453781514,0.674308853739493,1.0,3/11,8.02%,KCND3;KCNJ5;KCNH2
prerank,lysine-acetylated histone binding (GO:0070577),0.48476690519208315,1.3116476680268847,0.14556962025316456,0.6562139451572725,1.0,7/20,13.06%,ZMYND8;KMT2A;PHIP;BRD7;TAF1;BRD2;YEATS4
prerank,acetylation-dependent protein binding (GO:0140033),0.48476690519208315,1.3116476680268847,0.14556962025316456,0.6562139451572725,1.0,7/20,13.06%,ZMYND8;KMT2A;PHIP;BRD7;TAF1;BRD2;YEATS4
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.45022511506715723,-1.3114763831716085,0.11965811965811966,0.4852390008755488,1.0,11/21,32.24%,CDK14;CDKL2;CDK5;CDK6;CDKL4;CDK11B;CDK2;CDK8;CDK13;CDK19;CDK1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.45022511506715723,-1.3114763831716085,0.11965811965811966,0.4852390008755488,1.0,11/21,32.24%,CDK14;CDKL2;CDK5;CDK6;CDKL4;CDK11B;CDK2;CDK8;CDK13;CDK19;CDK1
prerank,translation initiation factor activity (GO:0003743),-0.3903623166404772,-1.308713971979444,0.10944206008583691,0.4863730108549854,1.0,12/36,17.56%,EIF3E;EIF3H;EIF3M;EIF2B2;MTIF3;EIF4E;EIF3F;AGO2;EIF1B;EIF3K;EIF4G3;EIF2B1
prerank,phosphotyrosine residue binding (GO:0001784),-0.39744269666390913,-1.303459888843237,0.10655737704918032,0.49361753248174217,1.0,19/37,28.81%,BCAR3;PIK3R1;SHE;PLCG2;VAV2;YES1;PFN1;IRS1;LDLRAP1;SH3BP2;PTPN6;HCK;SYK;RASA1;SHD;PTPN11;GRB2;PTPN3;SAMSN1
prerank,GTPase regulator activity (GO:0030695),-0.28779167026639585,-1.296778678898881,0.016713091922005572,0.5046715793697365,1.0,43/212,9.52%,ARHGAP31;NRP1;ARHGAP10;PREX2;TBC1D4;CHN2;RABGAP1L;DOCK1;RAPGEF2;ARHGAP42;SLIT2;RGS3;RGS12;RGS5;SIPA1L2;RASGRP3;STARD8;SH3BP4;TBC1D8;CHN1;IQGAP1;ASAP2;BCR;ARAP3;STARD13;TBC1D12;JUN;USP6NL;TBCD;TBC1D5;ARAP1;TBC1D2B;SIPA1L3;ARHGAP32;TBC1D1;ARHGAP35;RGS6;EVI5L;IPO7;SEC23A;ABR;PDE6D;TBC1D13
prerank,protein phosphatase 1 binding (GO:0008157),0.47017511448590427,1.2964090744799757,0.15730337078651685,0.6953883342246041,1.0,4/21,7.65%,SH3RF2;PPP1R3F;PPP1R16A;PHACTR4
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5334588519679311,1.2954003639036669,0.19183673469387755,0.6893864738074515,1.0,4/11,9.99%,SLC25A42;SLC19A1;SLC25A25;SLC25A23
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5495928498248022,1.2913446064626355,0.19560878243512975,0.6937048721902569,1.0,4/11,11.47%,TRPV1;ITPR1;RYR2;TRPM2
prerank,histone methyltransferase binding (GO:1990226),0.5439496950593795,1.2896138941835213,0.19301848049281314,0.6905007273758907,1.0,3/11,10.72%,CBX1;PHF1;LCOR
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.43978997790209573,1.288181456652088,0.14366729678638943,0.68607287645758,1.0,5/27,6.01%,SLC22A6;SLC22A8;SLC5A5;SLC26A1;SLC25A11
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.46492877274780303,1.287120927821554,0.15860735009671179,0.6807807343707466,1.0,4/22,8.69%,CPEB2;ELAVL4;EXOSC8;ELAVL1
prerank,filamin binding (GO:0031005),0.5376325314343492,1.2868319183289794,0.17343173431734318,0.6730002937079143,1.0,4/11,11.10%,NEBL;RFLNA;CRMP1;TMEM67
prerank,calcium channel activity (GO:0005262),0.3541089026958847,1.2852689377299855,0.08838821490467938,0.6694408408755457,1.0,8/84,1.76%,CACNA1D;CACNA2D3;ANXA6;SLC24A3;CACNG7;TRPV1;CACNB1;CACNB3
prerank,GTP binding (GO:0005525),-0.2922515052359117,-1.2845763547103703,0.04477611940298507,0.5310973801540374,1.0,55/172,22.94%,RHOJ;RHOBTB1;RHOA;INSR;RAB14;RAP1A;ATL3;EEF1A1;MFHAS1;RAB6A;RAB31;GTPBP10;RALB;GNL3;GBP4;RAP2A;GCH1;GBP5;TUBA1A;TGM2;RASL12;EIF2B2;BMS1;RAB22A;KRAS;NRAS;RRAGA;RAB27A;RND3;RERG;ARL5A;RAB11B;RAB1B;GLUD1;RAP2B;ARF5;ADSS1;GNL1;MRAS;NUDT16;RHOBTB3;ARL8B;ARHGEF5;CDC42;RRAGD;AGAP2;RAB27B;RHOB;RAC3;RAB35;ARL4D;TUBE1;TUBA4A;RND2;RHOT2
prerank,receptor antagonist activity (GO:0048019),0.49379984306154406,1.2820037070840105,0.17408123791102514,0.6719619419212809,1.0,3/17,11.01%,ADH7;DKK3;FST
prerank,Hsp90 protein binding (GO:0051879),-0.3950898813228424,-1.2809206347923587,0.15315315315315314,0.5346092596139945,1.0,9/33,13.25%,SLC12A2;KDR;ERN1;RPS3;PTGES3;AHR;UNC45B;HDAC6;CSNK2A1
prerank,acetyltransferase activity (GO:0016407),0.4252499285037805,1.2795913848219376,0.13857677902621723,0.6714674886895506,1.0,5/31,4.93%,SPHK1;GNPNAT1;SAT1;DBT;ACAT1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.359318188912534,1.2786473386226453,0.11513157894736842,0.6663816840203263,1.0,18/74,15.83%,NADK2;SPHK1;GK;FAM20A;TKFC;PANK1;PIK3CB;NT5C3A;PANK2;TRPT1;DGKI;CHKB;PI4KA;SPHK2;DGKE;DGKD;IPPK;HK1
prerank,insulin-like growth factor binding (GO:0005520),-0.48345811138336503,-1.277221648490479,0.1858974358974359,0.5386973873686203,1.0,4/15,5.12%,ITGA6;INSR;ITGB4;IGFBP6
prerank,hormone receptor binding (GO:0051427),-0.4938367953551153,-1.2743017135879828,0.1831578947368421,0.5402240643673546,1.0,6/14,21.50%,SOCS2;JAK1;NCOA6;NPPC;PTHLH;CCK
prerank,G protein-coupled receptor activity (GO:0004930),0.30254068229343734,1.2741487143202113,0.04813664596273292,0.6721422719234413,1.0,35/239,10.90%,TAS1R2;LGR4;GCGR;PTH2R;GPR135;GPR62;GPR143;NPR3;C5AR2;BDKRB1;OPRD1;ADGRG4;GPR87;CRHR1;ADRA2A;LPAR2;ADGRB2;ADGRB3;BDKRB2;GPR45;GPR12;GPR26;NTSR2;LPAR1;NMUR1;DRD3;ADGRV1;LTB4R2;GABBR1;C3AR1;ADGRL1;GPR37;ADGRG3;GABBR2;GRPR
prerank,amino acid binding (GO:0016597),-0.4037794781875621,-1.2719590701545815,0.14565217391304347,0.540332559091918,1.0,21/31,32.22%,NOS3;GRM7;SRR;GLRB;GRIN2B;GCLC;DDAH1;GLRA2;THNSL2;CAD;GRIN1;ASS1;DDAH2;AARS2;SHMT2;CASTOR1;AGXT;SHMT1;GNMT;NOS2;NOS1
prerank,calcium channel regulator activity (GO:0005246),-0.3829860712274627,-1.2716982354867545,0.1297539149888143,0.5351628392427684,1.0,5/37,4.52%,PRKG1;STIM2;YWHAE;STIMATE;SLC30A1
prerank,metallocarboxypeptidase activity (GO:0004181),0.4406663025997968,1.2703432695659624,0.17009345794392525,0.6758370753885615,1.0,4/26,8.89%,AEBP1;CPN1;AGBL4;CPA2
prerank,pre-mRNA binding (GO:0036002),0.43835372727837796,1.2702577292264492,0.155893536121673,0.668364368407658,1.0,6/28,11.60%,CELF2;DDX5;HNRNPU;HNRNPL;PTBP1;SLBP
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.2852175421640033,-1.2700096714235911,0.0377906976744186,0.5337716548265133,1.0,40/188,15.17%,MEF2C;PBX1;BNC2;ETS1;TCF12;FLI1;FOXO3;CTCF;RUNX1;STAT3;PRDM16;TBX18;SIX1;JUN;TFEB;SOX17;CREB3L1;VSX1;NFYA;PSPC1;XRCC5;ETV5;AR;KLF11;PRDM5;ELK1;AHR;KLF4;TAL1;MAFK;PER1;SOX7;HHEX;SOX18;LIN54;SOX12;SUV39H1;MTERF3;ARID5A;ATF6B
prerank,sodium:proton antiporter activity (GO:0015385),-0.5276094268098265,-1.267612914055664,0.1680161943319838,0.5338806839960538,1.0,2/11,3.62%,SLC9A2;SLC9B2
prerank,glutamate receptor activity (GO:0008066),0.47169010110084075,1.2653854161012617,0.1926782273603083,0.6749174237382134,1.0,6/19,16.58%,GRID2;GRIN2D;GRIK5;GRIK2;GRIA2;GRM8
prerank,G protein-coupled amine receptor activity (GO:0008227),0.45430918654977426,1.2618952606142215,0.17536534446764093,0.6628281410142656,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,serotonin receptor activity (GO:0099589),0.45430918654977426,1.2618952606142215,0.17536534446764093,0.6628281410142656,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.45430918654977426,1.2618952606142215,0.17536534446764093,0.6628281410142656,1.0,7/22,16.76%,CHRM2;HTR7;HRH2;HTR1F;CHRM1;HTR1A;HRH1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.2748878094307841,-1.2618362312124485,0.026058631921824105,0.5432756298330088,1.0,54/254,17.32%,MECOM;LEF1;MEF2C;ERG;ZBTB16;ELK3;ETS1;PLAGL1;TCF12;MEOX2;FOXO1;FOXO3;RUNX1;STAT3;NFATC1;PRDM16;PLSCR1;SIX1;NFIA;REL;JUN;ESR1;KLF7;SOX17;CREB3L1;SMAD1;ETV1;NRF1;ETV5;AR;ELF4;TFCP2L1;NFAT5;ELK1;IRF2;KLF4;RFXAP;HHEX;SOX18;FOXF2;FOSL2;MAFF;SOX12;TFCP2;NR4A2;ZNF445;ATF6B;FOXO4;NR1H4;ATF4;NFKB2;RREB1;FOXD2;SP7
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5372436316912125,-1.258585478468774,0.20039292730844793,0.5461610059072585,1.0,4/10,3.05%,SLCO3A1;SLCO1C1;SLCO2A1;SLCO2B1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.45907198338045796,-1.2571187517366087,0.16396761133603238,0.5386590606211015,1.0,7/16,27.92%,ANO1;TTYH2;ANO4;ANO2;ANO6;ANO10;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),-0.45907198338045796,-1.2571187517366087,0.16396761133603238,0.5386590606211015,1.0,7/16,27.92%,ANO1;TTYH2;ANO4;ANO2;ANO6;ANO10;TTYH3
prerank,Wnt-activated receptor activity (GO:0042813),-0.47533420346707167,-1.2564821899623984,0.18831168831168832,0.5346611742673516,1.0,7/15,13.72%,ROR1;FZD6;LRP5;PKD1;FZD4;TSPAN12;FZD1
prerank,carboxypeptidase activity (GO:0004180),0.40112103141020183,1.250919380242363,0.1651031894934334,0.6893108009650304,1.0,5/35,8.89%,AEBP1;CTSA;CPN1;AGBL4;CPA2
prerank,carboxylic acid binding (GO:0031406),-0.3784984893237299,-1.2474971034748707,0.1286031042128603,0.551891558078195,1.0,15/38,18.58%,NOS3;GRM7;SRR;GLRB;GRIN2B;EPDR1;GCLC;PSAP;SESN3;GLRA2;THNSL2;GLUD1;CAD;GRIN1;UBR1
prerank,transmitter-gated ion channel activity (GO:0022824),0.419231425677377,1.2427055784394723,0.19029850746268656,0.7071319217911193,1.0,8/29,15.09%,GABRG1;GRID2;GRIN2D;GRIK5;GRIK2;GABRG3;GABRB2;GRIA2
prerank,hexosyltransferase activity (GO:0016758),-0.3091566948026944,-1.2424107577923138,0.089058524173028,0.5591651947743395,1.0,31/101,24.08%,TMTC2;GCNT2;CSGALNACT1;EXT1;B3GNT2;B4GALT4;MTAP;TMTC1;GBE1;MGAT4A;B4GALT5;HEXA;CHSY3;GCNT1;MFNG;POGLUT3;MGAT4B;HAS1;LFNG;B3GAT3;ALG6;POMT2;TMTC3;HAS2;ALG5;B3GNT3;DPY19L3;B3GALT5;B4GALNT3;B3GNT8;EXT2
prerank,antiporter activity (GO:0015297),0.4637651923613675,1.2419530105025292,0.20555555555555555,0.7017869400479828,1.0,6/20,13.33%,SLC35E2B;SLC35E2A;SLC25A11;TMEM241;CLCN4;CLCN3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.40935624040830276,-1.2412531910216178,0.1868583162217659,0.556487005165224,1.0,12/24,29.66%,RPL41;RPL5;GNL3;RPS7;SYNCRIP;FMR1;RPS13;NCL;SHMT2;SHMT1;IGF2BP2;IGF2BP1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3166915917201487,1.240579626483032,0.09819967266775777,0.6983553349539505,1.0,21/134,9.99%,SLC6A13;SLC6A1;SLC22A6;SLC13A3;SLC16A11;SLC38A3;SLC6A9;SLC23A2;SLC23A1;SLC25A42;SLC16A12;SLC38A1;SLC26A1;MPC2;SFXN2;PDPN;SLC19A1;SLC25A25;SLC38A9;SLC25A12;SLC25A23
prerank,protein kinase C activity (GO:0004697),-0.483824885258289,-1.2401228725093252,0.21084337349397592,0.5538513989765743,1.0,5/14,7.90%,PRKCH;PRKD3;PRKD1;PRKCD;PRKCG
prerank,sterol transfer activity (GO:0120015),-0.45326570635229274,-1.2400793726659707,0.20162932790224034,0.5485528704685078,1.0,7/17,11.77%,ABCA1;PLTP;NPC2;OSBP;MTTP;STARD4;GRAMD1A
prerank,protein serine/threonine kinase activity (GO:0004674),-0.26060503194673257,-1.2396136008054677,0.021671826625386997,0.5444178027591339,1.0,107/334,23.11%,PRKCH;SNRK;BMPR2;MARK1;NEK7;ACVR1;HIPK1;ACVRL1;MAP3K5;RPS6KA5;STK38L;STK3;EGFR;LIMK2;BCR;AKT3;ALPK1;TGFBR2;IRAK3;CDK14;RPS6KA3;TNIK;PRKD3;BRD4;NUAK1;CASK;CPNE3;MAP3K20;CSNK1E;CAMK2D;MAST4;PAK2;CSNK1G1;PRKD1;CIT;ERN1;CDC42BPA;PRKCD;PLK2;CDKL2;CSNK1A1;MAPK1;CSNK1G3;PRKCG;RPS6KA2;STK24;CDK5;MAP4K4;EIF2AK3;STK33;MAPKAPK2;NEK3;BCKDK;VRK3;SQSTM1;GRK5;STK10;DYRK1A;PTK2B;STK32A;STK16;CSNK2A1;STK38;AKT2;PIK3R4;ACVR1C;IRAK2;PKN3;LIMK1;PRKACA;MKNK2;TAOK3;MAST2;MAP3K8;LATS1;MASTL;TAOK1;HUNK;STK35;MAPK12;CDK16;CDK6;MAPK3;CAMK1G;MARK3;STK17B;RIPK1;TRIO;CSNK1D;MAP3K6;DYRK2;CHEK1;ULK2;MYLK;SYK;ROCK1;TOP1;RIPK2;CDKL4;MAP3K4;SLK;SIK3;MAP4K3;MAPK11;CDK11B;GAK;STK32C
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5119874731989791,-1.239266344203712,0.2286282306163022,0.5400045820324485,1.0,3/11,9.26%,SGMS1;SGMS2;SAMD8
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.5123762439145072,-1.2388712270046764,0.18546845124282982,0.5360472894600201,1.0,7/12,32.24%,BRD4;MAPK1;CDK6;CDK8;CDK13;CDK19;CDK1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.4091128095715765,1.2362052243359383,0.1814814814814815,0.7045443496704993,1.0,6/28,13.92%,GABRG1;GRID2;GRIK5;GRIK2;CHRNB2;GABRG3
prerank,FAD binding (GO:0071949),0.4374854638076277,1.2357545623450876,0.19553072625698323,0.6986879037146954,1.0,9/24,15.32%,DDO;AIFM1;MICAL3;QSOX1;KMO;NDOR1;SQLE;CYB5R1;MTHFR
prerank,rRNA binding (GO:0019843),-0.3599128616165885,-1.2350873610382895,0.15711252653927812,0.540588774265918,1.0,12/42,17.02%,RPL5;RPLP0;RPS5;RPS3;RPL23;RPS9;NGRN;RPL12;CAVIN1;RPS13;GTF3A;PTCD3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.48721998070270167,1.234066653656563,0.22626262626262628,0.6961195141000971,1.0,2/14,1.22%,ADH7;ADH4
prerank,N-methyltransferase activity (GO:0008170),0.44937299685128707,1.2324203307976123,0.2085661080074488,0.6936130000985559,1.0,7/20,17.09%,FDXACB1;N6AMT1;RNMT;TRMT11;METTL5;METTL18;TRMT1L
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5213964048516277,1.230943792002184,0.24260355029585798,0.691117060118507,1.0,2/10,3.91%,TRPV1;GABRG1
prerank,ligand-gated cation channel activity (GO:0099094),0.34631339466349886,1.230084724134801,0.13580246913580246,0.6867416875311159,1.0,15/75,15.09%,P2RX6;KCNJ13;KCNJ5;GRIN3A;GRIN2D;KCNJ10;GRIK5;GRIK2;KCNH2;CHRNB2;KCNJ16;TRPM2;SHROOM2;TRPM8;GRIA2
prerank,"DNA binding, bending (GO:0008301)",-0.47124749925660236,-1.229266538456573,0.2156448202959831,0.5505325384593742,1.0,4/14,20.33%,LEF1;HHEX;TOP2A;HMGB1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.37457872362990197,1.227032950503268,0.18181818181818182,0.6889478647054227,1.0,8/47,6.78%,SLC6A13;SLC6A1;SLC38A3;SLC7A11;SLC25A44;SLC38A1;SLC7A13;PDPN
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3731285411868985,1.2252524880817166,0.17708333333333334,0.6872707900376641,1.0,3/48,0.80%,TRPM3;SLC41A1;TRPM6
prerank,growth factor receptor binding (GO:0070851),-0.3067942685560253,-1.2237408326310797,0.10075566750629723,0.559336732263376,1.0,20/95,14.74%,HIP1;IL6ST;IL1R1;VEGFC;ITGA5;PTPRJ;PLSCR1;ERN1;SNX1;IL6R;IL1RAP;SRC;PDGFC;FGF2;FGF7;ESM1;PIBF1;PDGFD;VEGFA;SNX2
prerank,calcium-release channel activity (GO:0015278),0.4658672749692534,1.2224199692830635,0.20901639344262296,0.6889635261200023,1.0,5/17,11.47%,TRPV1;ITPR1;ITPR2;RYR2;TRPM2
prerank,peptidase inhibitor activity (GO:0030414),0.4045379608312051,1.2203606611687303,0.205607476635514,0.6883165711955554,1.0,6/33,11.05%,TFPI;ITIH2;RENBP;SERPIND1;HRG;SPINT2
prerank,glucuronosyltransferase activity (GO:0015020),-0.44221646624897404,-1.2198613913091918,0.22736842105263158,0.5637820418999788,1.0,2/19,1.45%,CSGALNACT1;EXT1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.48567414628826466,-1.215877461467307,0.21604938271604937,0.5693973751044618,1.0,2/13,3.62%,SLC9A2;SLC9B2
prerank,mRNA 3'-UTR binding (GO:0003730),0.33819825902382594,1.2151675163294013,0.17128027681660898,0.6976641806649899,1.0,25/79,20.69%,CPEB2;CELF2;DDX5;ANGEL2;ELAVL4;HNRNPA2B1;PABPC4L;HNRNPU;EXOSC8;CPEB4;UTP23;ELAVL1;RNF20;BOLL;FXR2;CSDC2;PCBP4;ELAVL2;CCT5;RNPS1;CPEB3;LARP4B;ILF3;ELAVL3;LARP1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3598411711380543,-1.2143124764142803,0.18181818181818182,0.5683287773520765,1.0,4/35,1.79%,PLCB4;PLCE1;GPCPD1;PLCL1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.43471131071951197,-1.214299109476066,0.2190082644628099,0.5633530998709456,1.0,5/20,9.35%,MAGI3;CASK;TJP2;MPP1;DTYMK
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.48933809514473703,-1.212712568346485,0.23092369477911648,0.5622940756135014,1.0,2/12,3.62%,SLC9A2;SLC9B2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5072313916936235,-1.2118221838665193,0.232,0.5597033371848321,1.0,3/11,8.83%,LEF1;ZXDC;GATA2
prerank,myosin V binding (GO:0031489),-0.4528498165532292,-1.209450776338806,0.22708333333333333,0.5610515784488876,1.0,8/15,23.01%,RAB14;RAB6A;RAB3A;RAB11B;RAB11A;RAB3D;RAB27B;RAB3B
prerank,chemokine receptor binding (GO:0042379),-0.3767734223344827,-1.2085996759167308,0.188470066518847,0.5584984317583424,1.0,24/35,50.19%,CXCL12;CCL13;CCL25;CXCL16;CCL28;CCRL2;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CCL19;CCL14;CX3CR1;CCL1;CCL3;XCL1;CXCL13;CXCL2;CKLF
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5076973018591228,-1.2078039865283814,0.244,0.55546495628142,1.0,7/10,31.29%,ANKRD13A;DNAJC2;ANKRD13B;USP15;ANKRD13D;FAAP20;LAPTM5
prerank,phosphatidic acid binding (GO:0070300),-0.4233243998055898,-1.2072640316392482,0.23126338329764454,0.5522356296394819,1.0,6/19,10.77%,PITPNC1;RAPGEF2;MARK1;PLTP;RAPGEF6;JPH2
prerank,histone acetyltransferase binding (GO:0035035),0.4476185739560542,1.204148850658277,0.22266401590457258,0.7241198262814517,1.0,6/21,18.95%,EPAS1;PAX6;KANSL1L;STAT1;CITED2;MEF2A
prerank,protein phosphatase binding (GO:0019903),-0.2967379669360074,-1.2039468285014847,0.116751269035533,0.5552555152977807,1.0,24/117,10.09%,DAB2IP;MAP3K5;FOXO1;CDC27;PIK3R1;IQGAP1;EGFR;STAT3;ITGA1;MFHAS1;ANAPC5;STRN3;RACK1;MET;PPP1R16B;PXN;KCNQ1;SHOC2;CEACAM1;SOD1;FLT4;EIF2AK3;JAK1;GTF2F1
prerank,clathrin adaptor activity (GO:0035615),-0.45174737981689617,-1.2027786158922371,0.23529411764705882,0.5534959670042583,1.0,6/15,16.63%,HIP1;STON2;AP2B1;HIP1R;AP2A1;LDLRAP1
prerank,channel activity (GO:0015267),0.3716000781298865,1.2017001386183268,0.1900369003690037,0.7251522904975858,1.0,6/41,10.41%,P2RX6;TRPV1;TMEM120B;PDPN;MPV17;BCL2
prerank,signal sequence binding (GO:0005048),-0.36454229041593345,-1.1998015817653125,0.17105263157894737,0.5560824159940035,1.0,10/35,15.22%,NFKBIA;AP2B1;TIMM22;CAT;BABAM2;IPO5;KDELR3;CEMIP;SEC61A1;KPNA2
prerank,cholesterol binding (GO:0015485),0.370422087649186,1.199036082191651,0.1953405017921147,0.7261567378798145,1.0,10/47,9.09%,OSBPL8;ANXA6;SOAT2;SIDT1;GRAMD1B;STARD5;APOF;SOAT1;OSBPL5;NR1H3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4928544289698198,1.1980580434974542,0.2661290322580645,0.7223422312052044,1.0,2/12,1.69%,ADH4;NQO1
prerank,metalloexopeptidase activity (GO:0008235),0.3607924577023912,1.1979708521982146,0.17572463768115942,0.7161197336883172,1.0,4/51,2.65%,AEBP1;METAP2;CPQ;CPN1
prerank,N-acyltransferase activity (GO:0016410),0.4003665723854693,1.1968818096959484,0.23308270676691728,0.7128779468469512,1.0,5/32,6.88%,NMT2;GNPNAT1;PLAAT5;SAT1;GLYAT
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.4824082738890263,-1.1967540589013252,0.24949698189134809,0.5592361780446707,1.0,6/12,29.59%,B3GNT2;B3GNT3;B3GALT5;B3GNT8;B3GALT1;B3GNT6
prerank,phosphatase inhibitor activity (GO:0019212),-0.4150195741652454,-1.19643214381659,0.22176591375770022,0.5555348714696392,1.0,9/20,31.29%,PTN;MGAT5;PPP1R2;BOD1L1;SET;TESC;PPP1R1B;LMTK2;ANP32E
prerank,platelet-derived growth factor binding (GO:0048407),0.49645692242321526,1.193968739219705,0.2454728370221328,0.714568058004082,1.0,3/11,5.94%,COL5A1;PDGFRA;COL1A2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.4190177742019021,-1.1932564630353482,0.22567287784679088,0.5589585692268736,1.0,5/20,13.08%,SLC39A10;SLC30A1;SLC39A8;SLC39A7;SLC30A5
prerank,syntaxin-1 binding (GO:0017075),0.4192622750077339,1.1925173957520445,0.24521072796934865,0.7124463845964499,1.0,11/22,24.17%,UNC13C;SYT1;LRRK2;SNAP25;NSF;CPLX1;CPLX2;STXBP3;SYNPR;SNPH;STXBP2
prerank,steroid hydroxylase activity (GO:0008395),-0.44052744296601143,-1.1910482018136135,0.23255813953488372,0.560093176924956,1.0,3/16,5.23%,CYP7B1;CYP1B1;CYP39A1
prerank,chemokine activity (GO:0008009),-0.3782160586040189,-1.1903637601811183,0.22127659574468084,0.5573099672441753,1.0,22/31,50.19%,CXCL12;CCL13;CCL25;CXCL16;CCL28;CCL5;CXCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8;CCL19;CCL14;CCL1;CCL3;XCL1;CXCL13;CXCL2;CKLF
prerank,DNA replication origin binding (GO:0003688),-0.399567273935457,-1.188921753604036,0.22983870967741934,0.5564772901342053,1.0,12/23,32.32%,KAT7;ORC1;ORC2;CDC45;ORC5;POLA1;MCM3;MCM5;MCM6;GRWD1;ORC3;CDC6
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.38188186708472655,-1.1887680168931058,0.22489082969432314,0.5525796532147764,1.0,7/30,13.08%,SLC39A10;SLC40A1;SLC30A1;SLC39A8;SLC31A1;SLC39A7;SLC30A5
prerank,ATPase binding (GO:0051117),-0.30919711143666795,-1.188001238221564,0.1774193548387097,0.5501911636442074,1.0,17/71,9.94%,PDE4D;CAV1;SLC2A13;EGFR;ABCA1;ATP6V0A4;ESR1;RALB;NKD2;GABARAPL2;AR;CHMP4A;PPP3CA;UBXN1;SRC;ATP6V0A1;TRPC1
prerank,RNA polymerase binding (GO:0070063),0.4361265521278881,1.1874407925557964,0.24564796905222436,0.7215663500471139,1.0,5/18,13.50%,PABPN1;CCNT2;TAF10;TCERG1L;YTHDC2
prerank,retinoic acid receptor binding (GO:0042974),-0.43783454099614916,-1.1870359131854507,0.26595744680851063,0.5484808818338709,1.0,7/17,14.83%,ACTN4;TACC1;NRIP1;RARG;NCOA6;NR4A2;ARID5A
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.48403726997176233,-1.1865401098024826,0.26779026217228463,0.5452925544083874,1.0,3/12,10.41%,TRAF5;TRIM37;BABAM2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.4572752827635432,1.1857620340787856,0.2759295499021526,0.7202819577393244,1.0,4/17,7.15%,GRIN3A;GRIN2D;GRIK5;GRIK2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.41355593125844226,1.185565496674214,0.24440298507462688,0.7147004507459567,1.0,3/27,2.73%,SLC8A3;SLC41A1;SLC23A1
prerank,ligand-gated calcium channel activity (GO:0099604),0.44116064435267616,1.1854230319790167,0.269811320754717,0.7090459343010426,1.0,6/19,13.91%,TRPV1;ITPR1;GRIN2D;RYR2;TRPM2;TRPM8
prerank,histone deacetylase binding (GO:0042826),-0.29715894720384745,-1.1825324618065427,0.13849765258215962,0.5505140636594127,1.0,27/88,19.85%,LEF1;MEF2C;YWHAE;MIER1;GLI3;YWHAB;NIPBL;HES1;ANKRA2;NACC2;HDAC9;RBBP4;HEY2;CIR1;TAL1;MTA1;NACC1;HDAC6;SP2;KPNA2;TOP2A;HDAC2;MIER2;MTA3;CCND1;PRDM1;SPI1
prerank,GTPase activity (GO:0003924),-0.26537791498586083,-1.1759020848809791,0.10086455331412104,0.5622866494890553,1.0,59/192,21.09%,RHOJ;DNM3;RHOBTB1;RHOA;RAB14;RAP1A;ATL3;EEF1A1;RAB6A;RAB31;GTPBP10;RALB;GNA11;GBP4;RAP2A;GCH1;GBP5;GNB1;ARHGDIB;EEF2;RASL12;NKIRAS1;BMS1;GFM1;RAB22A;DNAJC27;GNG5;GNB2;RAB3A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;RERG;SAR1A;RAB11B;GNA12;RAB5C;RAB1B;GFM2;RAP1GAP;RAP2B;GNL1;MRAS;SRPRA;RHOBTB3;RAB11A;GNA14;ARL8B;CDC42;RRAGD;AGAP2;RAB27B;RHOB;MTG1;RAC3;RAB35
prerank,protein heterodimerization activity (GO:0046982),0.288358156323321,1.1754569036251934,0.15023474178403756,0.7332699875866459,1.0,36/178,14.90%,ATP1A2;EPAS1;BMP6;NPAS3;ABCG5;TOP2B;RRAGC;MIGA2;ARNT2;TENM1;PGLYRP3;SIM1;CHUK;ZHX1;ATP1B2;ADRA2A;ADD2;BDKRB2;ADCY8;IKBKG;FZD9;LSM5;PAFAH1B2;BCL2;GABBR2;USF1;TAF1;BHLHE41;QTRT2;MICU1;CYBA;ARNT;QTRT1;FXR2;DGKD;SMC3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.45929472541423116,-1.1741699876290201,0.2662192393736018,0.5623531103559739,1.0,8/13,32.05%,SH3BP4;ARHGDIB;ARHGDIA;RANBP1;GPSM2;GDI1;ITGB1BP1;GDI2
prerank,protein kinase binding (GO:0019901),-0.24198333596338545,-1.173528146410906,0.030418250950570342,0.5597672568150377,1.0,90/479,13.98%,UTRN;ACTB;LIMS1;GHR;FRMD5;CAV1;PDLIM5;SLC12A7;SLC12A2;BMPR2;DAB2IP;PTN;RHOBTB1;RHOA;ACVR1;ACVRL1;PKD1;IQGAP1;FOXO3;BCL2L1;CAVIN2;PLCG1;STAT3;EEF1A1;PTPRJ;PPP1R12A;CSPG4;IRAK3;PTPRK;ESR1;CACUL1;PLCG2;ADCY4;GCH1;ITGB1;SPRED2;TFRC;TJP2;SMAD1;PAK2;CIT;RACK1;ADAM10;EEF2;TRIM14;PRKCD;KCNQ1;CALM3;RELB;RPS7;RB1CC1;ANKRA2;APC;SPRY2;RPS3;NBR1;EMP2;CEACAM1;ACTA2;HDAC7;HDAC9;PTPN1;MAPKAPK2;BCAR1;CIR1;NEDD9;RPTOR;DUSP3;YWHAZ;CAV2;ACSL3;BAG5;FBXO5;HSPB1;SQSTM1;GRK5;GSKIP;TPR;ROR2;RND3;TRPV4;STK38;PEBP1;PTPRC;CD24;IRS1;PGAM1;CNTLN;PPP1CC;AP2A1
prerank,copper ion binding (GO:0005507),0.37067486654351794,1.171440181751182,0.23540856031128404,0.7385977557841148,1.0,14/42,22.10%,MOXD1;LOXL3;SUMF1;LACC1;CUTC;RNF7;ATP7A;IL1A;PRNP;P2RX4;AOC2;PAM;ATP13A2;COA6
prerank,E-box binding (GO:0070888),-0.36219157330467294,-1.1708957646732654,0.2178649237472767,0.5617807660560928,1.0,8/34,11.58%,ZEB1;BHLHE40;HES1;AHR;TAL1;PER1;SREBF2;TWIST1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.38642199292437385,-1.1703579717926174,0.23870967741935484,0.5590457054338753,1.0,3/25,6.75%,HIP1;ARAP3;PLEKHA4
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.37000040219296326,-1.170105697298139,0.23667377398720682,0.5556723223691252,1.0,10/32,14.08%,SLC6A6;SLC1A5;SLC7A5;SFXN1;SLC38A5;SLC43A2;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.30657298921418247,-1.1689642095707526,0.1836734693877551,0.5544235146689794,1.0,27/70,29.96%,GCNT2;CSGALNACT1;EXT1;B3GNT2;MGAT4A;HEXA;CHSY3;GCNT1;MFNG;POGLUT3;MGAT4B;HAS1;LFNG;B3GAT3;HAS2;B3GNT3;B3GALT5;B4GALNT3;B3GNT8;EXT2;GCNT4;RFNG;POGLUT1;B3GALT1;CSGALNACT2;B3GNT6;B4GALNT1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.4592810472936672,1.1660232580742118,0.2857142857142857,0.7483570094187624,1.0,6/14,22.61%,AIFM1;NOX1;KMO;CYBA;NCF1;MICAL1
prerank,phosphatase activity (GO:0016791),0.3277187872239778,1.16582946273133,0.1950354609929078,0.7427984467096387,1.0,14/73,15.10%,ATP1A2;PON1;LPIN1;DUSP11;PXYLP1;PRUNE1;ARMT1;PLPPR3;ACP6;CILP2;PPP1CB;PTPRO;DUSP28;EPHX2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.38080415787198096,-1.1647897315190312,0.25279642058165547,0.5600023572448464,1.0,4/25,2.70%,FMO1;MICAL2;NOS3;FMO2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4506274275412342,1.1644128808371803,0.2751937984496124,0.7412215738682633,1.0,8/16,25.04%,SLC13A3;SLC25A11;SLC25A12;SLC38A7;SLC25A13;SLC13A5;SLC25A18;SLC1A4
prerank,carboxylic ester hydrolase activity (GO:0052689),0.32150881464694187,1.1637813877398582,0.20465890183028287,0.7372536936660354,1.0,14/85,12.53%,CEL;LIPA;ASPG;PON1;PLAAT5;PLA2G4C;DDHD2;ABHD5;TARS2;MRPL58;PAFAH1B2;PLA2G15;ABHD3;GDE1
prerank,dynactin binding (GO:0034452),0.48319182096859165,1.163130945000323,0.2704761904761905,0.7334205008124123,1.0,3/12,9.94%,SNX6;HTT;BICD1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.35704404970581516,-1.162080771367399,0.25925925925925924,0.5625068109189394,1.0,13/35,24.52%,PEAK1;BMX;TEC;LYN;SRC;YES1;DYRK1A;PTK2B;BTK;HCK;SYK;FYN;FES
prerank,ATP hydrolysis activity (GO:0140603),0.36336680248907144,1.1620734418068652,0.2535211267605634,0.7307312403212078,1.0,11/41,11.47%,HSPA1A;ABCA4;RUVBL2;TDRD9;ABCB10;ATAD1;CHD3;TOR1B;ABCD1;MYO18A;CLU
prerank,ion channel inhibitor activity (GO:0008200),-0.3488697218250159,-1.1609549645424928,0.22270742358078602,0.5610664161321746,1.0,10/35,16.14%,NEDD4L;STX1A;SLC30A1;CAMK2D;RACK1;KCNMB2;MCUB;STX7;STX8;CFTR
prerank,GABA receptor binding (GO:0050811),0.48683985776562105,1.1598654121459808,0.27289719626168224,0.7312067830806335,1.0,3/11,8.62%,TRAK1;SHISA7;JAKMIP1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.43502501264449,-1.1567416106367223,0.28901734104046245,0.5674324674959282,1.0,6/14,23.56%,OTUD7B;MINDY1;USP7;MINDY2;USP15;ATXN3
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.48120541091128616,-1.150768732062341,0.2701612903225806,0.5777621925775233,1.0,5/11,13.43%,TRPC3;TRPC6;TRPC4;TRPC1;ITPR3
prerank,secondary active transmembrane transporter activity (GO:0015291),0.34565844569330095,1.1494711664960073,0.23674242424242425,0.7558644746804917,1.0,7/51,6.17%,SLC22A6;SLC22A8;SLC5A5;SLC35E2B;SLC35E2A;SLC25A11;TMEM241
prerank,hyaluronic acid binding (GO:0005540),-0.49025692931242104,-1.1475351222036563,0.294921875,0.5814708194464423,1.0,3/10,11.98%,LAYN;CD44;CEMIP
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.22617131420643072,-1.1465555798812275,0.03361344537815126,0.5798785997456851,1.0,148/731,17.32%,KLF12;MECOM;LEF1;FOXP1;MEF2C;ERG;ZBTB7C;ZBTB16;PBX1;ZFHX3;ELK3;EBF1;ZEB1;LRRFIP1;RARB;TBX15;FOXP2;ETS1;PLAGL1;TCF12;MEOX2;PPARD;FOXO1;TBX3;TEAD4;PBX3;RUNX2;FOXO3;CTCF;RUNX1;EBF2;STAT3;DACH2;NFATC1;PRDM16;H3-3A;TBX18;SIX1;NFIA;REL;DACH1;GLI3;JUN;ESR1;TBX1;NFIX;KLF7;BPTF;TFEB;SOX17;BHLHE40;PRRX2;CREB3L1;SMAD5;SMAD1;IRF9;NFYA;KLF8;HES1;ETV1;NR3C2;JDP2;NLRC5;NRF1;SP3;AR;ELF4;TFCP2L1;ZBTB11;KLF11;RFX7;TGIF1;RELB;HEYL;NACC2;ZKSCAN1;NRIP1;PRDM5;NFAT5;ZBTB1;FOXQ1;ZNF83;BACH2;HEY2;GATA2;ELK1;AHR;NR2C1;NFE2L1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;PER1;ZSCAN18;CEBPD;ZKSCAN8;SOX7;NFATC2;ZBTB41;SREBF2;TWIST1;TEAD1;MTA1;HHEX;SOX18;FOXF2;FOSL2;ZBTB24;POU2F1;RARG;TBX2;NACC1;HDAC6;NFIL3;MAFF;SOX12;HSF5;KLF2;ZBTB5;TFCP2;NR4A2;ZNF445;SKIL;E2F5;SP2;ATF6B;FOXO4;NR1H4;ATF4;ZFP1;ZBTB33;SP4;SIX4;NFKB2;ZNF691;ZFHX4;ZSCAN25;RREB1;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;ZNF496;SP7
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.4222228193478811,1.1449786735055523,0.27613412228796846,0.7636274383307898,1.0,4/19,7.15%,GABRG1;GRID2;GRIK5;GRIK2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.38474471558311785,-1.144331941213394,0.2621951219512195,0.5814970693254317,1.0,8/24,10.77%,PLA2G4A;DAB2IP;CERT1;PLEKHA8;OSBP;GOLPH3;PLEKHA5;JPH2
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3862570515107267,1.1435191049681672,0.31021194605009633,0.7623327787359616,1.0,1/26,0.05%,PPP1R1A
prerank,ubiquitin protein ligase binding (GO:0031625),-0.24863116439660068,-1.1423950477783706,0.11254019292604502,0.582210102112209,1.0,88/253,24.80%,VCL;FZD6;TRAF5;YWHAE;FOXO1;ACTG1;EGFR;PRR5L;NFKBIA;MID1;RPL5;TNFRSF1B;UBC;MFHAS1;FAF2;SPOPL;HERC2;JUN;DNAJA1;RALB;NKD2;GABARAPL2;SMAD5;RPS27A;TRIM37;UBB;AXIN2;XRCC5;UBE2J1;MAP1LC3B;ANKRA2;APC;UBXN1;USP7;TXNIP;ARIH1;JAK1;YWHAZ;PER1;PRDX6;RPL23;BAG5;SQSTM1;ISG15;FZD4;UBE2L3;RRAGA;HDAC6;GABARAP;CD40;FBXW7;CCT2;HM13;UBE2J2;PRKAR2B;AUP1;PA2G4;BAG1;PRKACA;UBE2A;RTN4;SLF2;PCBP2;UBE2G1;RPA2;UCHL1;RIPK1;ARRB2;TRIB2;TRAF4;DIO2;FAF1;SKI;GLMN;RNF40;FHIT;SMAD6;BCL10;TRIB3;ATXN3;UQCRC1;TSG101;TMBIM6;CUL3;MUL1;CXCR4;SUMO2;CASP8
prerank,protein homodimerization activity (GO:0042803),-0.23104774667019964,-1.1407352134154654,0.06854838709677419,0.5821978660947909,1.0,122/589,15.39%,HIP1;ABCG2;SYNE1;GHR;ACTN4;PECAM1;ECE1;DAB2IP;ZBTB16;SLIT2;LRRFIP1;EXT1;LRP6;ANO1;FOXP2;B2M;ACVR1;FAP;TGFB2;PIP4K2A;MAP3K5;RBPMS;MYH9;BCL2L1;ZHX3;STAT3;MID1;RASIP1;TBX18;IRAK3;MKLN1;F11R;NOD1;MFF;MID2;TBX1;DEFA6;ACTN1;SCARB2;FLNA;GBP4;PANK3;BHLHE40;ACOX1;GCH1;TFRC;GSS;CISD2;MGLL;TPD52;TRIM37;CAMK2D;GBP5;XDH;S100A13;NECTIN3;ERN1;RACK1;HES1;TPM4;ADAM10;SNX1;TRPC6;PDE2A;NRF1;TRIM14;IL6R;SRR;CHMP4B;CHMP4A;DPY30;NACC2;ZBTB1;SPPL3;CEACAM1;TPM2;ABCD2;PEX7;CUBN;AOX1;PDGFC;FLT4;FBXO4;CAT;AHR;APOE;S100A6;S100A11;DROSHA;CAV2;MFSD1;PSAP;DSCAML1;YARS2;S100A16;HSPB1;STK10;FZD4;ASMT;PHB2;HHEX;TPST2;BLM;HIP1R;TPR;RRAGA;RPE;SMCHD1;NFS1;ENPP1;VEGFA;HOGA1;CIP2A;HM13;ZNF318;SNX2;IRAK2;S100A10;VAPB;NQO2;BAK1;RAP1GAP
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.22525171752191145,-1.1404865259943253,0.035555555555555556,0.5788922866313724,1.0,152/732,18.01%,KLF12;MECOM;LEF1;FOXP1;MEF2C;ERG;ZBTB7C;ZBTB16;PBX1;ZFHX3;ELK3;EBF1;ZEB1;LRRFIP1;RARB;TBX15;FOXP2;ETS1;PLAGL1;TCF12;MEOX2;PPARD;FOXO1;TBX3;TEAD4;PBX3;RUNX2;FOXO3;CTCF;RUNX1;EBF2;STAT3;DACH2;NFATC1;PRDM16;H3-3A;TBX18;SIX1;NFIA;REL;DACH1;GLI3;JUN;ESR1;TBX1;NFIX;KLF7;BPTF;TFEB;SOX17;BHLHE40;PRRX2;SMAD5;SMAD1;IRF9;NFYA;KLF8;HES1;ETV1;NR3C2;JDP2;NLRC5;NRF1;SP3;AR;ELF4;TFCP2L1;ZBTB11;KLF11;RFX7;TGIF1;RELB;HEYL;FOXN3;NACC2;ZKSCAN1;NRIP1;PRDM5;NFAT5;ZBTB1;FOXQ1;ZNF83;BACH2;HEY2;GATA2;ELK1;AHR;NR2C1;NFE2L1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;PER1;ZSCAN18;CEBPD;ZKSCAN8;SOX7;NFATC2;ZBTB41;SREBF2;TEAD1;MTA1;HHEX;SOX18;FOXF2;FOSL2;ZBTB24;POU2F1;RARG;TBX2;NACC1;HDAC6;NFIL3;MAFF;SOX12;HSF5;KLF2;ZBTB5;TFCP2;NR4A2;ZNF445;SKIL;E2F5;SP2;ATF6B;FOXO4;NR1H4;ATF4;ZFP1;ZBTB33;SP4;SIX4;NFKB2;ZNF691;ZFHX4;ZSCAN25;RREB1;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;ZNF496;SP7;MKX;FOXN2;JUNB;ZBTB37;PRRX1
prerank,phosphatidylinositol binding (GO:0035091),-0.2869501977656288,-1.1394541168223138,0.21933962264150944,0.5775226698840711,1.0,22/91,17.42%,HIP1;PITPNC1;ESYT2;PARD3;SCARB1;MCF2L;ANKFY1;SNX13;FCHO2;TNFAIP8L3;SNX1;ZFYVE16;ESYT3;AIDA;SNX10;HIP1R;ITPR3;SNX2;PITPNB;PIGK;EPB41;DENND1B
prerank,transaminase activity (GO:0008483),0.47902079333608844,1.1347611094122325,0.31237721021611004,0.7827911804196973,1.0,6/11,27.07%,BCAT2;GOT1;GOT2;BCAT1;PSAT1;ABAT
prerank,protein kinase regulator activity (GO:0019887),0.30623426942643356,1.1339630370246327,0.22920203735144312,0.779430602666267,1.0,8/95,4.22%,PRKAG2;SH3BP5L;PRKAG3;GPRC5A;GPRC5C;GPRC5B;CCNT2;SH3BP5
prerank,cytokine activity (GO:0005125),0.29195335625368213,1.129578167996254,0.23529411764705882,0.7870208371755407,1.0,12/131,7.55%,BMP7;BMP6;WNT4;IL18;WNT5B;WNT7A;IL17D;BMP3;BMP8A;WNT6;NRG1;INHA
prerank,estrogen receptor binding (GO:0030331),-0.348169986354022,-1.1278642941895536,0.25925925925925924,0.6010226900975375,1.0,11/32,14.83%,LEF1;TACC1;WIPI1;ESR1;NRIP1;DDX54;PHB2;DCAF13;RERG;NCOA6;ARID5A
prerank,diacylglycerol kinase activity (GO:0004143),-0.4693359590844439,-1.1269172961515332,0.3249475890985325,0.599481117101622,1.0,3/11,3.98%,DGKH;DGKZ;AGK
prerank,tRNA methyltransferase activity (GO:0008175),-0.41726433381057026,-1.1226923233847153,0.28830645161290325,0.6056049727052422,1.0,7/16,19.64%,METTL2A;METTL2B;THUMPD2;FTSJ1;TRMT44;TYW3;LCMT2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.43316530295751626,-1.1221270677233899,0.31556503198294245,0.6030603978041009,1.0,5/15,16.14%,SLC26A7;SLC26A2;SLC39A8;SLC26A6;CFTR
prerank,kinase activity (GO:0016301),0.2984599869591105,1.121317051254473,0.2601626016260163,0.806748416911125,1.0,27/109,17.57%,NADK2;SPHK1;GK;TKFC;PANK1;STK39;PSTK;PIK3CB;COQ8B;PGK1;PANK2;LRRK2;DGKI;CHKB;TAF1;EPHA4;PI4KA;SPHK2;DGKE;DGKD;IPPK;ABL1;CERK;CDKL5;PKMYT1;IP6K2;CDK5R1
prerank,G protein-coupled receptor binding (GO:0001664),0.28874611820443524,1.1201075129454119,0.23195084485407066,0.8043911678447417,1.0,22/132,14.28%,RNF43;WNT4;HSPA1A;WNT5B;TULP3;WNT7A;GPRC5B;ARR3;NTS;GPRASP2;WNT6;ARRB1;ARHGEF11;FZD7;RSPO1;C1QBP;BICD1;USP20;GRK3;GNAO1;PSMC5;HSPA1B
prerank,double-stranded DNA binding (GO:0003690),-0.2288930590436144,-1.1200532541155306,0.1078838174273859,0.6041932807797501,1.0,125/531,21.39%,KLF12;LEF1;FOXP1;MEF2C;ERG;PBX1;ELK3;RARB;TBX15;TCF12;MEOX2;PPARD;FLI1;RAD51B;TBX3;EGFR;RUNX2;FOXO3;POLR3F;NFATC1;TBX18;SIX1;CRY1;GLI3;JUN;ESR1;TBX1;NFIX;TFEB;BHLHE40;PRRX2;CREB3L1;SMAD5;VSX1;IRF9;LHX6;AIM2;HES1;ETV1;NR3C2;JDP2;XRCC5;REXO4;SP3;ETV5;ELF4;TFCP2L1;KLF11;RFX7;TGIF1;MBNL2;RPS3;NFAT5;FOXQ1;BACH2;HEY2;GATA2;ELK1;HMBOX1;AHR;NR2C1;IRF2;KLF4;HOXA6;ETS2;CPSF4;CEBPD;SOX7;NFATC2;SREBF2;TEAD1;SOX18;DMC1;KIN;RARG;TBX2;MAFF;SOX12;HSF5;KLF2;TFCP2;NR4A2;ZNF445;SP2;ATF6B;FOXO4;ATF4;ZFP1;ZBTB33;SIX4;NFKB2;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;TDG;FOXN2;JUNB;NEIL3;ZBTB37;NR2F1;ZCCHC3;HIVEP1;FOXE1;PRDM1;IRF5;SOX8;ZNF177;PAX3;RAD51AP2;HOXA4;FOXL2;NFATC3;XPA;HMGB1;LMX1B;ATF3;HSF4;ZBP1;CENPX;ZBTB45;JUND;MAU2;TOP1
prerank,Toll-like receptor binding (GO:0035325),-0.4764553135393004,-1.119686461536352,0.32612966601178783,0.6012603421417095,1.0,7/11,34.79%,DAB2IP;MYD88;CD36;TLR6;TLR1;S100A9;TLR2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.32858897242633894,1.1179517559131444,0.26936619718309857,0.8051298314198996,1.0,9/55,11.47%,CACNA1D;ANXA6;SLC24A3;TRPV1;ITPR1;PKD2L2;ITPR2;RYR2;TRPM2
prerank,ephrin receptor binding (GO:0046875),-0.38045316806888646,-1.1161683466689192,0.2963709677419355,0.6060786729865089,1.0,6/21,8.94%,ANKS1A;CHN1;LYN;EFNA5;SRC;PTPN1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.487153981426948,1.1158628195374802,0.32625482625482627,0.8058432749944933,1.0,4/10,19.29%,ECHDC3;ECHS1;ECHDC2;HSD17B4
prerank,transcription coregulator binding (GO:0001221),0.334872914554326,1.115696657913003,0.26788990825688075,0.8004552882713304,1.0,16/50,17.96%,RORA;SMAD3;THRB;CCNT2;USP11;PHF1;MED25;LCOR;ZBTB49;TERT;CTBP2;PER2;CHD6;RELA;MTF2;HDGF
prerank,potassium channel regulator activity (GO:0015459),0.33782991606818924,1.112682010729684,0.2788104089219331,0.8035967753038304,1.0,10/49,14.30%,KCNIP3;LRRC38;SLC5A3;WNK3;DLG1;WNK4;DPP10;KCNIP4;ENSA;KCNS3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4139646161348063,1.1113488699054286,0.3326923076923077,0.801875996749581,1.0,2/18,9.08%,HSD17B2;DHRS11
prerank,histone acetyltransferase activity (GO:0004402),0.3718109408705478,1.1110487509311968,0.3225806451612903,0.7971988799693591,1.0,11/30,19.95%,MCM3AP;KAT5;ARRB1;TAF10;CLOCK;KAT14;TAF1;BAZ1A;TADA3;KAT6B;KAT8
prerank,R-SMAD binding (GO:0070412),0.42097282888093807,1.1106039951873679,0.3145631067961165,0.7928940597944378,1.0,8/18,21.83%,DDX5;SMAD3;PAX6;MEN1;PMEPA1;SMAD4;SMAD2;TRIM33
prerank,cholesterol transfer activity (GO:0120020),-0.41527989563212797,-1.109910376429881,0.3201663201663202,0.6168570227239335,1.0,6/16,11.77%,ABCA1;PLTP;NPC2;MTTP;STARD4;GRAMD1A
prerank,low-density lipoprotein particle binding (GO:0030169),-0.41687877684325114,-1.1065605813781056,0.351129363449692,0.6215123336146797,1.0,5/16,4.66%,SCARB1;THBS1;CDH13;SCARF1;PLTP
prerank,endopeptidase regulator activity (GO:0061135),0.35154365153412215,1.1053992983241219,0.3066914498141264,0.8025563762514644,1.0,8/40,13.27%,TFPI;ITIH2;RENBP;SERPIND1;HRG;SPINT2;APH1A;ABCA2
prerank,cytokine receptor binding (GO:0005126),-0.2825134251017279,-1.1046104498721532,0.27205882352941174,0.6225151070860283,1.0,13/83,10.02%,KITLG;IL6ST;OSMR;LIFR;TGFB2;VEGFC;SOCS2;SPRED2;CXCL12;IL6R;IL34;IL1RAP;JAK1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4735100330470188,1.1035202661269876,0.3380855397148676,0.8026280758119706,1.0,5/10,24.96%,NSD1;SMYD2;NSD3;SETD2;SETD5
prerank,zinc ion binding (GO:0008270),-0.2362066985456732,-1.1011528213972612,0.16932907348242812,0.6271717943498859,1.0,66/293,15.19%,LIMS1;MSRB3;SHANK3;MYRIP;ECE1;ZEB1;CBLB;TNFSF10;CTCF;PLSCR1;ENPEP;KLF7;KAT6A;ZDHHC20;GCH1;ADH5;ARHGEF2;CRIP1;RNF125;TNKS;SEC24D;S100A13;MSRB2;ZNF3;CRIP2;HHIP;PDE2A;PAPPA;ARIH2;GRIN2B;HPF1;ZFPM2;SEC23A;SOD1;PTPN1;MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;ADH1A;ARIH1;KLF4;RABIF;RPS29;SIRT5;TES;RPS27;PTGR2;BLM;ACE2;SLC30A5;LNPEP;ENPP1;SEC24B;LANCL1;CLIP1;SMPDL3A;IFIH1;MT3;CA2;ADAM33;NQO2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.35594180479902754,-1.0988075282454974,0.3,0.6288874827175759,1.0,10/29,25.31%,PTPRJ;NFATC1;GCH1;NBR1;MAPKAPK2;TPR;DUSP6;DUSP1;PRMT1;DUSP7
prerank,ATP binding (GO:0005524),0.26005174357562033,1.0982685399735577,0.23338257016248154,0.8132016550594278,1.0,37/266,12.43%,ATP1A2;PRKAG2;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;OAS2;WNK3;BMPR1A;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;PRKCI;KSR1;MSH6;ABCD1;OAS3;TGFBR1;MYO18A;PEX1;MTHFS;DARS2;RTEL1;SYN3;PYGL
prerank,semaphorin receptor activity (GO:0017154),-0.45201899657197764,-1.0971742441869332,0.338,0.6291704950076917,1.0,2/11,0.78%,NRP1;NRP2
prerank,lipoprotein particle binding (GO:0071813),-0.3925205305722925,-1.0941945635188324,0.3347547974413646,0.6326229443302858,1.0,5/20,4.66%,SCARB1;THBS1;CDH13;SCARF1;PLTP
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.288763102374681,-1.089662254247128,0.29767441860465116,0.6397519482282267,1.0,14/71,12.02%,PTPRM;PTPRB;PTPRG;PTPN12;PTP4A2;PTPRJ;PALD1;PTPRK;UBASH3B;PTPN1;DUSP3;PTP4A3;PTPRZ1;DUSP23
prerank,chloride channel activity (GO:0005254),-0.30233397138944623,-1.089023942559473,0.2727272727272727,0.6375114383339265,1.0,13/59,16.14%,SLC26A7;CLIC4;ANO1;TTYH2;CLIC1;GABRA3;GLRB;CLCC1;GABRE;ANO4;GLRA2;ANO2;CFTR
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.2399217025361538,-1.0885608080208606,0.20496894409937888,0.6348359580510086,1.0,74/248,21.09%,RHOJ;DNM3;RHOBTB1;RHOA;ATP2B1;RAB14;RAP1A;MYH9;ATL3;EEF1A1;RAB6A;RAB31;GTPBP10;RALB;GNA11;GBP4;RAP2A;GCH1;GBP5;MYL6;GNB1;ARHGDIB;EEF2;ABCA3;RASL12;ABCD2;NKIRAS1;BMS1;CHD1L;GFM1;MYO19;RAB22A;DNAJC27;GNG5;DYNC1I1;GNB2;RAB3A;KRAS;NRAS;GNAI3;RRAGA;RAB27A;RND3;SMCHD1;RERG;SAR1A;RAB11B;GNA12;RAB5C;RAB1B;GFM2;RAP1GAP;KIF1C;RAP2B;CFTR;GNL1;RUVBL1;MRAS;SRPRA;KIF20B;RHOBTB3;RAB11A;GNA14;ARL8B;ABCG4;CDC42;GPR88;RRAGD;AGAP2;RAB27B;RHOB;MTG1;RAC3;RAB35
prerank,voltage-gated ion channel activity (GO:0005244),0.43429337136741075,1.087180143202907,0.3680297397769517,0.8415526270727826,1.0,6/14,24.41%,KCNA3;KCND2;VDAC1;VDAC2;VDAC3;HCN1
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2361735390111451,-1.0866513158817872,0.2119205298013245,0.6359634064734331,1.0,91/268,24.80%,VCL;FZD6;TRAF5;YWHAE;FOXO1;ACTG1;EGFR;PRR5L;NFKBIA;MID1;RPL5;TNFRSF1B;UBC;MFHAS1;FAF2;SPOPL;HERC2;JUN;DNAJA1;RALB;NKD2;GABARAPL2;SMAD5;RPS27A;TRIM37;UBB;AXIN2;XRCC5;UBE2J1;MAP1LC3B;ANKRA2;APC;UBXN1;USP7;TXNIP;ARIH1;JAK1;YWHAZ;PER1;PRDX6;HGS;RPL23;BAG5;SQSTM1;ISG15;FZD4;UBE2L3;RRAGA;HDAC6;GABARAP;CD40;FBXW7;CCT2;HM13;UBE2J2;PRKAR2B;AUP1;PA2G4;BAG1;PRKACA;UBE2A;RTN4;SLF2;PCBP2;UBE2G1;RPA2;UCHL1;RIPK1;ARRB2;TRIB2;TRAF4;DIO2;FAF1;DTX3L;SKI;GLMN;RNF40;FHIT;SMAD6;BCL10;TRIB3;ATXN3;UQCRC1;TSG101;TMBIM6;CUL3;MUL1;CXCR4;SUMO3;SUMO2;CASP8
prerank,pentosyltransferase activity (GO:0016763),0.34825963764651,1.0858239368306706,0.3333333333333333,0.839716132574873,1.0,16/36,24.24%,LARGE1;TNKS2;LACC1;PARP14;PARP4;UPP2;PARP16;QTRT2;QTRT1;SIRT1;UMPS;ART4;PARP10;QPRT;PNP;TIPARP
prerank,protease binding (GO:0002020),-0.270465486842359,-1.0846530172735434,0.2729528535980149,0.6371665166392251,1.0,18/99,12.61%,VWF;SLC2A13;FAP;F3;FN1;UBC;CARD16;ITGB1;CRADD;CST3;CCBE1;SERPINE1;SPATA2;PSAP;COL1A1;SERPINB9;COMP;ECM1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3046393389095528,-1.08449562015672,0.3039647577092511,0.6338448309116509,1.0,13/53,14.08%,SLC47A1;SLC1A5;SLC7A5;SFXN1;SLC1A3;SLC38A5;SLC43A2;SLC7A7;SLC7A1;SLC43A1;SLC1A1;SLC38A6;SLC36A4
prerank,double-stranded RNA binding (GO:0003725),-0.28722831904943225,-1.0843429885478926,0.30303030303030304,0.6304795797900022,1.0,22/70,23.33%,MBNL1;RFTN1;LRRFIP1;AGO1;ADARB1;ACTN1;DHX33;TFRC;SIDT2;AGO2;DROSHA;IFIH1;FMR1;FXR1;AGO4;MRPL44;ZBP1;MSN;EIF4H;PRKRIP1;ZFR;TARBP2
prerank,MAP kinase kinase activity (GO:0004708),0.4334072798054666,1.0833612909115844,0.37475728155339805,0.8417732180184453,1.0,4/15,10.91%,MAP2K6;LRRK2;MAPK10;MAPK14
prerank,adenyl nucleotide binding (GO:0030554),-0.4368068436304996,-1.0815237977915824,0.3555992141453831,0.6300169213654457,1.0,4/11,15.88%,BAG5;PFN1;GRPEL1;BAG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4368068436304996,-1.0815237977915824,0.3555992141453831,0.6300169213654457,1.0,4/11,15.88%,BAG5;PFN1;GRPEL1;BAG1
prerank,neuropeptide receptor activity (GO:0008188),0.36984155975276606,1.0796283961159951,0.35294117647058826,0.847439743536441,1.0,5/29,13.54%,GPR143;NMUR1;GPR37;GRPR;OPRM1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.34538115608210945,1.0785808660994511,0.33695652173913043,0.8447832354756047,1.0,8/38,14.45%,TFPI;SERPINA10;FURIN;SERPIND1;HRG;SPINT2;SERPINA9;SERPINE3
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4301530590908281,1.0783545113623356,0.36225596529284165,0.8400400209376857,1.0,3/14,8.02%,KCND3;KCNJ5;KCNH2
prerank,nuclear export signal receptor activity (GO:0005049),-0.44634864448378064,-1.0781421182446325,0.3531669865642994,0.6343215545001823,1.0,7/11,36.04%,XPO5;XPO6;NUP214;XPO7;NUP42;RAN;XPO1
prerank,ubiquitin protein ligase activity (GO:0061630),0.2592150435718975,1.0780471769515376,0.28419452887537994,0.835476324461728,1.0,58/228,21.19%,RNF220;RNF152;RNF43;SH3RF2;ASB2;PDZRN3;DTX1;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;TRIM71;SHPRH;RNF14;UBE4B;TRIM35;DTX2;PELI3;DTX3;RNF135;BRAP;TOPORS;FBXO6;RNF10;RNF6;PRPF19;RNF121;HLTF;RNFT1;RLIM;RING1;FBXO17;RNF138;RNF5;RNF7;RNF130;TRIM3;MDM2;RBBP6;ANKIB1;RNF139;RNF13;FBXL22;TRIM63;RNF26;RNF180;TRIM2;TRIM13;BFAR;TRIM41;NFX1;MYCBP2;UBOX5;HECW1;TRIM9;TRIM32
prerank,metal ion binding (GO:0046872),-0.22301001341470686,-1.0752311092828464,0.19066147859922178,0.6377477951816811,1.0,120/477,21.26%,CDH11;SNRK;SPARC;LTBP4;SPOCK2;RAPGEF2;PLA2G4A;ESYT2;CSGALNACT1;SLIT2;STIM2;MARK1;GSN;MAP3K5;RASGRP3;THBS1;STK38L;STK3;MICU3;CDH13;IQGAP1;CDH1;PLSCR1;IRAK3;EML1;PLSCR4;FBN1;ASPN;RAP2A;MAP3K20;GSS;TPD52;MCTP2;S100A13;ERN1;TPM4;HSPE1;PDE2A;CDC42BPA;ANXA1;SRR;TPT1;CALM3;PPP3CA;NCS1;TGM2;SYT4;PAPOLA;ADCY2;HMGCLL1;MT1H;MT1M;MT1X;MT1A;MT1E;MT1F;MT1G;MT1B;ESYT3;HPRT1;APOE;S100A6;NOTCH4;S100A11;GCLC;RP2;SNN;DYSF;HACL1;CRACR2A;S100A16;POSTN;FKBP9;COMP;RET;RPE;STK38;ARSA;ANXA7;MICU2;ITPR3;CALML4;ENPP1;LRP1;CDH2;ACVR1C;AGRN;MT3;S100A10;CEMIP2;MCTP1;AOC3;MAST2;DSG2;TOP2A;TDG;LATS1;GRIN1;PDXK;NUDT16;NUDT12;STK26;MAPK12;DSPP;MT2A;ASAH2;RASGRP2;CABYR;ACER3;DUT;ADGRL3;CDH23;MAP2K7;CALU;MAP3K6;DYRK2;SLIT1;SLIT3;MTPAP;CDH24
prerank,cytokine receptor activity (GO:0004896),-0.2755136412695762,-1.0740542526122965,0.2894736842105263,0.6368621364264961,1.0,16/83,11.84%,GHR;IL6ST;IL1R1;OSMR;LIFR;F3;CD44;IL17RD;IL6R;IL20RB;IL1RAP;CNTFR;IL4R;IL1RL2;CD74;FZD4
prerank,histone methyltransferase activity (GO:0042054),0.36242768672217995,1.073157084357142,0.35793357933579334,0.8455085628176277,1.0,9/32,15.21%,KMT5A;DOT1L;PRMT2;N6AMT1;SETD7;SMYD3;SMYD2;MEN1;NTMT1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.4221618480904986,-1.0730374642599358,0.3727454909819639,0.6358109600023626,1.0,4/13,10.34%,THUMPD2;TRMT10A;FTSJ1;TRMT10B
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.33055586859095276,-1.0720729385027998,0.34838709677419355,0.6346758033405964,1.0,10/33,16.46%,DCUN1D3;RNF144A;RNF144B;RNF125;RPS3;ARIH2;ARIH1;DCUN1D5;AUP1;RNF19A
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.3437362842728342,-1.0713024681825583,0.3542600896860987,0.632825713918226,1.0,10/27,23.27%,POLR3F;TENT2;POLR3H;POLR1F;POLR3B;POLR1A;POLR3A;POLR2I;POLR1H;POLR2F
prerank,snoRNA binding (GO:0030515),-0.3311342771053216,-1.070540918458131,0.33698030634573306,0.6311573465751712,1.0,19/30,33.66%,XRCC5;BMS1;NUDT16;NUFIP1;NOP58;NHP2;NUDT16L1;DKC1;IMP4;NOP56;NUDT1;NOP10;DDX21;DHX37;NUDT7;TSR1;ISG20;NOP14;HEATR1
prerank,receptor ligand activity (GO:0048018),0.2529251570469187,1.069861806398783,0.3086053412462908,0.8500871132844338,1.0,23/245,7.55%,BMP7;FGF1;BMP6;WNT4;IGF1;IL18;FGF4;WNT5B;METRNL;WNT7A;IL17D;TAFA3;CHGB;FGF9;BMP3;NRTN;TNFSF13;BMP8A;NTS;COLEC10;WNT6;NRG1;INHA
prerank,adenyl ribonucleotide binding (GO:0032559),0.24982668084439216,1.0697604752657692,0.2953890489913545,0.84490254225539,1.0,38/291,10.79%,ATP1A2;PRKAG2;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;PRKAG3;OAS2;WNK3;BMPR1A;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;SLC19A1;MYO3A;PRKCI;KSR1;MSH6;ABCD1;OAS3;ACSS2;MPPED2;TGFBR1;MYO18A;PEX1;MTHFS
prerank,bHLH transcription factor binding (GO:0043425),0.3961242491129146,1.069234505494857,0.36639676113360325,0.8412741389248798,1.0,7/19,17.54%,SMAD3;FHL2;MAP3K10;USF1;BHLHE41;SIRT1;KDM1A
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.3427984444566768,-1.0691343862855767,0.3554083885209713,0.6310790989512918,1.0,10/27,23.27%,POLR3F;POLR3H;POLR1F;POLR3B;PRIMPOL;POLR1A;POLR3A;POLR2I;POLR1H;POLR2F
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.21396522821163738,-1.0629655397394997,0.19230769230769232,0.642319426844788,1.0,131/597,20.49%,KLF12;LEF1;FOXP1;MEF2C;ERG;PBX1;ELK3;BNC2;RARB;TBX15;ETS1;TCF12;MEOX2;PPARD;FLI1;KAT7;TBX3;RUNX2;FOXO3;CTCF;RUNX1;STAT3;NFATC1;PRDM16;TBX18;SIX1;GLI3;JUN;ESR1;TBX1;NFIX;DHX33;TFEB;SOX17;BHLHE40;PRRX2;CREB3L1;SMAD5;VSX1;IRF9;NFYA;PSPC1;LHX6;HES1;ETV1;NR3C2;JDP2;XRCC5;SP3;ETV5;AR;ELF4;TFCP2L1;KLF11;RFX7;TGIF1;PRDM5;MBNL2;NFAT5;FOXQ1;BACH2;HEY2;GATA2;ELK1;HMBOX1;AHR;NR2C1;IRF2;KLF4;TAL1;MAFK;HOXA6;ETS2;CPSF4;PER1;CEBPD;SOX7;NFATC2;SREBF2;TEAD1;HHEX;SOX18;RARG;TBX2;ORC1;MAFF;SOX12;HSF5;SUV39H1;KLF2;MTERF3;TFCP2;NR4A2;ZW10;ARID5A;SP2;ATF6B;FOXO4;ATF4;ZFP1;ZBTB33;SIX4;NFKB2;ZNF250;FOXD2;BCL6B;HEY1;ZBTB48;FOXN2;ORC2;JUNB;ZBTB37;NR2F1;HIVEP1;CDC45;FOXE1;PRDM1;IRF5;ORC5;SOX8;ZNF177;PAX3;SPI1;HOXA4;POLA1;FOXL2;NFATC3;XPA;HMGB1;LMX1B;ATF3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.4579083277108157,1.0619727114206903,0.3786407766990291,0.8576653483478326,1.0,4/11,13.74%,PRMT2;FBXO11;PRMT9;PRMT3
prerank,transcription corepressor binding (GO:0001222),0.3649599990998116,1.0616846397595185,0.37218045112781956,0.8531571451945467,1.0,8/27,17.96%,RORA;USP11;PHF1;LCOR;CTBP2;PER2;MTF2;HDGF
prerank,protein kinase inhibitor activity (GO:0004860),-0.31111848691965205,-1.0605593739782853,0.3558951965065502,0.6448425273058029,1.0,16/42,23.95%,YWHAB;SPRED2;CIT;RACK1;NCK1;SPRY2;CDKN1C;RPTOR;PARVA;GSKIP;TAOK3;SOCS3;IBTK;PRKRIP1;CDKN1B;SOCS1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.3329564413711442,-1.058996577134733,0.350210970464135,0.6451221631134689,1.0,5/31,8.97%,SLC12A7;SLC12A2;ABCC9;SLC12A6;KCNK5
prerank,titin binding (GO:0031432),0.42660805843289734,1.0566462230257938,0.37945492662473795,0.8633029035258388,1.0,2/13,3.50%,ACTN2;CAPN3
prerank,acetylcholine receptor activity (GO:0015464),0.37329161275936956,1.0534527840439227,0.3844621513944223,0.8679137576559415,1.0,3/22,10.95%,CHRM2;CHRNB2;CHRM1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.45463074373825785,1.0498146231962255,0.39801980198019804,0.8737572120908046,1.0,2/10,15.15%,CDKN2A;HEXIM2
prerank,DNA polymerase activity (GO:0034061),0.3624381100155951,1.0483178725495086,0.3757115749525617,0.8729968589653451,1.0,8/22,19.85%,POLM;REV1;TERT;POLI;POLE;POLG;POLN;POLE4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2515238489419851,1.0483022042097183,0.34285714285714286,0.867683518390369,1.0,57/232,21.19%,RNF220;RNF152;RNF43;SH3RF2;ASB2;PDZRN3;DTX1;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;TRIM71;SHPRH;RNF14;TRIM35;DTX2;PELI3;DTX3;RNF135;BRAP;TOPORS;FBXO6;RNF10;RNF6;PRPF19;RNF121;HLTF;RNFT1;RLIM;RING1;PIAS4;FBXO17;RNF138;RNF5;RNF7;RNF130;TRIM3;MDM2;RBBP6;ANKIB1;RNF139;RNF13;FBXL22;TRIM63;RNF26;RNF180;TRIM2;TRIM13;BFAR;TRIM41;NFX1;MYCBP2;HECW1;TRIM9;TRIM32
prerank,NAD+ binding (GO:0070403),-0.42326672730651155,-1.0476432275776342,0.4067796610169492,0.6692743825905196,1.0,4/12,23.63%,SIRT5;HADH;GLUD1;SIRT6
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3429267710700666,-1.047458412342301,0.38876889848812096,0.6660699946077359,1.0,9/27,16.46%,DCUN1D3;RNF144A;RNF144B;RNF125;ARIH2;ARIH1;DCUN1D5;AUP1;RNF19A
prerank,microtubule plus-end binding (GO:0051010),-0.3584248667474488,-1.0445652717806428,0.3839835728952772,0.669887784864198,1.0,12/20,27.22%,DST;CLIP4;APC;CLIP2;CLIP1;PAFAH1B1;MAPRE2;DCTN1;KNSTRN;STIM1;MAPRE3;FBXW11
prerank,magnesium ion binding (GO:0000287),-0.24885520346692766,-1.044552835031476,0.35309278350515466,0.6664047068525218,1.0,35/135,21.15%,SNRK;MARK1;MAP3K5;STK38L;STK3;PLSCR1;IRAK3;RAP2A;MAP3K20;GSS;ERN1;PDE2A;CDC42BPA;SRR;PAPOLA;ADCY2;HPRT1;GCLC;RP2;HACL1;STK38;MAST2;TOP2A;TDG;LATS1;PDXK;NUDT16;NUDT12;STK26;MAPK12;DUT;MAP2K7;MAP3K6;DYRK2;MTPAP
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3949076785286228,1.0374840438329194,0.4220532319391635,0.8956296702696547,1.0,2/18,0.92%,TGFBR3;SMAD3
prerank,PDZ domain binding (GO:0030165),0.30472259694577325,1.0368442630298242,0.36991150442477877,0.892191411333892,1.0,13/61,11.42%,TGFBR3;ARHGAP29;CXXC4;GRID2;FZD8;FZD3;LLGL2;NSF;FZD7;DLG4;PDZK1;PLEKHA2;SYNJ2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.39619019319914317,1.0368181507993444,0.42585551330798477,0.8868882514918898,1.0,3/17,7.80%,DPYD;DHCR24;PTGR1
prerank,poly-pyrimidine tract binding (GO:0008187),0.37325178104588963,1.0365440858728288,0.3821892393320965,0.8823295860390009,1.0,5/23,8.08%,RBM11;PABPC4L;HNRNPU;PATL1;PTBP1
prerank,ribosomal large subunit binding (GO:0043023),0.4447434065214285,1.0364513629787555,0.4127310061601643,0.8773542825731893,1.0,3/11,7.87%,CPEB2;CPSF6;NEMF
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3390038689475953,1.0333312972158701,0.4056795131845842,0.8815662257933521,1.0,8/32,19.38%,KCNA3;KCNC3;KCNH2;KCNC2;KCNS3;KCNA4;KCNQ3;KCNQ5
prerank,ubiquitin-protein transferase activity (GO:0004842),0.23775180074611751,1.0318579152021297,0.37589670014347204,0.88073173055144,1.0,84/346,21.24%,RNF220;RNF152;RNF43;UBE2E2;DDB2;SH3RF2;ASB2;PDZRN3;DTX1;HECTD3;TRIM62;SIAH2;RNF41;RNF126;TRIM5;KCMF1;DZIP3;MAEA;TRIM71;KLHL13;SHPRH;RNF14;FBXO11;TRIM35;DTX2;PELI3;DTX3;RNF135;TRAF7;BRAP;TOPORS;FBXO6;RNF10;RNF20;RNF6;PRPF19;RNF121;TAF1;HLTF;RNFT1;UBE2W;OBI1;FBXO9;RLIM;PML;RING1;RNF31;FBXO17;RNF138;RNF5;RNF7;UBE2R2;RBCK1;RNF130;RNF213;KLHL20;TRIM3;MDM2;RBBP6;UBE2S;ANKIB1;RNF139;RNF13;FBXL22;KCTD13;TRIM63;RNF26;RNF180;FBXO22;TRIM2;TRIM13;BFAR;FBXL5;KLHL42;TRIM41;NFX1;RNF146;MYCBP2;RMND5A;KLHL21;HECW1;TRIM9;TRIM32;RNF103-CHMP3
prerank,NAD binding (GO:0051287),0.3528059322536349,1.0296720429292943,0.4232209737827715,0.8820409515405262,1.0,4/26,10.60%,ADH4;SORD;ALDH1A1;ALDH2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.431449596970055,-1.0268361470755798,0.436,0.7030849951388477,1.0,6/10,41.11%,DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;DUSP16
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.431449596970055,-1.0268361470755798,0.436,0.7030849951388477,1.0,6/10,41.11%,DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;DUSP16
prerank,telomeric DNA binding (GO:0042162),-0.3239713091627615,-1.0267074405598757,0.4054669703872437,0.6997569496709929,1.0,14/32,26.19%,RPA1;XRCC5;HMBOX1;TERF2IP;BLM;ZBTB48;NCL;PURA;TEN1;CTC1;TINF2;UPF2;HNRNPD;TERF2
prerank,protein kinase activator activity (GO:0030295),0.3003794153511842,1.0265365324283995,0.4314079422382672,0.8863016684201204,1.0,6/60,4.06%,PRKAG2;RICTOR;GPRC5A;FAM20A;GPRC5C;GPRC5B
prerank,active ion transmembrane transporter activity (GO:0022853),0.32662819319887665,1.02472835390905,0.4267161410018553,0.8867575703849592,1.0,8/37,12.68%,SLC22A6;SLC22A8;ATP13A3;COX7A1;COX7A2L;UQCRH;CYB5A;COX10
prerank,chemokine binding (GO:0019956),0.3369205400506843,1.0245382448576628,0.4098671726755218,0.8821386656294747,1.0,3/30,6.78%,CCR9;ACKR2;PDPN
prerank,beta-tubulin binding (GO:0048487),0.33954305784025135,1.0229264982992785,0.3981308411214953,0.8820706600421354,1.0,17/31,28.24%,GJB6;EML4;IFT74;PDCD5;HTT;SMC3;CCT5;CDK5R1;DLEC1;PACRG;LRPPRC;SPAST;ARL8A;BCAS3;MAP1S;EMD;RACGAP1
prerank,alpha-tubulin binding (GO:0043014),0.3421232629040938,1.0214075308790898,0.4524714828897338,0.8818573387907318,1.0,13/31,28.24%,EML4;DNAL1;TBCE;CDK5R1;DLEC1;WASHC1;PACRG;SETD2;SPAST;ARL8A;FNTA;TBCEL;RACGAP1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3847266274846956,-1.0208488283046966,0.4271255060728745,0.710716492315441,1.0,4/15,10.77%,PLA2G4A;SH3PXD2B;PLEKHA5;JPH2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.43549196874156176,-1.0185306804938734,0.4613778705636743,0.712946440272994,1.0,3/10,6.88%,FAP;NAALAD2;PRCP
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.3870788439688006,-1.0163446188116223,0.4396039603960396,0.714791894255725,1.0,6/15,17.11%,PIK3R1;SOCS2;PIK3R6;SOCS5;CISH;SOCS3
prerank,phosphatidylglycerol binding (GO:1901611),-0.40080372150795346,-1.0163264157671699,0.4426877470355731,0.7112149237432956,1.0,2/13,4.66%,PITPNC1;PLTP
prerank,DNA polymerase binding (GO:0070182),0.3782639512406282,1.0162761413328794,0.43079922027290446,0.8923065044025207,1.0,6/18,19.36%,FANCD2;FANCI;RTEL1;SMG6;HSP90AA1;LONP1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3378850163634659,1.0159514065020927,0.4373795761078998,0.8882491190503446,1.0,6/32,11.87%,KDM7A;BBOX1;TET1;PHF8;KDM2A;KDM4A
prerank,glutathione transferase activity (GO:0004364),0.3595084995901941,1.0156119747565395,0.44061302681992337,0.8843530845721184,1.0,7/23,18.30%,GSTM2;PTGES;GSTO1;GSTM1;GSTA3;GSTZ1;MGST2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.3501029544586128,1.0112346704707207,0.45539033457249073,0.8921969052586889,1.0,6/28,10.91%,PRKAA2;TNK2;MAP2K6;LRRK2;MAPK10;MAPK14
prerank,symporter activity (GO:0015293),0.4423256467291082,1.010187350299573,0.45493562231759654,0.8904310485575002,1.0,1/10,0.70%,SLC5A5
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.41049904559053607,-1.010024630012807,0.4451345755693582,0.7233940363991038,1.0,6/12,21.15%,TENT2;PAPOLA;TENT4B;TENT5C;TENT5A;MTPAP
prerank,alanine transmembrane transporter activity (GO:0022858),-0.40241781471251314,-1.0085325377314314,0.4732510288065844,0.7233268407480079,1.0,4/12,17.44%,SLC6A6;SLC38A5;SLC36A4;SLC7A8
prerank,fibroblast growth factor binding (GO:0017134),-0.34846351377019624,-1.0082806857442561,0.4279661016949153,0.7203078000393894,1.0,6/21,17.34%,THBS1;GLG1;S100A13;FGFRL1;GPC1;FGFR3
prerank,ATPase activator activity (GO:0001671),0.37177823447488045,1.0081377480645874,0.4674329501915709,0.8915698129854313,1.0,4/20,9.18%,ATP1B3;ATP1B2;DNAJB4;DNAJC10
prerank,single-stranded DNA helicase activity (GO:0017116),-0.36419159408963037,-1.0077307594998068,0.46153846153846156,0.7180393988268379,1.0,12/19,38.63%,HELQ;WRNIP1;RFC4;MCM5;MCM6;RFC2;DSCC1;HELB;CHTF18;PIF1;DHX9;POLQ
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.37688564208591935,-1.0067463973692015,0.45136186770428016,0.7169316826018969,1.0,1/15,0.90%,PLA2G4A
prerank,potassium:proton antiporter activity (GO:0015386),-0.4335219420746809,-1.0049449135847643,0.47551020408163264,0.7180053162602601,1.0,1/10,0.96%,SLC9A2
prerank,metalloaminopeptidase activity (GO:0070006),-0.3726502421874046,-1.002936420225564,0.4484848484848485,0.7195549990612377,1.0,5/16,25.28%,ENPEP;LNPEP;RNPEPL1;ERAP1;XPNPEP1
prerank,phosphatase binding (GO:0019902),-0.2491863661526562,-1.0025429835858215,0.43596059113300495,0.7169689100504201,1.0,35/105,21.61%,MAP3K5;CDC27;PIK3R1;IQGAP1;EGFR;STAT3;ITGA1;CRY1;ANAPC5;RACK1;MET;PXN;MAPK1;SHOC2;CEACAM1;FLT4;EIF2AK3;JAK1;GTF2F1;TERF2IP;NFATC2;VRK3;SYTL2;CSRNP2;MAST2;PPP6R1;ELL;CARHSP1;RPA2;MAPK3;TRPC4AP;JAK3;MAP2K7;JUP;SH3YL1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3289593606931608,-1.0021531503623657,0.4585987261146497,0.7144325129312298,1.0,8/27,16.63%,DNAJA1;ANKRA2;APOE;LRP1;AP2A1;LANCL1;APBB3;LDLRAP1
prerank,galactosyltransferase activity (GO:0008378),0.4238582695693211,1.0016429579138844,0.44642857142857145,0.9053195499258618,1.0,4/11,8.84%,B4GALT2;B4GALT1;B3GALT6;B4GALT3
prerank,thioesterase binding (GO:0031996),-0.4098541355901114,-1.001389333029162,0.45610687022900764,0.7128160581538713,1.0,3/11,20.49%,TRAF5;CDC42;TRAF4
prerank,nuclear receptor coactivator activity (GO:0030374),-0.28107148615751937,-1.000786814576535,0.4618937644341801,0.7108450589746876,1.0,19/52,23.82%,ACTN4;TACC1;ETS1;DCAF6;ACTN1;SLC30A9;FGF2;ELK1;SS18;TMF1;NCOA6;ENY2;MED14;ZMIZ2;ZMIZ1;MED13;NCOA3;CCDC62;MED24
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.4122740454749574,-0.9987127923923256,0.4662698412698413,0.7124016201677327,1.0,5/11,26.19%,RPA1;TERF2IP;RPA2;CTC1;TERF2
prerank,tau-protein kinase activity (GO:0050321),0.36043212015025006,0.9969658839453698,0.46923076923076923,0.91422252750246,1.0,3/20,4.82%,ROCK2;PHKG2;TTBK2
prerank,RNA binding (GO:0003723),-0.19125181022796817,-0.9964669835941419,0.5407407407407407,0.7143340355245958,1.0,300/1321,19.29%,SPTBN1;MBNL1;SYNE1;SORBS2;ACTN4;AHNAK;DCN;RFTN1;TMSB4X;LRRFIP1;FNDC3B;FNDC3A;YWHAE;SPATS2L;RBPMS;RPS15;MYH9;RPL38;RPL18A;RPL41;MACF1;RBM3;STAT3;EEF1A1;RPS12;RPS20;ZMAT3;AGO1;DARS1;FAU;QKI;RPL32;RPL5;ADARB1;CAST;ZC3H7A;UBC;RPS10;DAP3;CTNNA1;CS;DHX32;RPL10;RPS23;RPS24;JUN;GTPBP10;EIF3E;RPL7;ALKBH1;RPL37A;ACTN1;KCTD12;SERBP1;FLNA;EIF3H;DHX33;GNL3;SMC1A;CCDC9B;CPNE3;TFRC;MAP3K20;DCP1B;CISD2;RPS17;DNAJC21;RPS16;MRPL20;CSNK1E;RPL39;RPS27A;FASTKD1;PABPC1;TRNAU1AP;PSPC1;RBM33;MAP4;EXOSC1;PRR3;FCF1;RACK1;RPL13;SNRNP200;HSPE1;XRCC5;EEF2;YBX3;PPIA;RPLP0;CDC40;RPL30;REXO4;RBM28;RPS5;TRIM56;SMNDC1;RPL35A;PSMA6;TPT1;RPS8;RPF1;SYF2;TRIM25;MRPL21;NOVA2;PUM2;SIDT2;SNRPD1;RPS7;RPL22;ALDOA;MYBBP1A;MBNL2;RPS3;RPS28;KTN1;G3BP1;FRG1;RPL29;SPEN;BMS1;SRP19;RPL7A;RPS26;LSM7;GFM1;THUMPD1;PTPN1;SURF6;RPL6;RPL18;RPS25;EIF4E;TENT4B;PELP1;AGO2;RPL36;TRMT10A;COL14A1;DDX54;RPL28;RBM42;GTF2F1;YWHAZ;FASN;RPL27;DROSHA;TRMT10B;LARP1B;RSRC2;CPSF4;ZCCHC24;LRRC59;TCF20;RTF1;RPL24;FBRSL1;WDR33;RPL23;RPL17;MRPL23;TES;DIDO1;YARS2;SECISBP2L;S100A16;MRPS31;HSPB1;IPO5;RPS9;RPS27;SNRPD2;YLPM1;NCBP2;NMD3;NCOA5;NGRN;TDRD7;RPL22L1;SYNCRIP;TNS1;PDIA4;RRP7A;DCAF13;RBM7;KIN;TPR;SAP18;R3HDM1;UBE2L3;RPL21;FUS;MRPL10;ELAC2;ERH;PFN1;ACAA2;RPL34;ANXA7;HNRNPAB;PEBP1;RPL10A;RBM6;LRP1;KMT2C;PPP1CC;RPL12;RBFOX2;POLR1G;TASOR;UBAP2L;PUM1;RPL35;RBMS3;CMSS1;CCDC124;RPL14;ZC3H4;CAVIN1;MRPL12;IFIH1;ALDH18A1;SRP14;DDX27;DDX23;EIF1B;ESF1;NCBP1;KPNA2;SRSF3;AQR;DHX38;TEP1;KIF1C;EIF4G3;RPL19;HELZ;DDX49;GLRX3;DHFR;FMR1;RPL37;RPS18;PA2G4;PPIE;RRP12;PDAP1;RPS13;RBM10;UNC50;RPS15A;TBRG4;RTN4;DDX25;RPP21;RPP38;RBM25;DNAJC2;RRBP1;PTCD3;FXR1;MRPS12;PCBP2;MRPL1;NUSAP1;ADAT1;N4BP1;TOP2A;HDAC2;DUS3L;MRPL43;SRPRA;DYNC1H1;PWP2;AGO4;MRPL45;NUDT16;HMGN2;BARD1;MANF;CSTF1;ZCCHC3;MCAT;PCBP1;ASS1;XPO5;MRPL44;RIDA;AIMP1;DSP;USP10;CKAP4;NTPCR;ZC3H12A;NUFIP1;UBTF;DIMT1;RBM46;CHCHD1
prerank,GTPase binding (GO:0051020),-0.22497081385276158,-0.9960669626756139,0.46703296703296704,0.7119806378259184,1.0,36/194,12.53%,SPTBN1;CAV1;RABGAP1L;FGD5;PLCE1;FGD6;SH3BP4;IQGAP1;ABCA1;RASIP1;UNC13B;ANKFY1;CDC42EP5;EXOC4;USP6NL;FLNA;ARHGEF2;STRN3;PAK2;EPS8;GNB1;ARHGDIB;RUSC2;YBX3;RAPGEF4;RAPGEF6;EVI5L;SOD1;PDE6D;ATG16L1;WHAMM;CDC42EP2;GNB2;FNBP1L;RANBP9;ARHGAP1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.32314240771210334,0.9957479079206879,0.46567717996289426,0.9127499748931803,1.0,12/35,15.95%,TRMT9B;TARS2;NT5C3A;MRPL58;BCDIN3D;DUS1L;TRPT1;QRSL1;QTRT2;QTRT1;MTFMT;DTWD2
prerank,endodeoxyribonuclease activity (GO:0004520),0.36010916823003813,0.994826548647262,0.45660377358490567,0.9104479006577092,1.0,4/20,16.96%,ERCC1;MBD4;MRE11;EXOG
prerank,DNA binding (GO:0003677),0.216730171889135,0.992547428141989,0.46923076923076923,0.9121313616607554,1.0,157/694,20.17%,DENND4A;RORA;EPAS1;HLF;NUPR1;SMAD3;DDB2;APLP2;SPHK1;MSX2;CXXC5;THRB;SCRT1;CHD4;ARID4A;NR6A1;PPARA;NFYB;ESRRA;SLTM;ERCC1;PMS2;SIM1;POLRMT;TET1;MEIS1;AIFM1;PCID2;PQBP1;PAX6;IKZF1;RBPJ;DNMT3A;AUNIP;ARID3A;HNRNPU;TFPT;HOXA7;PBX4;NFYC;ZKSCAN3;SUPV3L1;E2F1;CEBPA;MEIOB;SPRTN;NR2F2;CHD3;MSH4;KDM5B;NLRP3;PHF1;MBD4;MAFA;MSH6;PPARGC1A;HINFP;MAX;ZNF711;NR1H3;ZDHHC1;ZBTB22;ZIC2;SSBP2;TDP2;RXRA;CLOCK;CR2;PRDM2;PSIP1;SSBP1;PARP4;MRE11;TOPORS;CSRNP3;BCL2;WBP11;BCLAF3;E2F4;CSRNP1;STAT1;USF1;BATF;ZFPL1;FUBP1;MBD1;TAF1;ZBTB49;SOX9;PURB;MSH3;TERT;HDAC4;FOXC1;MEN1;ARNT;PLAGL2;RAD51D;RNF138;CENPC;POLR3C;POLE;AIFM2;TLR8;PRKDC;RPA3;RBM5;SAFB2;ERF;ABL1;HIC2;MCM7;POLR2D;HDGFL2;ILF2;POLG;GTF3C1;LHX4;TRNP1;MCMDC2;SAFB;CLSPN;CAMTA2;SOX6;RELA;MTF2;RAD52;SRRT;TCF7L2;TCF4;HDGF;SMC1B;NHEJ1;TSHZ3;ZBTB6;ARID5B;MLXIPL;MLX;FOXL1;TFAP4;POU6F1;MEF2A;SOX2;HMCES;LONP1;MEIS3;RFX2;COLEC11;DDIT3;POLR2A;SNAPC1;GTF3C4;POU2F2;ILF3;CGGBP1;DDX3X;SPTY2D1
prerank,GABA receptor activity (GO:0016917),0.35976631344560833,0.991724931101624,0.4371482176360225,0.9095572400491466,1.0,6/21,18.56%,GABRG1;GABBR1;GABBR2;GABRG3;GABRB2;GABRB3
prerank,ion gated channel activity (GO:0022839),-0.32847299287584303,-0.9915927488147035,0.4688888888888889,0.7197494791580341,1.0,5/24,15.99%,KCNT2;ANO1;TTYH2;ANO4;ANO2
prerank,voltage-gated chloride channel activity (GO:0005247),0.42634729319735365,0.9912410922084802,0.45708582834331335,0.9062255114200995,1.0,4/10,13.33%,CLCN6;CLCN2;CLCN4;CLCN3
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.31220291862711846,0.9909370391308036,0.4755639097744361,0.902257438177746,1.0,11/44,13.72%,KMT5A;DOT1L;KMT2A;N6AMT1;NSD1;SETD4;KMT5C;SETD7;SMYD3;SMYD2;MEN1
prerank,serine-type endopeptidase activity (GO:0004252),0.2765322483616767,0.9908781798241545,0.46572934973637964,0.897735500554171,1.0,16/80,18.74%,PCSK4;FURIN;F10;PLAT;HTRA2;PLG;CORIN;CTRL;KLK8;CTSH;PRSS36;HGF;KLK1;PRSS53;DPP4;RHBDF1
prerank,transcription cis-regulatory region binding (GO:0000976),-0.20581708675408456,-0.9904196085439142,0.49809885931558934,0.7191331795476453,1.0,60/406,12.36%,LEF1;FOXP1;MEF2C;ACTN4;PBX1;ELK3;TRPS1;BNC2;ETS1;PLAGL1;TCF12;FLI1;FOXO3;CTCF;RUNX1;STAT3;PRDM16;AGO1;TBX18;SIX1;ZNF25;DACH1;GLI3;JUN;ZBTB46;TFEB;SOX17;CREB3L1;VSX1;NFYA;PSPC1;LHX6;ZNF3;XRCC5;TWIST2;SP3;ETV5;AR;KLF11;ZNF436;FOXN3;PRDM5;RPS3;ELK1;AGO2;AHR;IRF2;KLF4;TAL1;MAFK;ETV6;RFXAP;PER1;SOX7;TWIST1;TEAD1;HHEX;SOX18;FOXF2;FOSL2
prerank,DNA-binding transcription factor binding (GO:0140297),0.23983441913716477,0.9874426800833517,0.4992526158445441,0.9028458483667775,1.0,36/189,14.03%,ZMYND8;SMAD3;MAGEA2;CXXC5;BEX1;FHL2;CHD4;PPARA;NFYB;POU1F1;GTF2I;IFI27;RBPJ;ATN1;KAT5;NLRP3;MIER3;HES6;MAP3K10;DMAP1;BBS5;LDB2;LDB1;BCL2;STAT1;USF1;TTC8;TAF1;ZBTB49;BHLHE41;PURB;PIAS4;GABPA;HDAC4;NOC2L;PSMC5
prerank,methylation-dependent protein binding (GO:0140034),0.293399239098168,0.9859973562812975,0.45567375886524825,0.9022618608845909,1.0,10/57,11.87%,ZMYND8;KDM7A;SGF29;PHF8;PHF1;PHF2;MSH6;MPHOSPH8;TDRD3;KDM4A
prerank,ephrin receptor activity (GO:0005003),0.3752298639525661,0.9837030095741359,0.45951417004048584,0.8993876075987648,1.0,5/17,15.96%,EPHA8;EPHA6;EPHA4;EPHA10;EPHB1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.3752298639525661,0.9837030095741359,0.45951417004048584,0.8993876075987648,1.0,5/17,15.96%,EPHA8;EPHA6;EPHA4;EPHA10;EPHB1
prerank,methylated histone binding (GO:0035064),0.2894705150283703,0.9820559809519723,0.479646017699115,0.8994709738108335,1.0,11/62,11.87%,ZMYND8;KDM7A;SGF29;PHF8;PHF1;PHF2;MSH6;MPHOSPH8;TDRD3;TAF1;KDM4A
prerank,sequence-specific DNA binding (GO:0043565),0.21535130106033926,0.9794265378713217,0.5395590142671854,0.9024097768009975,1.0,70/590,11.18%,MAF;RORA;EPAS1;HLF;CREB5;SMAD3;OSR1;NR2E1;HMX2;MSX2;CXXC5;OVOL2;THRB;ZSCAN29;ZBTB38;CXXC4;SCRT1;MYBL2;FBXL19;NR6A1;ARNT2;PPARA;ZNF23;ESRRA;POU1F1;SLTM;UBP1;HOXB9;KMT2A;POLRMT;MAFG;TET1;PAX6;RBPJ;HNRNPU;ZBTB26;HOXA7;PBX4;DRGX;ZKSCAN3;E2F1;DPF1;HOXB6;BCL11B;NR2F2;TEF;KLF15;KDM5B;NLRP3;HES6;MAFA;PPARGC1A;KDM2A;MAX;ZNF711;E2F8;ZBTB22;HOXB4;RXRA;CLOCK;PRDM2;SMG5;CSRNP3;BCL2;E2F4;CSRNP1;USF1;BATF;MBD1;TAF1
prerank,metalloendopeptidase activity (GO:0004222),-0.255342724211672,-0.9789085676272005,0.4897025171624714,0.7438964614427803,1.0,17/76,17.35%,ADAMTSL3;ECE1;ADAMTSL1;ADAMTS5;ADAMTS17;ADAMTS6;ADAM10;ADAMTS1;ADAM19;ADAMTS14;MMP11;ADAMTS20;ADAMTS2;ADAM33;PHEX;ADAMTS12;MMP2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.4252602029399295,0.9787159622911851,0.49190283400809715,0.8997600419133251,1.0,3/10,15.51%,RENBP;GFUS;DSE
prerank,phosphatase activator activity (GO:0019211),-0.377536167690506,-0.9784140686795714,0.4822834645669291,0.741699032545984,1.0,6/14,20.72%,CALM3;PPP2R5C;GTF2F1;BMP2;B3GAT3;PPP2R5B
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.29027493698886603,-0.9772145370416383,0.5,0.7413179193642676,1.0,16/40,23.06%,METTL2A;METTL2B;THUMPD2;NNMT;PCMTD2;PRMT7;ASMT;DNMT3B;PCMTD1;SUV39H1;ICMT;GAMT;MEPCE;LCMT1;DNMT1;HNMT
prerank,voltage-gated anion channel activity (GO:0008308),0.38319062081486344,0.9756204609091265,0.48722986247544203,0.9037362731223895,1.0,6/15,17.31%,CLCN6;CLCN2;CLCN4;CLCN3;VDAC1;VDAC2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4059274121843562,-0.9746958771079363,0.48906560636182905,0.7439976001594246,1.0,3/11,13.26%,DAB2IP;ROR2;STK38
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.4047288565201253,0.9728513707448502,0.47572815533980584,0.906901394977864,1.0,6/11,25.95%,UBE4B;PRPF19;UBOX5;AMFR;UBR5;RBX1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.2918500075377698,0.9696608793621231,0.5044404973357016,0.9115110028797425,1.0,11/49,13.57%,OPTN;DZIP3;TNIP3;IKBKG;ABRAXAS1;ZFAND6;SPRTN;TNIP2;IKBKE;BAG6;OTUD7A
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.37785793156722064,-0.9690275717168795,0.5134575569358178,0.7543235633143047,1.0,2/14,1.84%,SLC26A7;SLC26A2
prerank,calcium ion binding (GO:0005509),0.2232831242532456,0.9684891137703685,0.5529753265602322,0.9102639217324567,1.0,45/323,12.06%,SYT11;SYT12;DSC2;DSC3;ANXA6;MAN1C1;ADAMTS13;FBLN1;PON1;CPNE1;PLSCR2;ENPP3;ANXA5;CDH15;CDH3;CDH17;S100A4;CAPN3;SMOC2;SYT9;ITPR1;PLA2G4C;SYT1;CDH10;CALR3;CDH18;SYT13;CRNN;ADGRV1;SLC25A12;SLC25A23;SYT10;GJB2;ITPR2;AMY1A;AMY1C;AMY1B;RYR2;GALNT3;TRPM2;CANX;DMP1;CCDC47;KCNIP4;CPNE6
prerank,transition metal ion binding (GO:0046914),0.21838594001164652,0.9662025067289617,0.5583333333333333,0.9123173628764533,1.0,59/397,12.63%,MOXD1;UPB1;ZMYND8;SMAD3;KDM7A;ADH7;ADH4;ADAMTS13;CXXC5;SORD;CXXC4;ENPP5;CHD4;FBXL19;ENPP3;ETHE1;PITRM1;PPM1M;BBOX1;GLRA1;LOXL3;KMT2A;ARG2;TET1;PHF8;LARGE1;B4GALT1;LACC1;GALT;CHD3;QPCT;KDM5B;PHF2;CSRP1;KDM2A;CPA2;TDP2;RXRA;TRAF7;PRDM2;MPPED2;NSD1;CUTC;HRG;DOHH;ZFPL1;MBD1;PLA2G15;GALNT3;KDM5C;EPRS1;ENDOU;RABGGTB;KDM4A;GYG1;GALNT2;RBAK;FDX1;PIAS4
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3537858188863996,-0.9648539759624111,0.5031446540880503,0.7608876173433103,1.0,6/16,22.81%,CD38;RPS3;OARD1;TDG;NEIL3;SMUG1
prerank,small GTPase binding (GO:0031267),-0.22096443122480444,-0.9623586520298623,0.5613079019073569,0.7630965071604304,1.0,26/169,9.06%,CAV1;RABGAP1L;FGD5;PLCE1;FGD6;SH3BP4;IQGAP1;ABCA1;UNC13B;ANKFY1;CDC42EP5;EXOC4;USP6NL;FLNA;ARHGEF2;STRN3;PAK2;EPS8;ARHGDIB;RUSC2;YBX3;RAPGEF4;RAPGEF6;EVI5L;SOD1;PDE6D
prerank,manganese ion binding (GO:0030145),0.2904848963850163,0.9588076973367796,0.504424778761062,0.9288546337086127,1.0,12/48,15.25%,PPM1M;ARG2;LARGE1;B4GALT1;TDP2;MPPED2;GALNT3;ENDOU;GYG1;GALNT2;GALNT1;ABL1
prerank,MHC class II protein complex binding (GO:0023026),-0.39236936985203275,-0.9583336681770158,0.5089463220675944,0.7694697989336966,1.0,2/11,11.83%,YWHAE;CD74
prerank,myosin II binding (GO:0045159),-0.39601444645683437,-0.9581583071324247,0.5246913580246914,0.7664143418653662,1.0,2/10,1.86%,SHROOM4;GSN
prerank,histone deacetylase activity (GO:0004407),-0.34013726571277436,-0.9572430286754653,0.5010351966873706,0.76519855374812,1.0,7/19,23.63%,MIER1;HDAC9;HDAC6;HDAC2;MIER2;SIRT7;SIRT6
prerank,anion transmembrane transporter activity (GO:0008509),-0.3901608529684605,-0.9569489196598077,0.505859375,0.762411010990179,1.0,3/12,4.90%,ABCG2;SLCO2B1;SLC39A8
prerank,proton transmembrane transporter activity (GO:0015078),0.30205965976964405,0.9548529994410704,0.5166051660516605,0.9355392819712303,1.0,9/39,13.33%,COX7A1;COX7A2L;ATP6V1B2;UQCRH;CLCN4;CYB5A;MFSD3;COX10;CLCN3
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.3834154822362764,-0.952799878292142,0.5106837606837606,0.7689576501408328,1.0,5/12,13.71%,INSR;PIK3R1;SOCS2;IGF2;IRS1
prerank,nucleotide diphosphatase activity (GO:0004551),0.3728266372712772,0.9524295194870986,0.535483870967742,0.9378577676717816,1.0,4/14,13.39%,ENPP5;NUDT4;CILP2;NUDT11
prerank,cation transmembrane transporter activity (GO:0008324),0.2886837073409066,0.9493900581523289,0.5462794918330308,0.9420217869752887,1.0,10/48,15.67%,SLC41A1;SLC38A3;SLC6A9;SLC38A1;SFXN2;SLC38A9;SLC66A1;SLC22A2;SLC38A7;MMGT1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.37982014181342116,-0.9485022744486765,0.5265306122448979,0.7757421484221318,1.0,3/12,13.71%,PIK3R1;SH2B2;IRS1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.20320041230724276,0.947494478598215,0.6637055837563451,0.9428082083174681,1.0,91/831,10.09%,AEBP1;ZKSCAN2;MAF;RORA;EPAS1;HLF;CREB5;SMAD3;KCNIP3;NPAS3;OSR1;NR2E1;HMX2;MSX2;SOX5;OVOL2;THRB;ZSCAN29;ZBTB38;SCRT1;MYBL2;CREBRF;NR6A1;ARNT2;PBX2;ZNF431;PPARA;ZNF23;SALL4;ZFP3;NFYB;ESRRA;GLIS3;POU1F1;UBP1;HOXB9;TFDP2;SIM1;ENO1;HOXB3;MAFG;MEIS1;PEG3;CCAR1;RUVBL2;MLXIP;PAX6;IKZF1;RBPJ;IKZF2;MZF1;DNMT3A;HNRNPU;ZFHX2;ZBTB26;HOXA7;PBX4;RFX8;NFYC;DRGX;ZKSCAN3;E2F1;CEBPA;HOXB6;BCL11B;NR2F2;TEF;KLF15;ZSCAN22;HOXA3;ZNF569;KDM6B;ZNF467;HES6;MAFA;HINFP;HIF3A;MAX;NR1H3;E2F8;ZBTB22;HDX;ZIC2;HOXB4;RXRA;CLOCK;ZFP90;PRDM2;NSD1;SALL3;FOXP4
prerank,neuropeptide receptor binding (GO:0071855),0.3738196959081256,0.9452684209599735,0.5107632093933464,0.9446091318291362,1.0,2/14,7.70%,NTS;SHANK1
prerank,endopeptidase inhibitor activity (GO:0004866),0.26250774075814437,0.9447637043761044,0.5692821368948247,0.9416226072717152,1.0,8/82,5.67%,TFPI;ITIH2;COL4A3;TIMP3;RENBP;SERPINA10;FURIN;SERPIND1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3843730459841026,0.9438618291298673,0.54296875,0.9396861047908308,1.0,4/13,17.39%,AGPAT4;ABHD5;LCLAT1;AGPAT2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3338833010761816,0.9437852471808746,0.5419103313840156,0.935472861861547,1.0,7/21,19.85%,POLM;REV1;POLI;POLE;POLG;POLN;POLE4
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.31927413605421945,0.9429877301045095,0.5486238532110091,0.9331377102251682,1.0,5/29,9.70%,SLC13A3;SLC26A1;SLC25A11;SLC19A1;SLC25A12
prerank,metallopeptidase activity (GO:0008237),-0.23237739588508,-0.9427560221007143,0.5850515463917526,0.7858401311680023,1.0,26/113,18.06%,ADAMTSL3;ECE1;ADAMTSL1;ADAMTS5;EIF3H;ADAMTS17;LAP3;ADAMTS6;ADAM10;PAPPA;ADAMTS1;ADAM19;ADAMTS14;MMP11;METAP1D;ADAMTS20;ACE2;LNPEP;ADAM15;ADAMTS2;ADAM33;PHEX;ADAMTS12;MMP2;NUDT16;PSMD14
prerank,peptidase activator activity (GO:0016504),-0.32783827151590755,-0.9423584747256332,0.5356415478615071,0.7833796797743648,1.0,7/22,21.46%,CAV1;CASP8AP2;PCOLCE;ADRM1;PSMD14;PSENEN;PSME1
prerank,solute:sodium symporter activity (GO:0015370),0.32177778586089667,0.9421057444144977,0.5431861804222649,0.9311940670950964,1.0,4/27,9.13%,SLC5A3;SLC5A10;SLC4A9;SLC34A3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.21555283130417224,-0.9417721544831924,0.6095505617977528,0.7813653264354692,1.0,29/181,11.88%,ACTB;ACTN4;TACC1;MDFIC;PPARD;TBX3;NFKBIA;LMO2;STAT3;NFATC1;MIER1;CRY1;JUN;DNAJA1;BHLHE40;HES1;PSMA6;AR;NRIP1;SPEN;HEY2;ZFPM2;ARID1A;ELK1;KLF4;TAL1;MYOCD;HSPB1;MTA1
prerank,ubiquitin binding (GO:0043130),-0.24280477172542303,-0.9398402931521708,0.5707196029776674,0.7825744439984782,1.0,27/73,26.65%,FAF2;NBR1;UBXN1;VPS36;DDI2;USPL1;MVB12B;HSPB1;SQSTM1;RAD23B;UBXN2A;FBXW7;AUP1;ADRM1;N4BP1;TOP2A;UCHL1;NEDD4;GGA3;FAF1;TOM1L1;NUP62;TSG101;CXCR4;OTUB2;RNF168;OTUB1
prerank,Notch binding (GO:0005112),0.3394750171177049,0.9390587807843854,0.55,0.9356435013818434,1.0,3/22,3.42%,SNED1;DTX1;GALNT11
prerank,protein phosphatase regulator activity (GO:0019888),0.28070240706160454,0.938527017240586,0.5600739371534196,0.9327310824109676,1.0,6/53,8.96%,PPP2R2B;PPP1R16A;DMPK;PPP4R4;PHACTR4;EIF2AK2
prerank,nucleotidase activity (GO:0008252),-0.3573602352131796,-0.9371748040564977,0.5529411764705883,0.7854085935884594,1.0,5/15,22.12%,BPNT2;NT5C1A;NT5E;NT5C;ACP3
prerank,GTPase inhibitor activity (GO:0005095),0.3803389719233521,0.9362817828269365,0.5333333333333333,0.9345667368690628,1.0,3/13,6.94%,CPEB2;TNK2;ARL2
prerank,serine-type peptidase activity (GO:0008236),0.2526304677968448,0.9355733368914315,0.5592334494773519,0.9322983728294791,1.0,19/96,18.74%,PCSK4;FURIN;PREP;F10;PLAT;HTRA2;PLG;CORIN;CTRL;KLK8;CTSH;ENDOU;PRSS36;HGF;KLK1;ST14;PRSS53;DPP4;RHBDF1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3164257316264266,0.9346662212180789,0.5480225988700564,0.9303171421662577,1.0,6/27,10.59%,SLC41A1;SLC23A1;ITPR1;TUSC3;MAGT1;ITPR2
prerank,solute:proton symporter activity (GO:0015295),-0.3549476877373086,-0.9336103562221479,0.5708502024291497,0.7904055868702856,1.0,3/16,13.11%,SLC2A13;SLC39A8;SLC2A9
prerank,hexose transmembrane transporter activity (GO:0015149),-0.36724704128633007,-0.9325851685644695,0.5486542443064182,0.7892955067705213,1.0,2/12,6.34%,SLC2A1;SLC2A3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.30797731455209787,0.931066845184111,0.55893536121673,0.9357527410493187,1.0,7/33,13.15%,CTR9;CCAR2;HNRNPU;LLPH;CDC73;RPRD2;SMYD2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.40531959118416677,0.9304079490323264,0.5450819672131147,0.9334471570886945,1.0,3/10,14.21%,OTUD4;STAMBP;DESI2
prerank,adrenergic receptor binding (GO:0031690),0.3636653941197936,0.9302334932175752,0.5414258188824663,0.9296878935267907,1.0,5/16,9.85%,MAGI2;ADRA2A;ARRDC3;DLG4;C1QBP
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3156776779219139,-0.9281822558751616,0.5872689938398358,0.7962329495952727,1.0,7/22,16.63%,DNAJA1;ANKRA2;APOE;AP2A1;LANCL1;APBB3;LDLRAP1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.37283791205364936,-0.9228038000657218,0.5691382765531062,0.8053569054270574,1.0,6/12,15.28%,PIK3C2A;PIK3R6;PIK3CA;PIK3CD;PIK3C3;IPMK
prerank,androgen receptor binding (GO:0050681),0.32083858957565076,0.922684413546112,0.5468451242829828,0.9454832702306989,1.0,6/25,10.62%,DDX5;PRMT2;RNF14;NSD1;PRKCB;RNF6
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.37032481982357834,0.9207682527011765,0.575098814229249,0.9465203431224423,1.0,4/14,8.72%,ACO1;CIAO3;NDUFS1;EXO5
prerank,cAMP response element binding (GO:0035497),0.4005268754394989,0.9205758381327108,0.5331991951710262,0.9428234222630599,1.0,1/10,0.61%,CREB5
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2661055718673992,0.920485685546375,0.5791304347826087,0.9388791732092409,1.0,14/60,16.68%,LRRK1;PPM1M;PPEF2;CTDSPL;PPM1G;LRRK2;PPM1D;PPP1CB;CDC14B;PPP6C;PPP2CB;PPP3R1;UBLCP1;PPM1B
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.36350477113982194,0.9177057815511521,0.548,0.9421185541318358,1.0,4/14,21.75%,CAPN3;CAPN15;CAPN10;CAPN11
prerank,lipase activator activity (GO:0060229),0.3997212417520324,0.917533855779311,0.5491803278688525,0.9385069322962367,1.0,2/10,6.70%,ARHGAP6;PDPK1
prerank,telomerase RNA binding (GO:0070034),0.32903142962963244,0.9169272224591241,0.5862745098039216,0.936010763587274,1.0,10/22,25.38%,HNRNPU;SMG5;TERT;SMG6;GAR1;SNRPB;PINX1;DCP2;HNRNPC;WRAP53
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2060139471286251,0.9148822433278117,0.7052341597796143,0.936967376162047,1.0,47/431,10.42%,ATP1A2;PRKAG2;ANXA6;HSPA1A;P2RX6;OXSR1;TRPV1;SPHK1;ABCG5;GCK;DMPK;RRAGC;OAS2;WNK3;RHOBTB2;BMPR1A;RAB42;RAB21;ATL1;GBP3;NVL;ABCF3;NIM1K;MYO9B;PLK1;SYN2;HNRNPU;PNPLA8;PGK1;WNK4;PDK2;ARL2;PRKCI;LRRK2;KSR1;ARL5B;MSH6;ABCD1;RIT1;RHOQ;OAS3;TUBG1;DRG1;TGFBR1;RHOU;MYO18A;PEX1
prerank,heme binding (GO:0020037),0.26453183045785983,0.9147670010412571,0.6252072968490879,0.9331809420972678,1.0,14/65,14.39%,CYP26B1;CYP11B1;SDHD;FLVCR1;EIF2AK1;CYP27A1;CYCS;HCCS;SDHC;HRG;SLC48A1;CYB5A;CYP51A1;PGRMC1
prerank,hormone activity (GO:0005179),0.2754740835706222,0.9129452643015886,0.5974729241877257,0.9337664030666786,1.0,6/54,11.22%,IGF1;METRNL;CHGB;INHA;VIP;GRP
prerank,inward rectifier potassium channel activity (GO:0005242),0.3209569307802972,0.9121379159991561,0.5987903225806451,0.9317578560333014,1.0,5/24,9.74%,KCNJ13;KCNJ5;KCNJ10;KCNH2;KCNJ16
prerank,phospholipase A2 activity (GO:0004623),0.3195517609824494,0.9114960890256505,0.5866666666666667,0.9293016055088394,1.0,6/26,16.09%,PLAAT5;PLA2G4C;PNPLA8;PLA2G15;ABHD3;PLAAT3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.36631774339917145,-0.9096113633311576,0.5653061224489796,0.8326309137286795,1.0,4/11,19.68%,AKR1B1;AKR1A1;RDH11;DHRS13
prerank,ribosomal small subunit binding (GO:0043024),0.3477462797156787,0.9073820887759908,0.558648111332008,0.9356233415865467,1.0,1/17,0.46%,CPEB2
prerank,glycine binding (GO:0016594),0.3940523927364289,0.9068004821710536,0.584,0.932982964895305,1.0,3/11,6.12%,GRIN3A;GLRA1;GLDC
prerank,SH2 domain binding (GO:0042169),-0.28658744135351644,-0.9063201529682643,0.5954545454545455,0.8366095245979374,1.0,8/31,13.71%,AFAP1L2;SH3PXD2B;RACK1;SRC;SQSTM1;SH2B2;TRPV4;IRS1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.36037440426434275,-0.9047666629542461,0.6049149338374291,0.8366606834741599,1.0,3/12,10.37%,ENTPD1;ENTPD6;ENTPD2
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.36904564175673354,-0.9043750097292574,0.5833333333333334,0.8341177881238142,1.0,11/12,53.08%,ELOVL4;GPR88;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,protein kinase C binding (GO:0005080),-0.262541035223373,-0.903744962272245,0.6326086956521739,0.832018112872519,1.0,14/43,18.88%,PDLIM5;CAVIN2;ADCY4;RACK1;HDAC7;HDAC9;HSPB1;SQSTM1;GRK5;TRPV4;IRS1;TOP2A;HINT1;DSP
prerank,calcium activated cation channel activity (GO:0005227),-0.33014626299190886,-0.9037393867843997,0.6037735849056604,0.8285741611206059,1.0,7/17,31.53%,ANO1;KCNMB2;ANO6;ANO10;KCNN1;KCNMB4;KCNMA1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3533770447712552,0.8993114536583691,0.5824175824175825,0.9474266358094288,1.0,6/14,26.54%,SLC7A11;SLC25A12;SLC38A7;SLC25A13;SLC25A18;SLC17A8
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.34928050161143104,0.8991249733419876,0.5772994129158513,0.9399783507807364,1.0,6/16,14.53%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.34928050161143104,0.8991249733419876,0.5772994129158513,0.9399783507807364,1.0,6/16,14.53%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V0E2;ATP6V1C1;ATP6V0D2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3449809285593416,-0.8990867893116309,0.5622317596566524,0.8353083021599607,1.0,4/14,12.11%,SPOCK2;NGF;RECK;LXN
prerank,ubiquitin-specific protease binding (GO:1990381),0.33099011074769863,0.8980469496785068,0.591796875,0.9386906173345154,1.0,8/19,28.29%,DERL1;LCOR;BAG6;CHMP3;SART3;AMFR;SUMO1;PRKN
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.27538299460173554,-0.8979703639698862,0.6283185840707964,0.8309355731140018,1.0,9/34,19.44%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.27538299460173554,-0.8979703639698862,0.6283185840707964,0.8309355731140018,1.0,9/34,19.44%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;NDUFA1;NDUFS7;NDUFS8
prerank,ankyrin binding (GO:0030506),0.33267308233626147,0.8972071550953061,0.576,0.9368308952952696,1.0,2/19,2.85%,CACNA1D;FLNC
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.33829681258623623,-0.8950468067411154,0.5896907216494846,0.8340263694627634,1.0,3/15,12.49%,SLC1A5;SLC1A3;SLC1A1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.26872356259594404,0.894100546458635,0.6156583629893239,0.940458219531445,1.0,15/53,17.54%,DDO;DPYD;AIFM1;MICAL3;QSOX1;KMO;NDOR1;GCDH;SQLE;AIFM2;LDHD;CYB5R1;MTHFR;ILVBL;KDM1A
prerank,nuclear receptor binding (GO:0016922),0.2338513340763141,0.8909861674990863,0.685025817555938,0.9441045241342422,1.0,19/111,11.18%,PPARGC1B;DDX5;SMAD3;BRD8;HMGN3;SMARCD3;PRMT2;RNF14;MED1;PPARGC1A;TAF10;MED25;RXRA;NSD1;PRKCB;RNF6;LCOR;STAT1;TAF1
prerank,microtubule binding (GO:0008017),-0.19548496921600783,-0.889018249504345,0.8187134502923976,0.8438445062573563,1.0,77/222,27.45%,MTUS1;DNM3;DST;STARD9;MACF1;MID1;EML1;MID2;FAM161A;GABARAPL2;ARHGEF2;SGIP1;MAP4;CLIP4;MAP7D3;MAP1LC3B;APC;RPS3;CDK5;MAP4K4;NEFM;WHAMM;MAP9;FGF13;MACO1;DYNC1I1;CLIP2;KIF23;RMDN1;HDAC6;TRPV4;GAS2L1;REEP3;CLIP1;VAPB;KATNB1;KIF1C;MAP1B;FMR1;PAFAH1B1;MAST2;TOGARAM1;NUSAP1;PEX14;CEP295;GAPDH;CRIPT;KIF20B;RAB11A;CCDC69;KIF13A;REEP1;RP1;MAPRE2;PRC1;DCTN1;TPX2;KNSTRN;FSD1;KIFC1;MAP6D1;CDK5RAP2;POLB;STIM1;SYBU;NDEL1;KIF22;REEP2;VAPA;KIF14;KATNA1;MAPRE3;CCSAP;CCDC170;CAMSAP2;FBXW11;DNM1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.27158295864780463,-0.8819653321149842,0.6659877800407332,0.8553833467021299,1.0,3/35,3.38%,FOXP1;H3-3A;AGO1
prerank,iron ion binding (GO:0005506),0.26855871435686646,0.8818699173654357,0.6343692870201096,0.9626072255857449,1.0,9/48,13.53%,KDM7A;ETHE1;TET1;PHF8;HAAO;PHF2;DOHH;FDX1;CDO1
prerank,RNA polymerase II complex binding (GO:0000993),0.2876949474832621,0.8815318141138969,0.6380597014925373,0.9595056688486985,1.0,7/32,13.15%,CTR9;CCAR2;HNRNPU;CDC73;SCAF1;RPRD2;SMYD2
prerank,palmitoyltransferase activity (GO:0016409),0.2972001680994983,0.8813041560887959,0.6235955056179775,0.9561318520920505,1.0,9/28,17.44%,ZDHHC12;ZDHHC24;ZDHHC1;ZDHHC16;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,tau protein binding (GO:0048156),0.2787436910178644,0.8800250751241594,0.6469465648854962,0.9550033868101814,1.0,4/40,4.82%,ROCK2;MAP2;PICALM;TTBK2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.39263023291154797,0.8793779167514272,0.6334012219959266,0.9527555521791363,1.0,3/10,16.80%,CRMP1;DPYSL2;OPLAH
prerank,protein phosphatase 2A binding (GO:0051721),-0.2972972117759888,-0.8760217751021786,0.6557377049180327,0.8644725748012908,1.0,4/23,5.44%,DAB2IP;FOXO1;MFHAS1;STRN3
prerank,O-acyltransferase activity (GO:0008374),0.2863242037304876,0.8746130310905678,0.6575875486381323,0.9600613725201005,1.0,6/30,12.75%,SOAT2;PLA2G4C;SOAT1;MOGAT1;PLA2G15;DGAT2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.34185861432832154,0.8737953624865841,0.602,0.9581158718140103,1.0,2/15,10.02%,KMT2A;SETD4
prerank,sequence-specific mRNA binding (GO:1990825),-0.37432340605646475,-0.8736945449691333,0.6188679245283019,0.8658536259247498,1.0,4/10,25.43%,DHFR;FMR1;RBM24;TYMS
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3023111643590064,0.8715480737266831,0.6101694915254238,0.959483541272575,1.0,8/24,17.44%,ZDHHC12;ZDHHC24;ZDHHC1;ZDHHC6;ZDHHC3;ZDHHC21;GLUL;ZDHHC23
prerank,FMN binding (GO:0010181),-0.3613522344164277,-0.8695200101439772,0.6412371134020619,0.8709671973815427,1.0,5/11,32.22%,NOS3;POR;PNPO;NOS2;NOS1
prerank,ATPase regulator activity (GO:0060590),-0.2610485031819276,-0.869446777426364,0.6945701357466063,0.8676465161259844,1.0,11/38,17.83%,DNAJC1;DNAJA1;FNIP2;DNAJA2;BAG5;PFN1;GRPEL1;KATNB1;BAG1;PLN;TOR1AIP2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3300603548353023,-0.8673676350658582,0.6494845360824743,0.8682710330250212,1.0,8/15,33.61%,SCARB1;ZFYVE16;SNX10;EPB41;WDFY3;ZFYVE9;SESTD1;SCIN
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.3687977918004809,0.8673233154310693,0.612,0.9655337376810659,1.0,4/12,18.56%,GABRG1;GABRG3;GABRB2;GABRB3
prerank,SUMO transferase activity (GO:0019789),0.3368774094114383,0.8656523756863341,0.638996138996139,0.9654150490516288,1.0,4/16,16.70%,TOPORS;PIAS4;HDAC4;MDM2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.32188640301895055,-0.8654758364566898,0.6308316430020284,0.8685262999877215,1.0,5/16,16.14%,SLC26A7;SLC26A2;SLC1A1;SLC26A6;CFTR
prerank,adenylate cyclase binding (GO:0008179),0.3796849151215554,0.8630085094848845,0.6415841584158416,0.9677462011417797,1.0,1/10,0.47%,ADCY5
prerank,chemoattractant activity (GO:0042056),-0.2788264377082916,-0.8624433610569198,0.6916488222698073,0.8715031413675585,1.0,5/26,13.82%,VEGFC;BMP4;FGF2;FGF7;VEGFA
prerank,phospholipase activator activity (GO:0016004),0.378077808875803,0.8619932434262279,0.6464646464646465,0.9662973470604137,1.0,2/10,6.70%,ARHGAP6;PDPK1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.3539961857173122,-0.8587434480961196,0.6183673469387755,0.875409924694893,1.0,7/11,55.10%,SLC25A47;SLC25A45;SLC22A4;SLC22A3;SLC22A1;SLC25A48;SLC25A29
prerank,GABA-A receptor activity (GO:0004890),0.3235691217835328,0.8580192057473249,0.622093023255814,0.9715387936957887,1.0,4/18,18.56%,GABRG1;GABRG3;GABRB2;GABRB3
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.34716271218344236,-0.8562973443976404,0.655705996131528,0.8766946625797558,1.0,5/12,22.29%,CISD2;XDH;AOX1;ISCA2;FXN
prerank,ionotropic glutamate receptor binding (GO:0035255),0.37469962992774297,0.8562764734696182,0.6361829025844931,0.971918050868181,1.0,4/10,9.52%,SHISA7;SHANK1;NSF;DLG4
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.341657550857482,-0.856227190436321,0.676923076923077,0.8734371033592038,1.0,5/12,31.02%,CNOT6L;PAN3;TOE1;CNOT1;NOCT
prerank,potassium ion antiporter activity (GO:0022821),0.3344386139831861,0.8559114461327034,0.6372549019607843,0.9690095120966573,1.0,3/15,15.52%,SLC24A3;SLC9A9;SLC9A3
prerank,hexosaminidase activity (GO:0015929),0.35326309238490866,0.8557072147723034,0.6489795918367347,0.9657187068865866,1.0,4/12,13.35%,NAGA;HEXD;SPAM1;HYAL1
prerank,calcium-activated potassium channel activity (GO:0015269),-0.3563297340824658,-0.8548418196996378,0.666,0.8729018582302875,1.0,7/11,36.66%,KCNMB2;KCNU1;KCNN3;KCNN1;KCNMB4;KCNMA1;KCNMB1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3463838139182189,0.8523707958967067,0.6288032454361054,0.9696798397188031,1.0,5/13,30.04%,DICER1;SLX4;DNASE1L2;DNASE1L1;ENDOV
prerank,ribosome binding (GO:0043022),-0.24747919707575985,-0.851989893966865,0.7355555555555555,0.8753898037792461,1.0,13/46,16.86%,NAA16;SERBP1;RACK1;EEF2;SRP19;MTIF3;TMCO1;GTPBP6;SEC61A1;NOMO1;FMR1;NCLN;NAA10
prerank,kinase inhibitor activity (GO:0019210),-0.2611029807466815,-0.8515217014361313,0.6948775055679287,0.8729695641122631,1.0,11/33,23.95%,LRP6;YWHAB;NCK1;CDKN1C;PARVA;GSKIP;TAOK3;SOCS3;PRKRIP1;CDKN1B;SOCS1
prerank,glucose transmembrane transporter activity (GO:0005355),0.32486176798400296,0.8512671156535777,0.6429906542056075,0.9684273851652798,1.0,2/17,2.69%,SLC5A3;SLC5A10
prerank,microtubule minus-end binding (GO:0051011),0.3622065327822691,0.8511659410890746,0.6745689655172413,0.9648858499738164,1.0,3/13,9.36%,TUBGCP5;CEP290;TUBGCP4
prerank,voltage-gated sodium channel activity (GO:0005248),-0.28909292621690197,-0.8502527156065224,0.6942800788954635,0.8719998594313633,1.0,6/22,21.60%,CACNA1G;SCN4B;CACNA1I;SCN3A;CACNA1H;SCN7A
prerank,mRNA binding (GO:0003729),0.20103395620670017,0.8493627014604638,0.8288690476190477,0.9652554305509364,1.0,54/249,20.35%,CPEB2;CELF2;DDX5;SRRM2;NOVA1;SRSF5;ANGEL2;CPSF6;ELAVL4;ACO1;HNRNPA2B1;PABPC4L;RBM47;HNRNPU;PTBP2;NCBP3;UNK;CPEB4;HNRNPL;PTBP1;UTP23;ELAVL1;SRRM4;C1QBP;RNF20;YTHDC1;FUBP1;SLBP;NUP98;BOLL;UPF3B;PURB;FXR2;RBM5;CSDC2;ETF1;GRSF1;PCBP4;SNIP1;ELAVL2;CCT5;RNPS1;RBPMS2;PTBP3;SRSF6;CELF6;CPEB3;RBFOX1;LARP4B;PUM3;SF3B1;EIF2A;DDX3X;EIF3A
prerank,gap junction channel activity (GO:0005243),0.30556879519553043,0.8485687485670085,0.6564885496183206,0.9633185087182748,1.0,3/22,12.96%,GJB6;GJB2;GJA3
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.3055392103606449,-0.8469622665142476,0.6824457593688363,0.874621262406701,1.0,5/17,18.32%,DTYMK;NME6;CLP1;NME2;AK4
prerank,solute:anion antiporter activity (GO:0140323),-0.33316344863238295,-0.84670253645716,0.6350210970464135,0.871773257306328,1.0,2/14,1.84%,SLC26A7;SLC26A2
prerank,damaged DNA binding (GO:0003684),0.25906474267911145,0.8462862164662962,0.6756756756756757,0.9644748762290853,1.0,4/44,5.75%,DDB2;ERCC1;XRCC1;AUNIP
prerank,RNA cap binding (GO:0000339),0.3273167224585095,0.8461081431363644,0.6597744360902256,0.9611761878552334,1.0,7/16,21.39%,CYFIP2;NCBP3;CYFIP1;EIF4E2;SNUPN;LARP1;DCPS
prerank,miRNA binding (GO:0035198),-0.26679216432850017,-0.8461012228959829,0.7250554323725056,0.8695952184790291,1.0,9/30,19.09%,AGO1;ZC3H7A;PUM2;AGO2;PUM1;FMR1;RBM10;AGO4;ZC3H12A
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.30088278085428843,0.8458952806479246,0.681214421252372,0.9580799896948416,1.0,8/22,17.80%,ATP6V0A2;ATP6V0B;ATP6V1B2;ATP6V1E1;ATP6V0E2;ATP6V1C1;ATP6V0D2;ATP2A1
prerank,phospholipase inhibitor activity (GO:0004859),0.37008036856086235,0.8435945242420712,0.6615087040618955,0.959394247435103,1.0,1/10,2.90%,ANXA5
prerank,cation:chloride symporter activity (GO:0015377),0.36630733905663804,0.8421716004080797,0.6524390243902439,0.9588017979239665,1.0,3/10,11.41%,SLC6A1;SLC12A5;SLC12A1
prerank,5'-3' exonuclease activity (GO:0008409),0.33407284009824445,0.8407581638946982,0.6932038834951456,0.9582503630930407,1.0,3/14,16.96%,CPSF3;MRE11;EXOG
prerank,sodium channel regulator activity (GO:0017080),-0.2536461166498493,-0.839264659413124,0.7542735042735043,0.8791638027559486,1.0,6/37,13.84%,NEDD4L;FXYD5;CAMK2D;FXYD6;FGF13;SCN4B
prerank,wide pore channel activity (GO:0022829),0.30015199394639763,0.8391925395709939,0.6628571428571428,0.9582248193836524,1.0,3/23,12.96%,GJB6;GJB2;GJA3
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.341131055370203,-0.8386221884984921,0.6602316602316602,0.8770657429517404,1.0,8/12,35.91%,GNS;ARSA;SGSH;ARSJ;IDS;SULF1;ARSI;SULF2
prerank,cytochrome-c oxidase activity (GO:0004129),0.3267955648791018,0.8385304368757718,0.681640625,0.95603259492131,1.0,4/15,12.68%,COX7A1;COX7A2L;CYB5A;COX10
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3405503684143296,-0.8385087871434748,0.6730769230769231,0.8739932897516216,1.0,3/11,17.86%,ALKBH1;RPS3;NEIL3
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.23067541685124193,-0.8376069332956955,0.7470997679814385,0.8725008644718562,1.0,22/57,29.48%,NDUFA10;NDUFA8;NDUFS6;NDUFA7;NDUFA5;NDUFA4;UQCR11;COX8A;UQCRFS1;COX4I1;NDUFA1;NDUFS7;NDUFS8;COX15;UQCR10;NDUFA4L2;CYBRD1;UQCRC1;NDUFB8;COX4I2;CYB561D2;NDUFA9
prerank,pseudouridine synthase activity (GO:0009982),-0.32771666386516995,-0.8374542340095708,0.6519114688128773,0.8695397656255057,1.0,5/13,29.10%,PUS3;PUS7L;DKC1;PUSL1;RPUSD3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.30443049721226095,-0.8366090197143708,0.6964656964656964,0.8679736028485414,1.0,7/18,20.35%,PIK3R1;SOCS2;PIK3R6;SOCS5;CISH;SOCS3;AGAP2
prerank,pyrophosphatase activity (GO:0016462),0.2517511623693747,0.8357574983476131,0.7332123411978222,0.9580982236371238,1.0,10/50,14.68%,BNIPL;FITM2;ENPP3;PRUNE1;PRUNE2;NUDT4;CILP2;TRPM2;NUDT11;PPA1
prerank,MAP kinase phosphatase activity (GO:0033549),0.35909245571695886,0.8344009535235288,0.662,0.9572614566295804,1.0,1/12,1.62%,DUSP29
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.3346379878811936,0.8288331500343837,0.7115009746588694,0.9650971918436897,1.0,2/13,4.09%,GABRG1;GLRA1
prerank,ferrous iron binding (GO:0008198),-0.2897360420490687,-0.8284546692266677,0.7171717171717171,0.8791901347048096,1.0,9/21,29.61%,FTO;ALKBH1;FTL;ALKBH2;FXN;EGLN3;FECH;FTH1;ACP5
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3318968674503244,-0.828334190791745,0.6881287726358148,0.8762110356157794,1.0,3/12,14.21%,SPPL3;DDI2;HM13
prerank,thyroid hormone receptor binding (GO:0046966),0.282984475760736,0.8274993110453512,0.7131931166347992,0.9642339637958622,1.0,5/28,9.97%,BRD8;HMGN3;PRMT2;MED1;NSD1
prerank,WW domain binding (GO:0050699),0.2863937826575932,0.8242829716128414,0.7060998151571165,0.9669934386490491,1.0,7/26,16.67%,NDFIP1;TNK2;CDC25C;WBP11;PMEPA1;NDFIP2;SCNN1A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.27377985056332854,-0.8239666588829883,0.7248995983935743,0.8809337672328204,1.0,7/24,19.48%,EEF2K;CAMK2D;MAPKAPK2;PTK2B;PHKA2;MKNK2;CAMK1G
prerank,NADPH binding (GO:0070402),-0.32524532456541144,-0.8239219468193562,0.698076923076923,0.8778073990602083,1.0,5/13,21.34%,QDPR;DHFR;CBR3;KCNAB1;GRHPR
prerank,endopeptidase activity (GO:0004175),-0.18043695744471067,-0.8220071388316782,0.9575070821529745,0.8780628144438039,1.0,47/257,18.92%,ADAMTSL3;ECE1;ADAMTSL1;HTRA3;PCSK5;FAP;F3;USP24;ADAMTS5;ADAMTS17;PIK3IP1;ADAMTS6;ADAM10;PSMA6;ADAMTS1;PSMB7;USP46;CASP7;ADAM19;ADAMTS14;USP7;DDI2;CTSO;USP35;PSMB6;MMP11;MALT1;CTSB;PSMB5;ADAMTS20;ACE2;USP47;TPP2;PSMB8;ADAMTS2;ADAM33;TYSND1;RHBDD1;CTSF;PHEX;ADAMTS12;CTSS;MMP2;PSMB4;UCHL1;PSEN2;USP10
prerank,translation elongation factor activity (GO:0003746),0.3222934530622207,0.8209305892811815,0.6855575868372943,0.9700994545670922,1.0,2/14,5.24%,GTPBP1;TUFM
prerank,poly(A) binding (GO:0008143),0.29582362240075266,0.8197919672485988,0.708411214953271,0.9689050327316131,1.0,4/21,8.35%,ELAVL4;PABPC4L;HNRNPU;TIA1
prerank,actinin binding (GO:0042805),0.2949780256156065,0.8187702756315116,0.7074569789674953,0.9673659616008659,1.0,3/21,8.50%,CACNA1D;CSRP3;CSRP1
prerank,ribonuclease activity (GO:0004540),0.24035800364281132,0.8180697564929191,0.7737226277372263,0.9653310741410199,1.0,11/56,16.96%,RNASEH2A;YBEY;CPSF3;EXOSC8;EXOSC2;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,motor activity (GO:0003774),-0.2218041488353008,-0.8169496280525893,0.8157303370786517,0.883677986068004,1.0,19/60,25.85%,MYH9;STARD9;DYNC1I2;MYL6;DYNLRB1;DNAH2;DYNC1I1;KIF23;KIF1C;KIF24;DNAH3;KIF20B;KIF13A;GPR88;MYO1E;KIFC1;KIF22;KIF4A;KIF14
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.3142966775809074,-0.8157588362534453,0.7171314741035857,0.8825830283547602,1.0,4/14,18.32%,DTYMK;NME6;NME2;AK4
prerank,anion:anion antiporter activity (GO:0015301),0.3143910139020338,0.81568024049024,0.6827852998065764,0.9666490545114359,1.0,6/17,16.05%,SLC26A1;SLC25A5;SLC25A11;SLC19A1;SLC4A3;SLC26A11
prerank,Hsp70 protein binding (GO:0030544),0.27280478005538467,0.8149252899763761,0.7282608695652174,0.9645821599544899,1.0,7/31,15.61%,DNAJC18;DNAJB14;PPEF2;DNAJC10;GPR37;TSC1;DNAJB2
prerank,growth factor activity (GO:0008083),0.22926095811056338,0.8123344919227867,0.7955706984667802,0.9659770653550774,1.0,12/74,15.61%,FGF1;FGF4;FGF9;NRTN;NRG1;INHA;ENDOU;BDNF;HBEGF;CSPG5;IL6;HGF
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.33729603524459567,0.8121348104548722,0.7159309021113244,0.962976295034209,1.0,6/12,21.39%,CYFIP2;NCBP3;CYFIP1;EIF4E2;LARP1;DCPS
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3517361726661821,0.8092019139045922,0.7044534412955465,0.9649237528639443,1.0,6/11,22.88%,CASP3;CFLAR;CASP12;PYCARD;CASP9;CASP6
prerank,aspartic-type peptidase activity (GO:0070001),-0.33674925448917625,-0.8077884144592115,0.7267326732673267,0.8923424047780778,1.0,2/10,8.63%,CTSD;DDI2
prerank,phospholipase activity (GO:0004620),0.23246152745115872,0.8075821172316989,0.8016949152542373,0.9647695652842145,1.0,15/67,16.09%,ASPG;PLAAT5;PLA2G4C;DDHD2;PNPLA8;SMPD3;SEC23IP;SMPD2;PLA2G15;ABHD3;GDE1;PLBD2;PLCB3;PDIA3;PLAAT3
prerank,NADP binding (GO:0050661),-0.2558243930818687,-0.8073636996170044,0.7387580299785867,0.8898265525106811,1.0,8/32,21.34%,NOS3;ME1;CAT;QDPR;DHFR;CBR3;KCNAB1;GRHPR
prerank,chloride channel inhibitor activity (GO:0019869),0.3491712424215866,0.8065835291301691,0.6892430278884463,0.9632841716882936,1.0,2/10,6.71%,WNK3;WNK4
prerank,RNA polymerase core enzyme binding (GO:0043175),0.2611712120342159,0.80542128372076,0.7696629213483146,0.9620417415065841,1.0,10/33,21.98%,CTR9;CCAR2;HNRNPU;CDC73;RPRD2;SMYD2;RRN3;SUPT4H1;SPTY2D1;WDR43
prerank,poly(U) RNA binding (GO:0008266),0.30014551929901495,0.8046566732478246,0.74573055028463,0.9601395154404786,1.0,3/20,6.28%,RBM11;PABPC4L;PATL1
prerank,poly-purine tract binding (GO:0070717),0.2796488554983487,0.8038324173687372,0.7564102564102564,0.9582639563090333,1.0,5/27,8.35%,ELAVL4;PABPC4L;HNRNPU;PATL1;TIA1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.3162210385389305,-0.7995958907366799,0.7534791252485089,0.8992986274892473,1.0,3/13,6.98%,SLC38A5;SLC7A7;SLC7A1
prerank,methyltransferase activity (GO:0008168),0.24449945957176716,0.7970634190412568,0.7811387900355872,0.966825401330991,1.0,15/46,21.97%,METTL27;ARMT1;N6AMT1;NSUN3;BCDIN3D;TRMT11;COMT;NSUN2;PRMT3;NTMT1;RRP8;COMTD1;COQ3;AS3MT;PRMT5
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.30772518172323715,-0.7959535295173139,0.7374517374517374,0.9018546961392903,1.0,5/14,17.39%,MTMR11;MTMR7;MTMR12;MTMR1;PTEN
prerank,I-SMAD binding (GO:0070411),-0.305533700493756,-0.7958195599731943,0.7163561076604554,0.8989547441581202,1.0,3/13,5.44%,SMURF1;SMAD5;SMAD1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.30110502812853046,-0.7946951418133558,0.7316561844863732,0.8974925891908204,1.0,4/14,16.72%,TSEN2;ELAC2;RPP21;RPP38
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.3431054282084733,0.793569121448569,0.7125,0.9695299719697792,1.0,3/10,18.78%,NOX1;CYBA;NCF1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.28613599210477175,0.7932529486481862,0.7455968688845401,0.9667569768552555,1.0,5/22,13.57%,OPTN;IKBKG;SPRTN;IKBKE;OTUD7A
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3380740498435564,0.7929631201346306,0.7349397590361446,0.9640061339329098,1.0,1/10,0.63%,DSC2
prerank,MHC class I protein binding (GO:0042288),0.31754076187746855,0.7893936797263259,0.7129629629629629,0.9668431584444593,1.0,1/13,2.18%,DERL1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.32206446296668145,-0.7892216342941197,0.7425149700598802,0.9030701938424405,1.0,7/11,43.29%,NAA16;NAA10;NAA15;NAA50;NAA60;NAA40;NAA11
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.3300110277328885,-0.7887774019828595,0.7216699801192843,0.9005128026250386,1.0,4/10,29.65%,NAA16;NAA10;NAA15;NAA50
prerank,tubulin binding (GO:0015631),0.18235474733833013,0.7863412528890094,0.9674556213017751,0.9688120173088526,1.0,33/295,10.61%,GJB6;FMN1;MTUS2;MAP2;EML4;KIF5C;TTLL6;CLIP3;IFT74;IRAG2;EML2;PLK1;PRUNE1;CLASP1;DNAL1;KIF3C;PDCD5;KIF16B;ABRAXAS1;AGBL4;TBCE;KIF13B;TUBGCP5;LRRK2;GOLGA2;HTT;SKA2;TUBGCP4;NDRG1;DRG1;APC2;SBDS;RITA1
prerank,DNA secondary structure binding (GO:0000217),-0.24319833956917847,-0.7808807901058483,0.8156182212581344,0.9094867268887146,1.0,5/31,12.68%,MEF2C;RAD51B;XPC;BLM;LIN54
prerank,leucine zipper domain binding (GO:0043522),0.34285938940022925,0.7808077598176452,0.7388663967611336,0.9747631099459887,1.0,1/10,2.44%,PAWR
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.24008170111167226,-0.7807724435986805,0.811816192560175,0.9064448335264044,1.0,7/34,12.38%,STK3;IQGAP1;CAB39;CALM3;SPRY2;IGF2;INCENP
prerank,chloride channel regulator activity (GO:0017081),0.3130572531779301,0.7803825986242628,0.727810650887574,0.9722339635194962,1.0,2/14,6.71%,WNK3;WNK4
prerank,transferrin receptor binding (GO:1990459),0.3341576706623125,0.780080191219042,0.746268656716418,0.9694447842594115,1.0,2/10,6.34%,CHUK;IKBKG
prerank,protein phosphatase activator activity (GO:0072542),0.31477729818169137,0.7777197282171866,0.7465069860279441,0.9700679596015681,1.0,2/13,7.65%,IGFBP3;PHACTR4
prerank,mannosyltransferase activity (GO:0000030),-0.2733204408547685,-0.7767871831290499,0.8111111111111111,0.9091847644294946,1.0,2/21,5.06%,TMTC2;TMTC1
prerank,peptide hormone receptor binding (GO:0051428),0.332485463988287,0.7756021723996829,0.7265625,0.9703759281069266,1.0,3/11,19.82%,VIP;PSMC5;GNRH1
prerank,ligand-gated anion channel activity (GO:0099095),0.2991331352829823,0.7752802230349676,0.763915547024952,0.9677347267326964,1.0,5/17,18.56%,GABRG1;GLRA1;GABRG3;GABRB2;GABRB3
prerank,single-stranded DNA binding (GO:0003697),0.20908869345580633,0.773562272641592,0.8764805414551607,0.9672773875539038,1.0,22/93,19.36%,ERCC1;PMS2;HNRNPU;MEIOB;SPRTN;SSBP2;TDP2;SSBP1;WBP11;FUBP1;PURB;MSH3;RAD51D;RNF138;POLR3C;RPA3;MCM7;POLR2D;MCMDC2;RAD52;HMCES;LONP1
prerank,NF-kappaB binding (GO:0051059),0.2711252482000349,0.7712838196742978,0.7663551401869159,0.9675720223797568,1.0,5/24,17.40%,CDKN2A;CPNE1;COMMD7;COMMD6;RELA
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.2700921904396838,-0.7651633024495651,0.7845849802371542,0.9224129492761016,1.0,5/20,16.55%,EIF3H;USP7;EIF3F;USP47;USP50
prerank,mRNA methyltransferase activity (GO:0008174),0.3150259014836418,0.7631990639506374,0.75,0.9766776332062782,1.0,5/12,23.41%,RNMT;NSUN2;TRMT61B;TRMT10C;METTL8
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.30890948717543837,0.7624594616568113,0.7494824016563147,0.9747460959900448,1.0,4/12,17.40%,RUVBL2;STAT1;TAF1;RELA
prerank,endoribonuclease activity (GO:0004521),0.24882038370220425,0.7616897304045926,0.8207547169811321,0.9726858288713446,1.0,8/32,16.96%,YBEY;CPSF3;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.2237785692288221,0.7574301461475965,0.8754512635379061,0.9759290663427326,1.0,10/54,15.49%,UPB1;ASPG;PM20D1;MIER3;ASPA;GLS2;HINT3;HDAC4;NAAA;SIRT1
prerank,alpha-actinin binding (GO:0051393),-0.2540045468527429,-0.7555235580458546,0.805327868852459,0.9319699325410681,1.0,4/24,11.65%,PDLIM5;PALLD;SYNPO2;LDB3
prerank,lysophospholipase activity (GO:0004622),-0.25954608177304045,-0.7523648299809566,0.8319148936170213,0.9330380492532531,1.0,4/20,14.39%,PLA2G4A;MGLL;ABHD4;PLA2G6
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2087483566671413,0.7508830948255142,0.8928571428571429,0.9823031203010752,1.0,15/75,19.29%,ADH7;ADH4;SORD;ME2;PTGR1;DHRS11;BDH1;SDR42E1;GFUS;LDHD;LDHB;PRXL2B;HSD17B11;HMGCR;HSD17B4
prerank,single-stranded RNA binding (GO:0003727),0.23711646293510455,0.7496381148608943,0.8377862595419847,0.9809093581368291,1.0,15/43,25.35%,RBM11;HNRNPU;PTBP1;ZFR2;SRA1;AGO3;TLR8;POLR2D;LONP1;ILF3;DDX3X;DHX58;SNRPC;JMJD6;U2AF2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.2297583468954134,-0.7488515816863185,0.8704545454545455,0.9345671291888014,1.0,11/34,21.77%,UBE2D3;UBE2J1;UFC1;UBE2F;UBE2L3;UBE2Q1;UBE2J2;UBE2A;UBE2G1;UBE2QL1;UBE2Z
prerank,general transcription initiation factor binding (GO:0140296),-0.24645219868757667,-0.7472311839709433,0.853763440860215,0.9334170485264561,1.0,5/25,17.42%,ESR1;AR;AHR;HHEX;RUVBL1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.321205591731187,0.7457044501354287,0.792,0.9832551165873945,1.0,2/10,7.91%,B4GALT1;B3GALT6
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.31808250866246623,0.7419741276662951,0.7560483870967742,0.9852604632723448,1.0,2/10,4.38%,PIK3R3;PIK3CB
prerank,phospholipase binding (GO:0043274),0.3025217377476306,0.7413134186080834,0.8011583011583011,0.9829667259122653,1.0,2/13,6.70%,ARHGAP6;PDPK1
prerank,peptidoglycan binding (GO:0042834),0.32346481967943197,0.7406803766726535,0.7902912621359224,0.9807095276631838,1.0,3/10,15.83%,PGLYRP3;NLRP3;HK1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32492311554635045,0.7405413139018739,0.7875751503006012,0.977768747943047,1.0,10/10,67.53%,APEX1;MGME1;TATDN1;DCLRE1A;POLD1;EXD2;EXO1;DCLRE1B;DCLRE1C;FEN1
prerank,lipid phosphatase activity (GO:0042577),-0.2897920851978078,-0.7402722788907151,0.8291139240506329,0.9387034175186629,1.0,5/14,24.39%,PLPP1;PLPP3;SGPP1;PLPP2;PLPP6
prerank,deubiquitinase activity (GO:0101005),-0.1880452168920901,-0.7391447753870206,0.9445727482678984,0.9370664284722321,1.0,24/88,25.21%,USP53;USP24;EIF3H;USP46;OTUD7B;MINDY1;USP7;USP35;EIF3F;MINDY2;USP47;USP50;JOSD1;PSMD14;UCHL1;USP10;ZC3H12A;UCHL5;USP15;CYLD;ATXN3;OTUB2;USP1;UFD1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.313282256993493,0.7389686813316331,0.7784552845528455,0.9767681825476161,1.0,1/11,4.43%,ARG2
prerank,endonuclease activity (GO:0004519),0.22059817489474468,0.7368609869388835,0.8825688073394495,0.9765637912795745,1.0,10/49,16.96%,YBEY;CPSF3;MBD4;MRE11;ENDOU;AGO3;DICER1;SND1;SMG6;EXOG
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.2932214077517775,0.7316233634117753,0.8167006109979633,0.9804217080042261,1.0,4/15,17.39%,AGPAT4;ABHD5;LCLAT1;AGPAT2
prerank,deoxyribonuclease activity (GO:0004536),0.29392621712527345,0.730666099764545,0.8138195777351248,0.9786527395673063,1.0,9/14,32.22%,MBD4;MRE11;DNASE1L2;APEX1;DNASE1L1;MAP1S;ZRANB3;NME1;ERCC5
prerank,P-type ion transporter activity (GO:0015662),-0.29271788487980976,-0.7299687956442747,0.8317025440313112,0.944867722328544,1.0,2/12,8.58%,ATP2B1;ATP2A3
prerank,exonuclease activity (GO:0004527),0.22144084138874962,0.7271315896445154,0.8904109589041096,0.980037112344104,1.0,8/46,16.96%,ENPP3;CPSF3;EXOSC8;MRE11;EXOSC2;AEN;POLG;EXOG
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.32047404411189845,0.7270288741446834,0.7911646586345381,0.9771102220747482,1.0,5/10,22.88%,CASP3;CFLAR;CASP12;CASP9;CASP6
prerank,carboxy-lyase activity (GO:0016831),0.25820011844026347,0.7267758470521049,0.8611632270168855,0.9744310772087923,1.0,7/23,23.25%,GGCX;GAD1;AZIN2;UMPS;FAHD1;PISD;BCKDHA
prerank,cysteine-type endopeptidase activity (GO:0004197),0.20134017064564597,0.7265040783981946,0.9442446043165468,0.9717715224545506,1.0,23/78,23.29%,CAPN3;USP11;CASP3;USP12;USP18;USP26;USP40;CFLAR;CTSH;USP20;PDIA3;USP42;USP9X;USP48;CASP12;CAPN15;USP16;PYCARD;CAPN10;CAPN11;CASP9;CASP6;LGMN
prerank,tropomyosin binding (GO:0005523),0.2809033630703852,0.72045932886243,0.8507462686567164,0.9760263371223796,1.0,2/16,9.02%,NEBL;TMOD2
prerank,regulatory RNA binding (GO:0061980),-0.2167821497636888,-0.7184292926285942,0.908883826879271,0.9548707155144509,1.0,12/38,25.43%,AGO1;ZC3H7A;PUM2;AGO2;PUM1;FMR1;RBM10;AGO4;ZC3H12A;PIWIL2;TARBP2;MATR3
prerank,kinesin binding (GO:0019894),-0.22490831755607366,-0.7173230638106002,0.8837719298245614,0.9529206431537773,1.0,5/27,19.70%,ACTB;AP1AR;ATCAY;ARHGEF10;PRC1
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.22066385087138285,-0.7127709319733981,0.9068736141906873,0.9546760183021349,1.0,7/38,16.63%,SHANK3;PIK3R1;NCK1;SPATA2;SH2B2;IRS1;LDLRAP1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.30074229456124,-0.7114940564683554,0.8397565922920892,0.9527969913999805,1.0,5/10,31.29%,ANKRD13A;ANKRD13B;ANKRD13D;FAAP20;LAPTM5
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19495400768383145,0.7095527137783678,0.9462738301559792,0.9854968595801589,1.0,19/83,19.12%,USP11;OTUD4;USP12;USP18;USP26;USP19;USP40;STAMBP;USP20;USP39;OTUD7A;DESI2;UCHL3;USP42;USP9X;USP48;USP31;USP21;USP16
prerank,CCR chemokine receptor binding (GO:0048020),-0.23222874069623023,-0.7075159369275055,0.8731501057082452,0.9539084903997759,1.0,19/28,48.65%,CCL13;CCL25;CCR2;NARS1;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL19;CCL14;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2680343002243223,-0.7063826343422269,0.8548057259713702,0.9517727849708626,1.0,5/16,17.39%,MTMR11;MTMR7;MTMR12;MTMR1;PTEN
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.2288159992697214,0.7052031748732523,0.9005424954792043,0.9874790510726859,1.0,11/37,19.41%,HARS2;TARS2;RARS2;QARS1;EPRS1;DARS2;TARS1;IARS2;FARSA;IARS1;YARS1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.29092524399372993,-0.7000729298021819,0.8516949152542372,0.9549094110306358,1.0,7/11,48.72%,CXCL12;CXCL5;CXCL1;PF4;PPBP;CXCL13;CXCL2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.26893757382934397,-0.6947356133135038,0.8734939759036144,0.9568592677882061,1.0,6/14,21.80%,QDPR;ALDH1L2;DHFR;NOXRED1;BLVRB;PYCR3
prerank,nucleotidyltransferase activity (GO:0016779),0.25822343925683566,0.6943722356585431,0.869811320754717,0.9956509261394588,1.0,5/19,14.82%,TENT4A;REV1;TUT4;TERT;CRPPA
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.2916143610343961,0.6896392678377601,0.8256513026052105,0.9974729784173374,1.0,11/11,70.86%,CNGB1;HCN1;CNGA1;KCNA10;HCN2;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4
prerank,omega peptidase activity (GO:0008242),0.18709355544502826,0.6886686205027888,0.9689655172413794,0.9954542229229187,1.0,20/89,19.12%,USP11;OTUD4;USP12;USP18;USP26;USP19;USP40;STAMBP;USP20;USP39;OTUD7A;DESI2;UCHL3;GGT5;USP42;USP9X;USP48;USP31;USP21;USP16
prerank,endopeptidase activator activity (GO:0061133),-0.2896179561279132,-0.6857329692402606,0.874274661508704,0.9619943521358194,1.0,4/10,21.46%,ADRM1;PSMD14;PSENEN;PSME1
prerank,5'-nucleotidase activity (GO:0008253),-0.2735481162259993,-0.6855219764891705,0.8802395209580839,0.9590723520051725,1.0,4/13,22.12%,NT5C1A;NT5E;NT5C;ACP3
prerank,calcium channel inhibitor activity (GO:0019855),-0.278116666894038,-0.6771995914900186,0.868,0.9634673328901678,1.0,2/11,9.50%,SLC30A1;MCUB
prerank,pyridoxal phosphate binding (GO:0030170),-0.23504006304807729,-0.6730059416339635,0.8993839835728953,0.9638283331758758,1.0,9/20,28.59%,SRR;PYGB;THNSL2;PDXK;PNPO;SHMT2;AGXT;CBS;SHMT1
prerank,four-way junction DNA binding (GO:0000400),0.2555043582784108,0.6724889249490212,0.8998109640831758,1.0,1.0,6/17,21.15%,MSH6;MEN1;RAD51D;ABL1;XRCC2;RAD51C
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.2137826086992004,-0.6711546157445758,0.9366053169734151,0.9621973131013405,1.0,8/29,24.76%,ACER2;GAA;PARG;ACER3;ENGASE;HPSE;PGGHG;GANAB
prerank,cysteine-type peptidase activity (GO:0008234),0.1868383882937059,0.6682461585657773,0.9741219963031423,1.0,1.0,17/73,19.12%,CAPN3;USP11;CASP3;USP12;USP18;USP26;ATG4D;USP40;CTSH;USP20;ATG4C;PDIA3;USP42;USP9X;USP48;USP21;USP16
prerank,tRNA binding (GO:0000049),0.20621467831338175,0.6668440669259141,0.9484902309058615,1.0,1.0,11/43,21.51%,TRMT9B;PSTK;NEMF;DARS2;NSUN2;TERT;NSUN6;ELP5;TRMT10C;EIF2A;DALRD3
prerank,aminopeptidase activity (GO:0004177),-0.21734117588065885,-0.6609773793872328,0.9388185654008439,0.9671310669737816,1.0,9/26,26.71%,ENPEP;LAP3;METAP1D;LNPEP;RNPEPL1;ERAP1;KDM8;XPNPEP1;JMJD7
prerank,snRNA binding (GO:0017069),0.20322714047116208,0.6560090594685141,0.960431654676259,1.0,1.0,14/42,23.82%,CCNT2;HNRNPU;LSM4;LSM11;LSM8;HEXIM2;SNU13;DDX39B;SNRPB2;LARP7;SART3;SF3B3;EFTUD2;SNRPC
prerank,phosphatidate phosphatase activity (GO:0008195),0.2648827189621129,0.6548785503684879,0.8825831702544031,1.0,1.0,2/13,8.88%,LPIN1;PLPPR3
prerank,adenylyltransferase activity (GO:0070566),0.24065749974137318,0.6522982895381214,0.9174484052532833,1.0,1.0,5/21,15.25%,OAS2;TENT4A;OAS3;PAPOLB;ABL1
prerank,MHC protein binding (GO:0042287),-0.223441567193773,-0.6513747205218773,0.9284253578732107,0.9710137085592176,1.0,3/20,11.83%,TAP2;ATP5F1B;CD74
prerank,disordered domain specific binding (GO:0097718),0.22946775978304115,0.6496378605125922,0.9314516129032258,1.0,1.0,1/23,0.70%,HSPA1A
prerank,exopeptidase activity (GO:0008238),0.19201347438083735,0.6451382369730441,0.9770318021201413,1.0,1.0,8/50,15.33%,METAP2;CTSA;DPP8;CPA2;DPP10;CTSH;CNDP2;TRHDE
prerank,phosphatidylinositol kinase activity (GO:0052742),0.2521077242597962,0.644848866228571,0.8888888888888888,1.0,1.0,4/15,15.99%,PIK3R3;PIK3CB;PI4KA;ATM
prerank,RNA stem-loop binding (GO:0035613),0.2690020509390996,0.643684105637055,0.892,1.0,1.0,5/12,24.95%,EPRS1;CPEB3;DDX3X;CSDE1;MYH10
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.2700161416403539,0.6432163094953804,0.902834008097166,1.0,1.0,6/11,28.34%,NUDT4;NUDT11;DCPS;DCP2;NUDT3;NUDT5
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.24880597561959744,-0.640060792566544,0.9290060851926978,0.9757414910595918,1.0,6/13,32.05%,KCNQ1;PRKAR2B;PRKAR1B;PKIA;PRKAR2A;CSK
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.22801385468554358,0.6385815523442911,0.9254302103250478,1.0,1.0,3/22,13.69%,DUSP29;MTMR2;DUSP19
prerank,phosphate ion binding (GO:0042301),-0.2673484155013232,-0.6364086289177905,0.8923679060665362,0.9749087273612689,1.0,4/10,31.14%,PDE2A;ADSS1;ADSS2;CHST14
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.23156932057165083,-0.6359522102010522,0.9211087420042644,0.9720458501238242,1.0,4/16,20.44%,SLC44A2;SLC44A1;SLC7A8;SLC5A7
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.21374200009051708,-0.6316690740314107,0.9627192982456141,0.9715323593760398,1.0,12/24,39.32%,DTYMK;NME6;NME2;AK4;PPIP5K1;PMVK;ITPKC;ITPKB;PPIP5K2;ITPKA;IP6K3;NME4
prerank,3'-5' exonuclease activity (GO:0008408),-0.18358715326777328,-0.6307708542360299,0.9727891156462585,0.9690027884799811,1.0,16/45,31.86%,CNOT6L;REV3L;REXO4;TRIR;TOE1;ERI2;EXD1;EXOSC4;EXOSC5;EXOSC3;XRN2;ERI1;DIS3L2;NOCT;ISG20;APLF
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2128991090261546,0.6253438662665678,0.949814126394052,1.0,1.0,4/28,13.90%,RNASEH2A;POP4;AGO3;DICER1
prerank,exoribonuclease activity (GO:0004532),-0.2573533669535174,-0.6251780700667205,0.9126984126984127,0.9692593933521296,1.0,5/12,26.86%,EXOSC1;ZC3H12A;EXOSC4;EXOSC5;EXOSC3
prerank,TBP-class protein binding (GO:0017025),-0.21392016654636753,-0.6223538831939034,0.9643605870020965,0.9679504870855199,1.0,4/21,17.42%,ESR1;AHR;HHEX;RUVBL1
prerank,MAP-kinase scaffold activity (GO:0005078),-0.2612796617778754,-0.6168205863808226,0.9145833333333333,0.967976996526659,1.0,1/11,2.65%,IQGAP1
prerank,RNA methyltransferase activity (GO:0008173),0.22398002434093184,0.6085788195336821,0.9420560747663551,1.0,1.0,2/19,8.94%,TRMT9B;BCDIN3D
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.19003437596682163,0.6083734278441287,0.9814814814814815,1.0,1.0,3/42,7.58%,CDKN2A;CCNT2;CCNYL1
prerank,microtubule motor activity (GO:0003777),0.1831753742122496,0.6064619511239977,0.9869402985074627,1.0,1.0,10/51,18.89%,DNAH1;KIF5C;KIF3C;KIF16B;KIF13B;KIF3A;SMC3;KIF1B;KIF3B;KIF1A
prerank,water transmembrane transporter activity (GO:0005372),-0.24405595514855133,-0.6059887570760557,0.9259259259259259,0.970253811549848,1.0,1/11,5.70%,AQP11
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.25968059139788036,-0.6050590845532748,0.9421157684630739,0.9677076732582219,1.0,5/10,40.29%,BRCA2;MSL3;NAA50;NAA60;NAA40
prerank,O-methyltransferase activity (GO:0008171),0.2655026338680177,0.6030970191588806,0.9289827255278311,1.0,1.0,3/10,19.74%,BCDIN3D;COMT;COQ3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.25388701989333595,-0.6008693109117369,0.9141221374045801,0.9666274526654864,1.0,4/10,25.58%,CDA;GDA;ADA;DCTD
prerank,mannose binding (GO:0005537),-0.24353777034937005,-0.599445060045527,0.9417879417879418,0.9642713697691075,1.0,1/12,4.00%,LMAN2L
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.19796823677169917,0.5984187076334778,0.967680608365019,1.0,1.0,9/33,23.21%,ANGEL2;EXOSC2;ANGEL1;USB1;DIS3L;CNOT8;PNLDC1;DCP2;PAN2
prerank,CoA hydrolase activity (GO:0016289),0.23038214529002937,0.5933136768948085,0.9539347408829175,1.0,1.0,5/16,22.40%,ABCD1;ACOT1;ACOT6;ACOT13;ACOT9
prerank,neuropeptide hormone activity (GO:0005184),0.21330318447333696,0.5836799794245858,0.9559386973180076,1.0,1.0,22/22,78.70%,VIP;GRP;PENK;PPY;HCRT;OXT;CORT;QRFP;GHRH;NPPA;ADCYAP1;UCN;CALCB;GAL;SPX;CRH;NMB;PNOC;NPFF;NPY;CCK;AGRP
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.2161646741690789,0.5835396072364955,0.9513618677042801,1.0,1.0,6/21,16.67%,WASF1;RYR2;WASF3;AKAP8;AKAP6;AKAP8L
prerank,gamma-tubulin binding (GO:0043015),0.21098271948516106,0.5828246072613921,0.9668615984405458,1.0,1.0,4/21,14.01%,TUBGCP5;TUBGCP4;NDRG1;RAD51D
prerank,vitamin D receptor binding (GO:0042809),0.23273959955875373,0.582016984333364,0.9423459244532804,1.0,1.0,2/14,9.58%,MED1;RXRA
prerank,U6 snRNA binding (GO:0017070),0.23156407539297752,0.5796380135631731,0.9601593625498008,1.0,1.0,6/14,26.06%,LSM4;LSM8;DDX39B;LARP7;SART3;PRPF8
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2000850397172799,0.5782156237946631,0.9790874524714829,0.9983860372494806,1.0,8/25,24.24%,TNKS2;PARP14;PARP4;PARP16;SIRT1;ART4;PARP10;TIPARP
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.23590043078233427,0.5738995774303067,0.9400386847195358,0.997448281929806,1.0,1/11,8.71%,CHRNB2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.17868768475667332,-0.5710261287088393,0.9825708061002179,0.9728025559345136,1.0,13/34,31.80%,CNOT6L;PAN3;TOE1;ERI2;EXOSC4;EXOSC5;EXOSC3;XRN2;ERI1;CNOT1;DIS3L2;NOCT;ISG20
prerank,ribonuclease P RNA binding (GO:0033204),0.24849725376920062,0.5679261106082435,0.9323770491803278,0.9969091266898252,1.0,1/10,5.54%,POP4
prerank,nuclear localization sequence binding (GO:0008139),0.21867867358405693,0.5608989280165185,0.95703125,0.996765231305407,1.0,4/18,16.46%,POM121;BRAP;TNPO2;IPO4
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.1850173260042225,0.5513353211324665,0.9835164835164835,0.9972859995657317,1.0,1/31,0.58%,UBE2E2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.20847650827626923,0.5427098604807453,0.9852670349907919,0.997378095497287,1.0,5/17,22.40%,ABCD1;ACOT1;ACOT6;ACOT13;ACOT9
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.1918254641118707,0.5383985766998964,0.9806576402321083,0.9959274254155701,1.0,20/21,59.62%,CHRNB2;GRM5;GRM1;CHRNA7;CHRFAM7A;CHRNA2;CHRNA6;DRD4;ANXA9;GRIA1;DRD1;CHRNA1;DRD5;CHRNA4;CHRNB3;CHRNB4;CHRNE;CHRNA3;CHRNG;CHRNA5
prerank,ribonuclease P activity (GO:0004526),0.22916843527624287,0.5377382451983987,0.9562624254473161,0.9933483471884497,1.0,1/11,5.54%,POP4
prerank,nuclear import signal receptor activity (GO:0061608),0.2040025106601286,0.5098765766262935,0.980276134122288,0.9974551920617938,1.0,4/15,22.18%,TNPO3;TNPO2;IPO4;RANBP6
prerank,3'-5' DNA helicase activity (GO:0043138),0.18975339606200986,0.4772300941921646,0.9787234042553191,1.0,1.0,1/16,3.36%,RECQL4
prerank,sodium channel activity (GO:0005272),0.14048036914550738,0.43957886105010074,1.0,1.0,1.0,9/37,24.41%,GRIK5;GRIK2;SHROOM2;SCN8A;SCNN1A;SCN9A;ASIC4;ASIC2;HCN1
prerank,carbohydrate kinase activity (GO:0019200),0.18597790610092896,0.4261773214136774,0.9920792079207921,1.0,1.0,11/11,81.42%,HK1;KHK;HK2;POMK;NAGK;GALK1;GNE;HK3;FGGY;XYLB;GALK2
prerank,nuclease activity (GO:0004518),0.1193700017533548,0.4024094316676553,1.0,0.9987578041426288,1.0,1/52,1.32%,RNASEH2A
